
<html lang="en"     class="pb-page"  data-request-id="36fd702c-e04c-4a3e-bb8d-5214533c4d72"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2014.57.issue-16;ctype:string:Journal Content;article:article:10.1021/jm500749d;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor" /></meta><meta name="dc.Creator" content="Weihe  Zhang" /></meta><meta name="dc.Creator" content="Deborah  DeRyckere" /></meta><meta name="dc.Creator" content="Debra  Hunter" /></meta><meta name="dc.Creator" content="Jing  Liu" /></meta><meta name="dc.Creator" content="Michael A.  Stashko" /></meta><meta name="dc.Creator" content="Katherine A.  Minson" /></meta><meta name="dc.Creator" content="Christopher T.  Cummings" /></meta><meta name="dc.Creator" content="Minjung  Lee" /></meta><meta name="dc.Creator" content="Trevor G.  Glaros" /></meta><meta name="dc.Creator" content="Dianne L.  Newton" /></meta><meta name="dc.Creator" content="Susan  Sather" /></meta><meta name="dc.Creator" content="Dehui  Zhang" /></meta><meta name="dc.Creator" content="Dmitri  Kireev" /></meta><meta name="dc.Creator" content="William P.  Janzen" /></meta><meta name="dc.Creator" content="H. Shelton  Earp" /></meta><meta name="dc.Creator" content="Douglas K.  Graham" /></meta><meta name="dc.Creator" content="Stephen V.  Frye" /></meta><meta name="dc.Creator" content="Xiaodong  Wang" /></meta><meta name="dc.Description" content="We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modificatio..." /></meta><meta name="Description" content="We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modificatio..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 6, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500749d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500749d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500749d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500749d" /></link>
        
    
    

<title>UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500749d" /></meta><meta property="og:title" content="UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0013.jpeg" /></meta><meta property="og:description" content="We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500749d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500749d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500749d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500749d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500749d&amp;href=/doi/10.1021/jm500749d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7031-7041</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500694p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500801r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weihe++Zhang">Weihe Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++DeRyckere">Deborah DeRyckere</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Debra++Hunter">Debra Hunter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Liu">Jing Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Stashko">Michael A. Stashko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katherine+A.++Minson">Katherine A. Minson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+T.++Cummings">Christopher T. Cummings</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minjung++Lee">Minjung Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Trevor+G.++Glaros">Trevor G. Glaros</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dianne+L.++Newton">Dianne L. Newton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Sather">Susan Sather</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dehui++Zhang">Dehui Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dmitri++Kireev">Dmitri Kireev</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+P.++Janzen">William P. Janzen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+Shelton++Earp">H. Shelton Earp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+K.++Graham">Douglas K. Graham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+V.++Frye">Stephen V. Frye</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaodong++Wang">Xiaodong Wang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, <sup>‡</sup>Department of Pharmacology, School of Medicine, and <sup>§</sup>Lineberger Comprehensive Cancer Center, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, Colorado 80045, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">⊥</span> <span class="aff-text">Biological Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 919-843-5486. E-mail: <a href="/cdn-cgi/l/email-protection#5a292c3c28233f1a3f373b3336742f3439743f3e2f"><span class="__cf_email__" data-cfemail="45363323373c20052028242c296b302b266b202130">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Tel: 919-843-8456. E-mail: <a href="/cdn-cgi/l/email-protection#512938303e353e3f2611243f327f343524"><span class="__cf_email__" data-cfemail="d0a8b9b1bfb4bfbea790a5beb3feb5b4a5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500749d&amp;href=/doi/10.1021%2Fjm500749d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7031–7041</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 28, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 May 2014</li><li><span class="item_label"><b>Published</b> online</span>6 August 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 August 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500749d" title="DOI URL">https://doi.org/10.1021/jm500749d</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500749d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5406</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">76</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500749d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Weihe&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;DeRyckere&quot;},{&quot;first_name&quot;:&quot;Debra&quot;,&quot;last_name&quot;:&quot;Hunter&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Stashko&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;A. Minson&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;T. Cummings&quot;},{&quot;first_name&quot;:&quot;Minjung&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Trevor&quot;,&quot;last_name&quot;:&quot;G. Glaros&quot;},{&quot;first_name&quot;:&quot;Dianne&quot;,&quot;last_name&quot;:&quot;L. Newton&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Sather&quot;},{&quot;first_name&quot;:&quot;Dehui&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Dmitri&quot;,&quot;last_name&quot;:&quot;Kireev&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;P. Janzen&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;Shelton Earp&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;K. Graham&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;V. Frye&quot;},{&quot;first_name&quot;:&quot;Xiaodong&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;7031-7041&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500749d&quot;},&quot;abstract&quot;:&quot;We previously reported a potent small molecule Mer tyrosine kinase inhibitor UNC1062. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of UNC1062 to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, 11, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that 11 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500749d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500749d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500749d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500749d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500749d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500749d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500749d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500749d&amp;href=/doi/10.1021/jm500749d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500749d" /></input><a href="/doi/pdf/10.1021/jm500749d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500749d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500749d%26sid%3Dliteratum%253Aachs%26pmid%3D25068800%26genre%3Darticle%26aulast%3DZhang%26date%3D2014%26atitle%3DUNC2025%252C%2Ba%2BPotent%2Band%2BOrally%2BBioavailable%2BMER%252FFLT3%2BDual%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D16%26spage%3D7031%26epage%3D7041%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jmcmar.2014.57.issue-16/production/jmcmar.2014.57.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We previously reported a potent small molecule Mer tyrosine kinase inhibitor <b>UNC1062</b>. However, its poor PK properties prevented further assessment in vivo. We report here the sequential modification of <b>UNC1062</b> to address DMPK properties and yield a new potent and highly orally bioavailable Mer inhibitor, <b>11</b>, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that <b>11</b> has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Drug metabolism and pharmacokinetics (DMPK) are key elements to be optimized in drug development. Poor PK properties have historically been identified as one of the main contributors to failure in advancing new compounds toward approval as medicines, along with drug safety issues and lack of phase II efficacy. On the basis of a survey conducted by the U.S. Food and Drug Administration (FDA) in 1991, 39% of clinical failure resulted from unfavorable PK properties of clinical candidates, including poor bioavailability, high clearance, low solubility, and difficult formulation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Since that time, medicinal chemists have focused on improvement of DMPK in the early drug discovery phase, allowing unsuitable compounds to be filtered out as these properties are optimized. This change was enabled by major improvements utilizing mass spectrometry of unlabeled compounds and has been further facilitated by the introduction of higher throughput in vitro and in vivo DMPK methodologies as well as in silico modeling techniques to help predict the effects that structural changes have on individual PK parameters.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Consequently, by the year 2000, the attrition rate of compounds due to poor DMPK dropped to less than 10%.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although multiple reports of medicinal chemistry efforts to improve DMPK properties of selected compounds exist,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> the process relies heavily on trial and error, and it remains challenging to optimize the DMPK profile for a given compound while retaining the required pharmacological profile. This manuscript presents our approach to improve the DMPK of an in vitro tool compound to generate an orally bioavailable lead targeting two receptor tyrosine kinases, Mer and the Fms-like tyrosine kinase 3 (Flt3).</div><div class="NLM_p last">Mer receptor tyrosine kinase (RTK) belongs to the Tyro3, Axl, and Mer (TAM) family of RTKs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Abnormal expression and activation of Mer has been implicated in the oncogenesis of many human cancers,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> including acute lymphoblastic leukemia (ALL),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> acute myeloid leukemia (AML),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> nonsmall cell lung cancer (NSCLC),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> melanoma,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and glioblastoma,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> where Mer functions to increase cancer cell survival, thereby promoting tumorigenesis and chemoresistance.<a onclick="showRef(event, 'ref7 ref8 ref9 cit10a ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 cit10a ref11">(7-9, 10a, 11)</a> Mer has recently been identified as a potential therapeutic target in leukemia and several types of solid tumors by demonstration that shRNA-mediated Mer inhibition abrogated oncogenic phenotypes, including decreased clonogenic growth, enhanced chemosensitivity, and delayed tumor progression in animal models. Similarly, activating mutations in Flt3, especially internal tandem duplications (ITD) in the juxtamembrane domain, are detected in approximately 30% of adult and 15% of childhood AMLs.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In AML, Flt3 ITD is considered to be a classic oncogenic driver.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Clinical responses to early Flt3 inhibitors were largely limited to transient reductions in peripheral blood and bone marrow blasts.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This has been attributed to insufficient Flt3 inhibitory activity and high toxicity of early compounds due to broad spectrum kinase inhibition.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Subsequently, enhanced potency Flt3 inhibitors with more selective kinase inhibitory profiles have been advanced and have demonstrated significant clinical activity, though none have been approved to date for the treatment of AML.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Since the Mer RTK is aberrantly expressed in ALL, and widely expressed in non-Flt3 mutant AML, an inhibitor demonstrating potent activity against both Mer and Flt3 with selectivity versus other kinases could be widely applicable in leukemias. A compound with this profile would additionally provide a chemical tool to assess the degree to which combined antisurvival and antichemoresistance activity, due to Mer inhibition, can augment inhibition of an oncogenic driver such as the Flt3-ITD mutation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Pyrrolo[2,3-<i>d</i>]pyrimidine Scaffold Improves DMPK</h3><div class="NLM_p">To date, there are only a few kinase-targeted compounds that have been designed intentionally as Mer inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> such as <b>UNC1062</b> (<b>1</b>),<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> while others were developed for different purposes but have Mer inhibitory activity as part of their kinase profiles.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Consequently, none of the latter reported inhibitors are believed to demonstrate pharmacology primarily related to Mer inhibition. We previously showed that compound <b>1</b> is a potent Mer inhibitor (IC<sub>50</sub> 1.1 nM) that blocked Mer phosphorylation in cell-based assays, including 697 B-ALL, BT-12 pediatric rhabdoid tumor, NSCLC, and melanoma cell lines.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> This compound also decreased colony formation in solid tumor cell lines.<a onclick="showRef(event, 'cit9a cit15b'); return false;" href="javascript:void(0);" class="ref cit9a cit15b">(9a, 15b)</a> Surprisingly, kinome profiling revealed that <b>1</b> was also very potent against Flt3 (IC<sub>50</sub> 3.0 nM) despite the relatively low overall homology between Mer and Flt3 kinase domains (42% identity) and significant differences within their ATP binding sites. While Flt3 activity lessens the utility of this lead as a specific chemical probe for Mer kinase,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the potential therapeutic utility of a dual inhibitor is compelling and warranted further development. Separate optimization efforts are being focused on development of even more selective Mer specific compounds. In addition, because of low solubility and absence of oral exposure, compound <b>1</b> was subjected to further chemical improvement to render it suitable for in vivo study. Therefore, the solubility and PK properties of <b>1</b> were addressed, while its activity and kinome profile were maintained in order to advance a Mer/Flt3 inhibitor as an agent to treat AML and ALL.</div><div class="NLM_p">On the basis of the reported X-ray structure of the <b>UNC569</b>/Mer complex,<a onclick="showRef(event, 'cit15a'); return false;" href="javascript:void(0);" class="ref cit15a">(15a)</a> the N2 nitrogen on the pyrazole ring appears to make no specific interactions with the Mer protein and therefore replacement with a carbon to introduce a new core structure, a pyrrolopyrimidine, was investigated. As shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the corresponding analogue of <b>1</b> in the pyrrolopyrimdine scaffold is <b>2</b> and we subsequently discovered that this modification resulted in improved solubility for members of this series during formulation for DMPK studies.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Pyrrolopyrimidine Analogue <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidines</h3><div class="NLM_p">Although there is only one difference (N vs CH) between compounds <b>1</b> and <b>2</b>, the synthesis of <b>2</b> is distinct (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). While the reaction sequence could be varied during the synthesis of pyrazolopyrimidines to enable late-stage variation at each substituent position,<a onclick="showRef(event, 'cit15a ref18'); return false;" href="javascript:void(0);" class="ref cit15a ref18">(15a, 18)</a> the <i>trans</i>-4-hydroxycyclohexyl group was most efficiently attached to the nitrogen at the N1 position of the pyrrole ring early in the synthesis of pyrrolopyrimidines. In addition, the <i>N</i>-alkylation reaction to introduce a <i>trans</i>-4-hydroxycyclohexyl group at the N1 position of <b>1</b> did not work for <b>2</b>. Instead, a Mitsunobu reaction was used to introduce this substituent. As shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, commercially available 5-bromo-2-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>3</b>) was chosen as the starting material and was converted to intermediate <b>5</b> by treatment with mono-TBS protected <i>cis</i>-cyclohexane-1,4-diol <b>4</b> in the presence of freshly prepared cyanomethylenetrimethyl phosphorane (CMMP) in 72% yield.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The S<sub><i>N</i></sub>Ar replacement of the chloride in <b>5</b> with butylamine under microwave irradiation at 150 °C yielded compound <b>6</b>. Suzuki-Miyaura coupling reaction of <b>6</b> with boronic acid <b>7</b> led to compound <b>8</b>. Finally, compound <b>2</b> was obtained in good yield (36% over 3 steps) following removal of the TBS group from <b>8</b> by treatment with 1% HCl.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> PK Property Improvement of Pyrrolo[2,3-<i>d</i>]pyrimidines</h3><div class="NLM_p">It was determined that compound <b>2</b> had similar activity and selectivity profiles (IC<sub>50</sub>’s: Mer, 0.93 nM; Axl, 29 nM; Tyro3, 37 nM; Flt3, 0.69 nM) as <b>1</b> within the TAM family. In addition, <b>2</b> had a lower melting point (215.4–216.2 °C) than <b>1</b> (234.2–234.6 °C), which suggested it would have better solubility.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Indeed, <b>2</b> proved more soluble in DMPK formulations, and following intravenous (iv) or oral (po) administration in mice, <b>2</b> had better oral exposure as compared to <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Mice were chosen for PK studies because they are an appropriate species for determination of therapeutic effects in preclinical leukemia models. Taken together, these data indicated that this scaffold modification approach to improving the PK properties of <b>1</b> was promising. However, the structure of <b>2</b> needed to be fine-tuned to further address PK limitations such as high clearance.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vivo PK Parameters of <b>1</b> and <b>2</b> (<i>n</i> = 3 Mice Per Time Point)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">iv<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">po<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUClast (h μM)</th><th class="colsep0 rowsep0" align="center" char=".">Vss (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUClast (h μM)</th><th class="colsep0 rowsep0" align="center" char=".">%F</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.23</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.78</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">iv Dose at 3 mg/kg.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">po Dose at 3 mg/kg.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">iv Formulation: 7.5% <i>v/v</i><i>N</i>-methyl pyrrolidone; 20% cremophor EL in water.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">iv Formulation: 5% NMP, 5% solutol HS in normal saline.</p></div></div></div><div class="NLM_p">In order to decrease the metabolic clearance of <b>2</b>, we considered modifications at each substituent position to either decrease log <i>P</i>, increase solubility, or decrease cytochrome P450 oxidation while retaining Mer/Flt3 potency. Our hypothesis that P450 oxidation was the dominant route of clearance was based on prior experience with compounds of this log <i>P</i> and molecular weight.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Re-examination of the SAR of the pyrazolopyrimidine scaffold revealed that a <i>trans</i>-4-hydroxycyclohexyl group at the N1 position was optimal, while alternative substitutions at this position either compromised the Mer potency or introduced undesired hERG activity.<a onclick="showRef(event, 'cit15a cit15b'); return false;" href="javascript:void(0);" class="ref cit15a cit15b">(15a, 15b)</a> Therefore, this substituent was fixed. However, SAR in the pyrazolopyrimidines demonstrated that the butylamine group at the C6 position could be replaced with other aliphatic groups and Mer potency retained. Additionally, substituents at the C3 position were positioned toward the solvent front in X-ray cocrystal structures, and we reasoned that different solubilizing groups might be well-tolerated at this position.<a onclick="showRef(event, 'cit15b'); return false;" href="javascript:void(0);" class="ref cit15b">(15b)</a> We therefore proceeded to make simultaneous changes in the C3 and C6 positions in order to rapidly explore their combined effect on DMPK properties in an economically feasible fashion. This modification strategy led to analogues <b>9</b>–<b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which were synthesized using the synthetic route presented in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and enzymatic activity of <b>9</b>–<b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar to <b>2</b>, these analogues were potent against both Mer and Flt3 and had some selectivity over Axl and Tyro3. Compound <b>9</b> incorporated a basic, solubilizing <i>N</i>-methyl piperazine group on the phenyl ring in addition to a 3-fluoro substituent. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, this led to increased oral bioavailability (25%, 3 fold better than <b>2</b>), although the clearance of <b>9</b> was still high (103 mL/min/kg) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). To further improve the metabolic stability of <b>9</b>, we tried to identify and block potential metabolic hot spots in the molecule. Two positions were explored simultaneously: fluorination of the meta position of the sulfonamide group on the phenyl ring and replacement of the butyl side chain of <b>9</b> by cyclopropyl ethyl to create analogue <b>10</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> On the basis of published studies with simple alkanes, the C–H bond strength of the cyclopropyl ring exceeds that of the terminal −CH<sub>3</sub> of the butyl group in <b>9</b> by approximately 7 kcal/mol, suggesting that this substituent might result in diminished P450-mediated oxidation liability for this aliphatic chain.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Indeed, analogue <b>10</b> demonstrated reduced clearance (76 mL/min/kg) and better oral bioavailability (67% vs 25% for <b>9</b>). We hypothesized that removing the sulfonamide group of <b>9</b> might be another way to further increase its solubility and improve PK properties, as sulfonamides are known to have high melting points relative to the corresponding amines.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> As a result, analogue <b>11</b> (<b>UNC2025</b>) was prepared and demonstrated excellent PK properties: low clearance (9.2 mL/min kg), longer half-life (3.8 h), and high oral exposure (100%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Furthermore, the HCl salt of <b>11</b> was highly soluble in normal saline (kinetic solubility: 38 μg/mL, pH = 7.4). Substitution of <b>11</b> with a cyclopropyl ethyl side-chain resulted in <b>12</b>, which demonstrated a further modest decrease in clearance, consistent with some contribution of P450 metabolism of the C3 side-chain to metabolic stability but with very similar overall PK properties to <b>11</b>. With excellent solubility and PK properties, as well as a much less expensive C3 substituent versus <b>12</b>, analogue <b>11</b> was chosen for further studies, including kinome selectivity profiling, cell-based assays, and pharmacodynamic assays using a mouse model to determine the activity of the compound in leukemic blasts in vivo.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Pharmacokinetic Parameters of <b>9</b>–<b>12</b> (<i>n</i> = 3 Mice Per Time Point)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">iv</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max </sub>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUClast (h μM)</th><th class="colsep0 rowsep0" align="center" char=".">Vss (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUClast (h μM)</th><th class="colsep0 rowsep0" align="center" char=".">% F</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.80</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">iv Formulation: 7.5% <i>v</i>/<i>v</i><i>N</i>-methyl pyrrolidone; 40% <i>v</i>/<i>v</i> PEG-400 in normal saline.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">iv Formulation: 5% DMSO, 5% solutol in normal saline.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">iv Formulation: normal saline (0.9% NaCl).</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Scale-up Route for <b>11</b></h3><div class="NLM_p">In vivo studies require gram quantities of compound, and although the synthetic route presented in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was successfully applied to prepare analogs for SAR purposes, it was costly and difficult to perform on a multigram scale, especially the Mitsunobu reaction. Large-scale preparation of the CMMP required for this reaction was also challenging. Therefore, an alternative synthetic route for the large-scale synthesis of <b>11</b> was developed, as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Starting with readily available 5-bromo-2,4-dichloropyrimidine (<b>13</b>), compound <b>14</b> was obtained in quantitative yield after an S<sub><i>N</i></sub>Ar replacement of the 4-chloro group with <i>trans</i>-4-aminocyclohexanol. A Sonogashira coupling reaction between <b>14</b> and ethynyltrimethylsilane yielded intermediate <b>15</b>, which was converted to intermediate <b>16</b> by in situ deprotection of the TMS group and formation of the pyrrole ring in 77% yield. To ease purification in the next few steps, the hydroxyl group of <b>16</b> was protected with a TBS protecting group to yield <b>17</b>. Bromination of <b>17</b> with NBS provided compound <b>5</b> which was converted to <b>6</b> via a second S<sub><i>N</i></sub>Ar replacement reaction with butylamine in high yield. Finally, analogue <b>11</b> was obtained by a Suzuki-Miyaura cross coupling reaction of <b>6</b> with 4-(4-methylpiperazino)methylphenylboronic acid pinacol ester <b>18</b> in the presence of Pd(PPh<sub>3</sub>)<sub>4</sub> and <i>K</i><sub>2</sub>CO<sub>3</sub> followed by deprotection of the TBS group. Although this reaction sequence is longer compared to the one shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, each reaction in this sequence can be easily scaled up and the overall yield is comparable (25% vs 26%). More than 170 g of <b>11</b> have been prepared via this route.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Scale-up Route for <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Selectivity Profiling</h3><div class="NLM_p">As most kinase inhibitors are ATP competitive and bind at a functionally conserved site, an understanding of selectivity within the context of the kinome is important for clinical development for two different but important reasons: (1) it is critical to understand which kinases are inhibited by in vivo concentrations of a drug candidate and contribute to the observed pharmacology in order to target the appropriate patients based on kinase mutational status and preclinical target validation based on shRNA and other gene-based approaches. (2) Multikinase inhibitors have demonstrated significant toxicity, and even though definition of individual kinase “anti-targets” is not well-developed, broad spectrum inhibitors are generally undesirable. Of these two issues, we focused on addressing the kinase pharmacology attributable to <b>11</b> most thoroughly at this stage. As there are numerous methods available for kinome profiling,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> in vitro and in cells, we sought to obtain a data set for correlation across in vitro and cellular assays in order to best predict the pharmacology that would emerge from the kinome profile of <b>11</b>.</div><div class="NLM_p">Therefore, the overall kinome profile of <b>11</b> was assessed in duplicate versus 305 kinases at Carna Biosciences using a microcapillary electrophoresis assay similar to our in house assay. A concentration of 100 nM was used as it is more than 100-fold above the IC<sub>50</sub> determined in our in vitro assay for Mer kinase and would therefore capture other kinases that could be partially inhibited when Mer is inhibited by >90%. Sixty-six kinases were inhibited by more than 50% at this concentration.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> IC<sub>50</sub> values against these kinases were determined at their ATP Km, and the top 10 kinases inhibited by <b>11</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Gratifyingly, of the 305 kinases tested, <b>11</b> inhibited Mer and Flt3 with the greatest potency. Interestingly, the IC<sub>50</sub> values against other kinases did not correlate with a sequence similarity to the Mer protein.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> On the basis of protein sequence within the kinase domain, Met is the closest kinase to the TAM family, and many Met inhibitors also inhibit the TAMs.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, <b>11</b> was more than 700-fold less active against Met compared to Mer, while it was equally potent against Flt3. In addition, the modest degree of selectivity of <b>11</b> for Mer over Axl and Tyro3 in this external profiling was roughly consistent with the selectivity estimated from our determination of their Morrison <i>K</i><sub><i>i</i></sub>’s [Mer, 0.16 ± 0.06 nM (<i>n</i> = 9); Axl, 13.3 ± 8.3 nM (<i>n</i> = 4); Tyro3, 4.67 ± 2.82 nM (<i>n</i> = 5); Flt3, 0.59 ± 0.32 nM (<i>n</i> = 4)].<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The in vitro observation that Mer and Flt3 were the kinases most potently inhibited by <b>11</b> was confirmed for Mer kinase in B-ALL 697 cell lysates using the ATP ActivX probe assay,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> where it demonstrated an IC<sub>50</sub> of 0.05 nM for Mer (although the redundancy of Mer and Tyro3 peptides does not distinguish these kinases). Despite the basic differences between these two assays, both indicated that Mer was a primary target for <b>11</b>. Reflecting on the selectivity considerations discussed above, we were curious to assess whether the potency of <b>11</b> versus the 8 other kinases in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (or kinases even less potently inhibited) could contribute significantly to its pharmacology. To begin to address this question, we decided to examine how well in vitro potency translated to inhibition of phospho-protein signaling in cells where the presence of serum protein, high intercellular concentrations of ATP, and cellular membrane permeability can significantly modulate compound activity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Carna IC<sub>50</sub> of the Top 10 kinases and Met kinase Inhibited by <b>11</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Kinase</th><th class="colsep0 rowsep0" align="center" char=".">FLT3</th><th class="colsep0 rowsep0" align="center" char=".">MER</th><th class="colsep0 rowsep0" align="center" char=".">AXL</th><th class="colsep0 rowsep0" align="center" char=".">TRKA</th><th class="colsep0 rowsep0" align="center" char=".">TRKC</th><th class="colsep0 rowsep0" align="center" char=".">QIK</th><th class="colsep0 rowsep0" align="center" char=".">TYRO3</th><th class="colsep0 rowsep0" align="center" char=".">SLK</th><th class="colsep0 rowsep0" align="center" char=".">NuaK1</th><th class="colsep0 rowsep0" align="center" char=".">KIT</th><th class="colsep0 rowsep0" align="center" char=".">Met</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="char" char=".">1.67</td><td class="colsep0 rowsep0" align="char" char=".">4.38</td><td class="colsep0 rowsep0" align="char" char=".">5.75</td><td class="colsep0 rowsep0" align="char" char=".">5.83</td><td class="colsep0 rowsep0" align="char" char=".">6.14</td><td class="colsep0 rowsep0" align="char" char=".">7.97</td><td class="colsep0 rowsep0" align="char" char=".">8.18</td><td class="colsep0 rowsep0" align="char" char=".">364</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sequence identity</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular Kinase Inhibition</h3><div class="NLM_p">In 697 B-ALL cells, <b>11</b> mediated potent inhibition of Mer phosphorylation with an IC<sub>50</sub> of 2.7 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Similarly, in Flt3-ITD positive Molm-14 acute myeloid leukemia cells, treatment with <b>11</b> resulted in decreased phosphorylation of Flt3 with an IC<sub>50</sub> of 14 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This phospho-protein readout is predictive of biological consequences attributable to these kinases, as incubation with <b>11</b> resulted in significant inhibition of colony formation in soft agar cultures of the A549 NSCLC and Molm-14 AML cell lines, which are known to be dependent on Mer<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and Flt3,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> respectively, for optimal expression of oncogenic phenotypes (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In contrast, a negative control compound <b>20</b>, a structurally similar but much weaker Mer and Flt3 inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C), had no significant effect on colony-forming potential in either cell line. It is noteworthy that the correlation of biological effect as compared to phospho-protein inhibition IC<sub>50</sub> correlates most closely for the ITD driver mutation in Flt3 (EC<sub>50</sub> for colony formation inhibition = IC<sub>50</sub> for p-Flt3 inhibition, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), while the biological effect attributed to Mer inhibition is right-shifted as compared to phospho-protein inhibition (EC<sub>50</sub> for colony formation inhibition > IC<sub>50</sub> for p-Mer inhibition, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Since it is difficult to reject the hypothesis that this right-shift is due to the need to inhibit a kinase other than Mer in the NSCLC colony formation assay, we decided to further explore the potency of <b>11</b> versus other kinases appearing in the selectivity data of Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>11</b> Inhibits activation of Mer in acute leukemia cells. 697 Cells were treated with the indicated concentrations of <b>11</b> for 1 h. Pervanadate was added to cultures for 3 min to stabilize the phosphorylated form of Mer. Mer was immunoprecipitated from cell lysates, and total MER protein and Mer phosphoprotein (p-Mer) were detected by immunoblot. (A) Representative Western blots. (B) Relative levels of p-Mer and Mer proteins were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> = 2.7 nM with a 95% confidence interval from 1.8 to 4.2 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>11</b> Inhibits activation of Flt3 in acute leukemia cells. Flt3-ITD positive Molm-14 cells were treated with the indicated concentrations of <b>11</b> for 1 h. Pervanadate was added to cultures for 3 min to stabilize the phosphorylated form of Flt3. Flt3 was immunoprecipitated from cell lysates and total Flt3 protein and Flt3 phosphoprotein (p-Flt3) were detected by immunoblot. (A) Representative Western blots. (B) Relative levels of p-Flt3 and Flt3 proteins were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> = 14 nM with a 95% confidence interval from 8.4 to 24 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>11</b> Inhibits colony formation in Mer-dependent and Flt3-dependent tumor cell lines. (A) A549 NSCLC cells or (B) Molm-14 AML cells were cultured in 0.35% soft agar overlaid with medium containing <b>11</b>, a negative control (<b>20</b>) (300 nM for A549 NSCLC cells and 50 nM for Molm-14 AML cells), or vehicle. Medium and compounds were refreshed 3 times per week. Colonies were stained and counted. Mean values ± standard error derived from 3 to 4 independent experiments are shown. Statistically significant differences were determined using the student’s paired <i>t</i> test (* <i>p</i> < 0.05, ** <i>p</i> ≤ 0.005, ***<i>P</i> < 0.0005 relative to vehicle only). (C) Structure and enzymatic IC<sub>50</sub>’s of compound <b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of their high degree of similarity to Mer, our overall interest in the TAM family, and the significant inhibition by <b>11</b> in enzymatic assays, Axl and Tyro3 were chosen from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> as sentinel kinases to further evaluate the selectivity of <b>11</b> in cell-based phospho-protein assays. In order to facilitate this comparison in a systematic fashion, chimeric proteins consisting of the extracellular and transmembrane domains from the epidermal growth factor receptor (EGFR) and the intracellular domain from Mer, Axl, or Tyro3 were expressed in 32D cells such that all three proteins could be identically stimulated with the EGF ligand for direct comparison. In this system, <b>11</b> mediated potent inhibition of the chimeric Mer protein with an IC<sub>50</sub> of 2.7 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), identical to its activity against endogenous Mer in 697 cells and consistent with the validity of this system for evaluation of selectivity. In contrast, much higher concentrations of <b>11</b> were required to effectively inhibit phosphorylation of Axl (IC<sub>50</sub> = 122 nM) and Tyro3 (IC<sub>50</sub> = 301 nM). Thus, the approximately 4- to 13-fold difference in activity for Mer relative to Axl and Tyro3 in Carna IC<sub>50</sub> profiling (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) translated to 40- to 100-fold selectivity for Mer over Axl and Tyro3, respectively, in phospho-protein readouts in cell-based assays. The simplest explanation for this difference in fold selectivity is that the Mer IC<sub>50</sub> (0.46 nM) slightly underestimates the true potency of <b>11</b> as seen when the method of Morrison is used to determine its <i>K</i><sub><i>i</i></sub>, which is equal to 160 picomolar, while the Carna IC<sub>50</sub>’s are more reflective of the potency of <b>11</b> versus Flt3, Axl, and Tyro3. In fact, a plot of in vitro potency versus cellular phospho-protein potency that utilizes the Mer <i>K</i><sub><i>i</i></sub> and the Carna IC<sub>50</sub>’s for Flt3, Axl, and Tyro3 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) results in a correlation coefficient (<i>R</i><sup>2</sup>) of 0.98 with a predicted 50-fold shift in potency in the cellular assay environment relative to Carna IC<sub>50</sub>’s. With this correlation in mind, we proceeded to evaluate how effectively <b>11</b> could inhibit Mer phosphorylation in vivo in order to establish pharmacodynamic evidence of target engagement and assess the drug concentrations required and how they relate to potential engagement of other kinase targets.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>11</b> Selectively inhibits Mer in cell-based assays. 32D Cells stably expressing chimeric receptors consisting of the extracellular ligand-binding and transmembrane domains of the EGF receptor and the intracellular kinase domain of Mer, Axl, or Tyro3 were treated with <b>11</b> or vehicle for 1 h prior to stimulation for 15 min with 100 ng/mL EGF. Chimeric proteins were immunoprecipitated from whole cell lysates and phospho-tyrosine-containing and total proteins were detected by Western blot. (A) Representative Western blots are shown. (B and C) Phosphorylated and total protein levels were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> values and 95% confidence intervals were determined by nonlinear regression and are 2.7 nM (1.7–4.2 nM) for Mer, 122 nM (64–230 nM) for Axl, and 301 nM (110–820 nM) for Tyro3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Correlation of in vitro and phospho-protein potency for <b>11</b> versus Mer, Flt3, Axl, and Tyro3 utilizing the Morrison <i>K</i><sub>i</sub> for Mer and the IC<sub>50</sub>’s from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for all others.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Pharmacodynamic Evaluation</h3><div class="NLM_p">To determine whether <b>11</b> can mediate inhibition of target proteins in vivo, we generated mice with human leukemia xenografts. In these mice, a single 3 mg/kg dose of <b>11</b> administered orally was sufficient to decrease Mer phospho-protein levels in bone marrow leukemia cells by greater than 90% (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The plasma concentration of <b>11</b> at the time of bone marrow collection can be estimated to be approximately 1.6 μM based on the PK data shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. In order to relate this concentration to the IC<sub>50</sub> versus p-Mer, we determined the plasma protein binding of <b>11</b> in mice to be 98.6% ± 0.4% (<i>n</i> = 3), resulting in a free fraction concentration of approximately 22 nM, 30 min after a 3 mg/kg oral dose. As this is roughly 10-fold above the cellular IC<sub>50</sub> versus p-Mer (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), inhibition of p-Mer in vivo by >90% at a 3 mg/kg oral dose is consistent with expectations at a 30 min time point after dosing (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for calculation of % <i>I</i> versus free fraction based on <i>K</i><sub><i>i</i></sub> and cellular potency for <b>11</b>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>11</b> Inhibits Mer phosphorylation in bone marrow leukemia cells in vivo. NOD/SCID/gamma mice were transplanted with 697 acute leukemia cells and allowed to engraft for 14 days. Leukemic mice were then treated with a single 3 mg/kg dose of <b>11</b> or saline vehicle administered by oral gavage. Femurs were collected 30 min later. Bone marrow cells were flushed and incubated for 10 min in the presence of 20% FBS and pervanadate phosphatase inhibitor to stabilize Mer phosphoprotein. Cell lysates were prepared and Mer was immunoprecipitated. (A) Phosphorylated and total Mer proteins were detected by Western blot. (B) Phosphorylated and total Mer protein levels were determined by densitometry. Mean values ± standard error are shown. Mer phosphoprotein was significantly decreased in leukemia cells collected from mice treated with <b>11</b> relative to mice treated with vehicle (0.07 ± 0.04 versus 1.00 ± 0.29; *(* <i>p</i> = 0.01, student’s unpaired <i>t</i> test; <i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These data for in vivo inhibition of p-Mer enable an estimate of the kinome pharmacology profile of <b>11</b> in vivo using the following assumptions: (1) in vitro potency translates to cellular phospho-protein potency for all kinases in the same way as for the TAMs and Flt3 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>); (2) pharmacological effects in vivo resulting from inhibition of a particular kinase require >90% inhibition of phospho-protein signaling from that kinase; (3) selectivity estimated at <i>C</i><sub>max</sub> is indicative of overall pharmacological selectivity. Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> is a ranked plot of the kinases predicted to be most potently inhibited by <b>11</b> versus the free concentration required for 90% inhibition. This rank order differs from that of Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> due to the effect of varying ATP <i>K</i><sub>m</sub>’s on the predicted inhibition of each kinase in vivo. For example, KIT has a particularly high <i>K</i><sub>m</sub> for ATP (370 μM) and is therefore predicted to be relatively easy to inhibit. At an oral dose of 3 mg/kg, <b>11</b> results in a <i>C</i><sub>max</sub> at 30 min of 22 nM (vertical line in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Only Flt3 and Mer are inhibited by 90%, while TRKA, KIT, and Axl kinases are predicted to be partially inhibited at this dose. Tyro3 and the other kinases are minimally inhibited and would require free concentrations at least 10-fold higher for >90% inhibition to occur. Therefore, the pharmacology of <b>11</b> is most likely to be dominated by effects on Mer and Flt3, while Axl pharmacology can serve as an indicator of potential activity emerging from partial inhibition of other kinases such as KIT and TRKA. With the use of the data from a recent study of the selectivity of nine clinically approved RTK inhibitors for comparison,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>11</b> falls in the midground of selectivity profiles, being more selective than dasatinib, less selective than imatinib, and similar to pazopanib in terms of the number of other kinases inhibited when the most potently inhibited kinases are >90% inhibited (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for comparisons). Additionally, the unique rank order of kinases inhibited by <b>11</b> provides the basis for differentiation compared to these other RTK inhibitors, both for effectiveness when targeting Mer and Flt3 and perhaps the side effect profile. While further efficacy studies and DMPK assessments in treated mice will be needed to fully validate the kinome basis for the preclinical pharmacology of <b>11</b>, this analysis provides a transparent and quantitative basis for study design and hypothesis testing.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Predicted free concentration of <b>11</b> required in vivo for 90% inhibition of the top 10 kinases from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The vertical line corresponds to the measured free concentration of <b>11</b> at 30 min following a 3 mg/kg oral dose (Cmax, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). (See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for methods and comparison to clinically approved RTK profiles assessed in the same manner.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, we have successfully generated a potent, pharmacologically selective, and orally bioavailable Mer/Flt3 dual inhibitor <b>11</b> with improved solubility and DMPK properties relative to a previous in vitro tool compound <b>2</b>. Importantly, oral treatment with <b>11</b> resulted in effective target inhibition in bone marrow leukemia cells in an animal model. A cost-effective synthetic route for preparation of <b>11</b> was also developed to support in vivo preclinical studies.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Details on the synthesis of all compounds are given in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The purity of all tested compounds was determined by LC–MS and NMR to be >95%.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Kinome Profiling Using ActivX ATP/ADP Probes</h3><div class="NLM_p last">Cellular lysate, inhibitor treatment, labeling reactions, digestion, and peptide capture were performed according to manufacturer’s published protocols with modifications detailed below. Briefly, 697 B-ALL cells were gently pelleted, washed twice with PBS, lysed using MPER supplemented with HALT protease/phosphatase inhibitor cocktail (Pierce), and subjected to Zeba (Pierce) gel filtration spin columns to remove residual ATP and ADP. Following filtration, the final protein concentration was adjusted to 5.0 mg/mL using reaction buffer and supplemented with additional 1X HALT protease and phosphatase inhibitor cocktail. Lysate was aliquoted, snap frozen in liquid nitrogen, and stored at −80 °C until labeling. Prior to labeling, 2.5 mg of total lysate (final volume, 500 μL) was thawed to room temperature and treated with 10 μL of 1 M MnCl<sub>2</sub> for 1 min. Then the lysate was treated with or without <b>11</b> [0, 0.01, 0.1, 1.0, 10, 100, and 1000 nM] for 10 min. Following treatment, the ATP probe was added for 10 min at a final concentration of 5 μM. The labeling reaction was quenched with 500 μL of 10 M urea in MPER, 10 μL of 500 mM DTT, and heated to 65 °C for 30 min with shaking. Samples were cooled to room temperature and alkylated with 40 μL of a 1 M iodoacetamide solution for 30 min protected from light. The solution was then subjected to Zeba (Pierce) gel filtration and digested with 20 μg of trypsin at 37 °C for 2 h with shaking. 50 μL of a 50% high capacity streptavidin agarose slurry was added and allowed to incubate for 1 h at room temperature with constant mixing on a rotator. Agarose beads were then captured, washed, and eluted. Purified peptides were frozen, lyophilized, and stored at −80 °C. Immediately before mass spectrometric analysis, peptides were resuspended in 25 μL of 0.1% TFA. Details on mass spectrometry analysis and data analysis are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell-Based Assays for Kinase Inhibition</h3><div class="NLM_p">697 B-ALL cells and Molm-14 AML cells were cultured in the presence of <b>11</b> or vehicle-only for 1.0 h. Pervanadate solution was prepared fresh by combining 20 mM sodium orthovanadate in 0.9× PBS in a 1:1 ratio with 0.3% (w/w) hydrogen peroxide in PBS for 15–20 min at room temperature. Cultures were treated with 120 μM pervanadate for 3 min prior to collection, and cell lysates were prepared in 50 mM HEPES (pH 7.5), 150 mM NaCl, 10 mM EDTA, 10% glycerol, and 1% Triton X-100, supplemented with protease inhibitors (Roche Molecular Biochemicals, no. 11836153001). Mer and Flt3 proteins were immunoprecipitated with anti-Mer (R&D Systems, no. MAB8912) or anti-Flt3 (Santa Cruz Biotechnology no. sc-480) antibody and Protein G agarose beads (InVitrogen). Phospho-proteins were detected by Western blot using an antiphospho-Mer antibody raised against a peptide derived from the triphosphorylated activation loop of Mer<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (Phopshosolutions, Inc.) or an antibody specific for phosphorylated Flt3 (Cell Signaling Technology, no. 3461). Nitrocellulose membranes were stripped and total proteins were detected using a second anti-Mer antibody (Epitomics Inc., no. 1633-1) or anti-Flt3 antibody (Santa Cruz Biotechnology no. sc-480). Relative phosphorylated and total protein levels were determined by densitometry using ImageJ, and IC<sub>50</sub> values were calculated by nonlinear regression.</div><div class="NLM_p last">32D Cells expressing a chimeric EGFR-Mer, EGFR-Axl, or EGFR-Tyro3 receptor were cultured in the presence of <b>11</b> or vehicle-only for 1.0 h before stimulation with 100 ng/mL EGF (BD Biosciences no. 354010) for 15 min. Cells were centrifuged at 1000<i>g</i> for 5 min and washed with 1× PBS. Cell lysates were prepared in 20 mM HEPES (pH 7.5), 50 mM NaF, 500 mM NaCl, 5.0 mM EDTA, 10% glycerol, and 1% Triton X-100, supplemented with protease inhibitors (10 μg/mL leupeptin, 10 μg/mL phenylmethylsulfonyl fluoride, and 20 μg/mL aprotinin) and phosphatase inhibitors (50 mM NaF and 1.0 mM sodium orthovanadate). Mer protein was immunoprecipitated using a custom polyclonal rabbit antisera raised against a peptide derived from the C-terminal catalytic domain of Mer and Protein A agarose beads (Santa Cruz Biotechnology). Axl and Tyro3 proteins were immunoprecipitated using an antibody directed against a FLAG epitope engineered into the chimeric proteins (Sigma-Aldrich, no. F1804). Phosphotyrosine-containing proteins were detected by Western blot with a monoclonal HRP-conjugated antiphosphotyrosine antibody (Santa Cruz Biotechnology, no. sc-508). Antibodies were stripped from membranes, and total proteins were detected with the same antibodies used for immunoprecipitation.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Soft Agar Colony Formation Assays</h3><div class="NLM_p last">A549 or Molm-14 cells were cultured in 1.5 mL of 0.35% soft agar containing 1× RPMI medium and 10% FBS and overlaid with 2.0 mL of 1× RPMI medium containing 10% FBS and the indicated concentrations of <b>11</b> or DMSO vehicle only. Medium and <b>11</b> or vehicle were refreshed 3 times per week. Colonies were stained with nitrotetrazolium blue chloride (Sigma-Aldrich, no. N6876) and counted after 2 weeks.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacodynamic Studies</h3><div class="NLM_p last">NOD.Cg-<i>Prkdc</i><sup><i>scid</i></sup><i>Il2rg</i><sup><i>tm1Wjl</i></sup>/SzJ (NSG) mice were transplanted with 2 × 10<sup>6</sup> 697 B-ALL cells by intravenous injection into the tail vein, and leukemia was established for 14 days prior to treatment with a single dose of 3 mg/kg <b>11</b> or an equivalent volume (10 mL/kg) of saline vehicle. Pervanadate solution was prepared fresh, as described above. Femurs were collected from mice 30 min after treatment, and bone marrow cells were flushed with 1 mL of room temperature RPMI medium + 20% FBS + 1 μM MgCl<sub>2</sub> + 100 untis/ml DNase + 240 μM pervanadate and incubated at room temperature in the dark for 10 min. Bone marrow cells were collected by centrifugation at 4 °C, lysates were prepared, Mer protein was immunoprecipitated, and total and phospho-Mer proteins were detected and quantitated by Western blot, as described above.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/jm500749d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and characterization of all compounds and biological methods. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500749d/suppl_file/jm500749d_si_001.pdf">jm500749d_si_001.pdf (636.11 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500749d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen V. Frye</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6013160612190520050d01090c4e150e034e050415"><span class="__cf_email__" data-cfemail="fd8e8b9b8f8498bd98909c9491d388939ed3989988">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaodong Wang</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91e9f8f0fef5feffe6d1e4fff2bff4f5e4"><span class="__cf_email__" data-cfemail="5f27363e303b3031281f2a313c713a3b2a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weihe Zhang</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah DeRyckere</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debra Hunter</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Liu</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Stashko</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine A. Minson</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher T. Cummings</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minjung Lee</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trevor G. Glaros</span> - <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dianne L. Newton</span> - <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Sather</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dehui Zhang</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitri Kireev</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William P. Janzen</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. Shelton Earp</span> - <span class="hlFld-Affiliation affiliation">†Center for Integrative Chemical Biology and Drug Discovery, Division
of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, ‡Department of Pharmacology,
School of Medicine, and §Lineberger Comprehensive Cancer Center, Department
of Medicine, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Biological
Testing Branch, Developmental Therapeutics Program, Leidos Biomedical Research, Inc, Frederick National Laboratory for
Cancer Research, Frederick, Maryland 21702, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas K. Graham</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, School of Medicine, University
of Colorado Denver, Aurora, Colorado 80045, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): D.K., W.P.J., H.S.E., D.K.G., S.V.F., and X.W. have stock in Meryx, Inc.<br /></br></div></li></ul></div><div class="ack" id="ACK-d4816e2080-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38454" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38454" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Nancy Cheng, Ms. Wendy M. Stewart, and Ms. Yingqiu Zhou for their help with MCE assays. This work was supported by the University Cancer Research Fund and Federal Funds from the National Cancer Institute, National Institute of Health, under Contract HHSN261200800001E. Additional support was provided by NIH 1R01CA137078 (D.G.) and the BCRF (H.S.E.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35162" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35162" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the Pharmaceutical Industry Reduce Attrition Rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&issue=8&author=I.+Kolaauthor=J.+Landis&title=Can+the+Pharmaceutical+Industry+Reduce+Attrition+Rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520Pharmaceutical%2520Industry%2520Reduce%2520Attrition%2520Rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D8%26spage%3D711%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Palmer, A. M.</span><span> </span><span class="NLM_article-title">New Horizons in Drug Metabolism, Pharmacokinetics and Drug Discovery</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=12682673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2lsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=57-62&issue=1&author=A.+M.+Palmer&title=New+Horizons+in+Drug+Metabolism%2C+Pharmacokinetics+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New horizons in drug metabolism, pharmacokinetics and drug discovery</span></div><div class="casAuthors">Palmer, Alan M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Along with minimal toxicity, good drug metab. and pharmacokinetic (DMPK) properties are essential for the clin. success of a drug candidate.  A major cause of failure of orally administered drugs during their development is the discovery that in humans they have low intestinal absorption and/or high clearance causing low and variable bioavailability.  In addn., drug interactions and the presence of active metabolites can prevent or complicate their successful development.  With poor pharmacokinetics it can be difficult to achieve a suitable dosage regimen for the required pharmacodynamic action.  The main role of DMPK in discovery is, therefore, the prediction of human pharmacokinetics and metab.  Reducing the rate of attrition during drug discovery and development is now considered essential, particularly as it is now possible to screen an ever-greater no. of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWHp2pRnOBHbVg90H21EOLACvtfcHk0lg52Pmy7kqyOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2lsrk%253D&md5=48ded4f26a1863ae96c1b2e688269009</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26atitle%3DNew%2520Horizons%2520in%2520Drug%2520Metabolism%252C%2520Pharmacokinetics%2520and%2520Drug%2520Discovery%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2003%26volume%3D16%26issue%3D1%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bo, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caenepeel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberich, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, C. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidasani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. E.</span><span> </span><span class="NLM_article-title">Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7796</span><span class="NLM_x">–</span> <span class="NLM_lpage">7816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300846z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7796-7816&issue=17&author=M.+H.+Normanauthor=K.+L.+Andrewsauthor=Y.+Y.+Boauthor=S.+K.+Bookerauthor=S.+Caenepeelauthor=V.+J.+Ceeauthor=N.+D.+D%E2%80%99Angeloauthor=D.+J.+Freemanauthor=B.+J.+Herberichauthor=F.-T.+Hongauthor=C.+L.+M.+Jacksonauthor=J.+Jiangauthor=B.+A.+Lanmanauthor=L.+Liuauthor=J.+D.+McCarterauthor=E.+L.+Mulladyauthor=N.+Nishimuraauthor=L.+H.+Pettusauthor=A.+B.+Reedauthor=T.+S.+Miguelauthor=A.+L.+Smithauthor=M.+M.+Stecauthor=S.+Tadesseauthor=A.+Taskerauthor=D.+Aidasaniauthor=X.+Zhuauthor=R.+Subramanianauthor=N.+A.+Tamayoauthor=L.+Wangauthor=D.+A.+Whittingtonauthor=B.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=K.+Yangauthor=L.+Zalamedaauthor=N.+Zhangauthor=P.+E.+Hughes&title=Selective+Class+I+Phosphoinositide+3-Kinase+Inhibitors%3A+Optimization+of+a+Series+of+Pyridyltriazines+Leading+to+the+Identification+of+a+Clinical+Candidate%2C+AMG+511"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm300846z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300846z%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBo%26aufirst%3DY.%2BY.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DFreeman%26aufirst%3DD.%2BJ.%26aulast%3DHerberich%26aufirst%3DB.%2BJ.%26aulast%3DHong%26aufirst%3DF.-T.%26aulast%3DJackson%26aufirst%3DC.%2BL.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DMiguel%26aufirst%3DT.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DStec%26aufirst%3DM.%2BM.%26aulast%3DTadesse%26aufirst%3DS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DAidasani%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DTamayo%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHughes%26aufirst%3DP.%2BE.%26atitle%3DSelective%2520Class%2520I%2520Phosphoinositide%25203-Kinase%2520Inhibitors%253A%2520Optimization%2520of%2520a%2520Series%2520of%2520Pyridyltriazines%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Clinical%2520Candidate%252C%2520AMG%2520511%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7796%26epage%3D7816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barlind, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birtles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannesson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noeske, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redzic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinblad, J.</span><span> </span><span class="NLM_article-title">Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10610</span><span class="NLM_x">–</span> <span class="NLM_lpage">10629</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301296t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10610-10629&issue=23&author=J.+G.+Barlindauthor=U.+A.+Bauerauthor=A.+M.+Birchauthor=S.+Birtlesauthor=L.+K.+Buckettauthor=R.+J.+Butlinauthor=R.+D.+M.+Daviesauthor=J.+W.+Erikssonauthor=C.+D.+Hammondauthor=R.+Hovlandauthor=P.+Johannessonauthor=M.+J.+Johanssonauthor=P.+D.+Kemmittauthor=B.+T.+Lindmarkauthor=P.+M.+Gutierrezauthor=T.+A.+Noeskeauthor=A.+Nordinauthor=C.+J.+O%E2%80%99Donnellauthor=A.+U.+Peterssonauthor=A.+Redzicauthor=A.+V.+Turnbullauthor=J.+Vinblad&title=Design+and+Optimization+of+Pyrazinecarboxamide-Based+Inhibitors+of+Diacylglycerol+Acyltransferase+1+%28DGAT1%29+Leading+to+a+Clinical+Candidate+Dimethylpyrazinecarboxamide+Phenylcyclohexylacetic+Acid+%28AZD7687%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm301296t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301296t%26sid%3Dliteratum%253Aachs%26aulast%3DBarlind%26aufirst%3DJ.%2BG.%26aulast%3DBauer%26aufirst%3DU.%2BA.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBirtles%26aufirst%3DS.%26aulast%3DBuckett%26aufirst%3DL.%2BK.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DEriksson%26aufirst%3DJ.%2BW.%26aulast%3DHammond%26aufirst%3DC.%2BD.%26aulast%3DHovland%26aufirst%3DR.%26aulast%3DJohannesson%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DLindmark%26aufirst%3DB.%2BT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DNoeske%26aufirst%3DT.%2BA.%26aulast%3DNordin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPetersson%26aufirst%3DA.%2BU.%26aulast%3DRedzic%26aufirst%3DA.%26aulast%3DTurnbull%26aufirst%3DA.%2BV.%26aulast%3DVinblad%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Optimization%2520of%2520Pyrazinecarboxamide-Based%2520Inhibitors%2520of%2520Diacylglycerol%2520Acyltransferase%25201%2520%2528DGAT1%2529%2520Leading%2520to%2520a%2520Clinical%2520Candidate%2520Dimethylpyrazinecarboxamide%2520Phenylcyclohexylacetic%2520Acid%2520%2528AZD7687%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10610%26epage%3D10629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coteron, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mazouni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belen Jimenez-Diaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span> </span><span class="NLM_article-title">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5540</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200592f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5540-5561&issue=15&author=J.+M.+Coteronauthor=M.+Marcoauthor=J.+Esquiviasauthor=X.+Dengauthor=K.+L.+Whiteauthor=J.+Whiteauthor=M.+Koltunauthor=F.+El+Mazouniauthor=S.+Kokkondaauthor=K.+Katneniauthor=R.+Bhamidipatiauthor=D.+M.+Shacklefordauthor=I.+Angulo-Barturenauthor=S.+B.+Ferrerauthor=M.+Belen+Jimenez-Diazauthor=F.-J.+Gamoauthor=E.+J.+Goldsmithauthor=W.+N.+Charmanauthor=I.+Bathurstauthor=D.+Floydauthor=D.+Matthewsauthor=J.+N.+Burrowsauthor=P.+K.+Rathodauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Structure-Guided+Lead+Optimization+of+Triazolopyrimidine-Ring+Substituents+Identifies+Potent+Plasmodium+falciparum+Dihydroorotate+Dehydrogenase+Inhibitors+with+Clinical+Candidate+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span></div><div class="casAuthors">Coteron, Jose M.; Marco, Maria; Esquivias, Jorge; Deng, Xiaoyi; White, Karen L.; White, John; Koltun, Maria; El Mazouni, Farah; Kokkonda, Sreekanth; Katneni, Kasiram; Bhamidipati, Ravi; Shackleford, David M.; Angulo-Barturen, Inigo; Ferrer, Santiago B.; Jimenez-Diaz, Maria Belen; Gamo, Francisco-Javier; Goldsmith, Elizabeth J.; Charman, William N.; Bathurst, Ian; Floyd, David; Matthews, David; Burrows, Jeremy N.; Rathod, Pradipsinh K.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5540-5561</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance.  In an effort to identify new potential antimalarials, we have undertaken a lead optimization program around our previously identified triazolopyrimidine-based series of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.  The X-ray structure of PfDHODH was used to inform the medicinal chem. program allowing the identification of a potent and selective inhibitor (DSM265) that acts through DHODH inhibition to kill both sensitive and drug resistant strains of the parasite.  This compd. has similar potency to chloroquine in the humanized SCID mouse P. falciparum model, can be synthesized by a simple route, and rodent pharmacokinetic studies demonstrated it has excellent oral bioavailability, a long half-life and low clearance.  These studies have identified the first candidate in the triazolopyrimidine series to meet previously established progression criteria for efficacy and ADME properties, justifying further development of this compd. toward clin. candidate status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpPPR2Tcs9rVg90H21EOLACvtfcHk0lgPtQNUOxQNkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D&md5=d92f71aeda04fbbbbcd8905a657df011</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Fjm200592f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200592f%26sid%3Dliteratum%253Aachs%26aulast%3DCoteron%26aufirst%3DJ.%2BM.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DBhamidipati%26aufirst%3DR.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%2BB.%26aulast%3DBelen%2BJimenez-Diaz%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DStructure-Guided%2520Lead%2520Optimization%2520of%2520Triazolopyrimidine-Ring%2520Substituents%2520Identifies%2520Potent%2520Plasmodium%2520falciparum%2520Dihydroorotate%2520Dehydrogenase%2520Inhibitors%2520with%2520Clinical%2520Candidate%2520Potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D15%26spage%3D5540%26epage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Metabolism-Guided Drug Design</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=631-652&issue=4&author=A.+F.+Stepanauthor=V.+Mascittiauthor=K.+Beaumontauthor=A.+S.+Kalgutkar&title=Metabolism-Guided+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMetabolism-Guided%2520Drug%2520Design%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D631%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">St Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">6002</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&issue=13&author=D.+J.+St+Jeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0li-knpORD99Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godowski, P. J.</span><span> </span><span class="NLM_article-title">Identification of Gas6 as a Ligand for Mer, a Neural Cell Adhesion Molecule Related Receptor Tyrosine Kinase Implicated in Cellular Transformation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2033-2039&issue=17&author=J.+Chenauthor=K.+Careyauthor=P.+J.+Godowski&title=Identification+of+Gas6+as+a+Ligand+for+Mer%2C+a+Neural+Cell+Adhesion+Molecule+Related+Receptor+Tyrosine+Kinase+Implicated+in+Cellular+Transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DK.%26aulast%3DGodowski%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520of%2520Gas6%2520as%2520a%2520Ligand%2520for%2520Mer%252C%2520a%2520Neural%2520Cell%2520Adhesion%2520Molecule%2520Related%2520Receptor%2520Tyrosine%2520Kinase%2520Implicated%2520in%2520Cellular%2520Transformation%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26issue%3D17%26spage%3D2033%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Linger, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=35-83&author=R.+M.+A.+Lingerauthor=A.+K.+Keatingauthor=H.+S.+Earpauthor=D.+K.+Graham&title=TAM+Receptor+Tyrosine+Kinases%3A+Biologic+Functions%2C+Signaling%2C+and+Potential+Therapeutic+Targeting+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%2BA.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DTAM%2520Receptor%2520Tyrosine%2520Kinases%253A%2520Biologic%2520Functions%252C%2520Signaling%252C%2520and%2520Potential%2520Therapeutic%2520Targeting%2520in%2520Human%2520Cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2008%26volume%3D100%26spage%3D35%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vankayalapati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span> </span><span class="NLM_article-title">Targeting Axl and Mer Kinases in Cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1535-7163.MCT-11-0116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=21933973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ylsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1763-1773&author=A.+Vermaauthor=S.+L.+Warnerauthor=H.+Vankayalapatiauthor=D.+J.+Bearssauthor=S.+Sharma&title=Targeting+Axl+and+Mer+Kinases+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Axl and Mer Kinases in Cancer</span></div><div class="casAuthors">Verma, Anupam; Warner, Steven L.; Vankayalapati, Hariprasad; Bearss, David J.; Sharma, Sunil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1763-1773</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTK) are cell-surface transmembrane receptors that contain regulated kinase activity within their cytoplasmic domain and play an important role in signal transduction in both normal and malignant cells.  The mammalian TAM RTK family includes 3 closely related members: Tyro-3, Axl, and Mer.  Overexpression or ectopic expression of the TAM receptors has been detected in a wide array of human cancers.  Growth arrest-specific gene 6 has been identified as the major ligand for these TAM RTKs, and its binding to the receptors has been shown to promote proliferation and survival of cancer cells in vitro.  Abnormal expression and activation of Axl or Mer can provide a survival advantage for certain cancer cells.  Inhibition of Axl and Mer may enhance the sensitivity of cancer cells to cytotoxic agents and would potentially be a therapeutic strategy to target cancer cells.  This review elucidates the role of Axl and Mer in normal cellular function and their role in oncogenesis.  In addn., we review the potential to inhibit these RTKs for the development of therapeutic targets in treatment of cancer.  Mol Cancer Ther; 10(10); 1763-73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogR8epfrv2ArVg90H21EOLACvtfcHk0li-knpORD99Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ylsrfJ&md5=5048fdf6f6874a61bfbc6576db18d61c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0116%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DWarner%26aufirst%3DS.%2BL.%26aulast%3DVankayalapati%26aufirst%3DH.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DTargeting%2520Axl%2520and%2520Mer%2520Kinases%2520in%2520Cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1763%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtzberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span> </span><span class="NLM_article-title">Ectopic Expression of the Proto-Oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2662</span><span class="NLM_x">–</span> <span class="NLM_lpage">2669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1078-0432.CCR-05-2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=16675557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltlamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2662-2669&issue=9&author=D.+K.+Grahamauthor=D.+B.+Salzbergauthor=J.+Kurtzbergauthor=S.+Satherauthor=G.+K.+Matsushimaauthor=A.+K.+Keatingauthor=X.+Y.+Liangauthor=M.+A.+Lovellauthor=S.+A.+Williamsauthor=T.+L.+Dawsonauthor=M.+J.+Schellauthor=A.+A.+Anwarauthor=H.+R.+Snodgrassauthor=H.+S.+Earp&title=Ectopic+Expression+of+the+Proto-Oncogene+Mer+in+Pediatric+T-Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Graham, Douglas K.; Salzberg, Dana B.; Kurtzberg, Joanne; Sather, Susan; Matsushima, Glenn K.; Keating, Amy K.; Liang, Xiayuan; Lovell, Mark A.; Williams, Sara A.; Dawson, Thomas L.; Schell, Michael J.; Anwar, Adil A.; Snodgrass, H. Ralph; Earp, H. Shelton</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2662-2669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The Mer receptor tyrosine kinase, cloned from a B-lymphoblastoid library, is the mammalian orthologue of the chicken retroviral oncogene v-eyk and sends antiapoptotic and transforming signals when activated.  To det. if Mer expression is ectopic in T-cell acute lymphoblastic leukemia (ALL) and potentially important in leukemogenesis, we analyzed Mer expression in normal human thymocytes and lymphocytes and in pediatric ALL patient samples.  Exptl. Design: Reverse transcription-PCR, flow cytometry, and immunohistochem. were used to det. expression of Mer in sorted human thymocyte populations, lymphocytes, and lymphocytes activated by phytohemagglutinin or phorbol 12-myristate 13-acetate/ionophore.  Mer expression in 34 T-cell ALL (T-ALL) patient samples was evaluated by reverse transcription-PCR, and Mer protein expression in a sep. cohort of 16 patient samples was assayed by flow cytometry and Western blot.  Results: Mer expression was absent in normal thymocytes or lymphocytes, and in T cells activated with phytohemagglutinin or phorbol 12-myristate 13-acetate/ionophore.  In contrast, Jurkat cells and T-ALL patient samples expressed unique 180 to 185 kDa Mer protein glycoforms.  Substantial Mer RNA levels were principally obsd. in a subset of T-ALL patient samples that expressed B220 (P = 0.004) but lacked surface expression of CD3 (P = 0.02) and CD4 (P = 0.006), a phenotypic profile consistent with immature lymphoblasts.  In addn., 8 of 16 T-ALL patient samples had Mer protein detected by flow cytometry and Western blot.  Conclusions: Transforming Mer signals may contribute to T-cell leukemogenesis, and abnormal Mer expression may be a novel therapeutic target in pediatric ALL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5MShoRa9blLVg90H21EOLACvtfcHk0lipp3cxM-5h7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltlamsrw%253D&md5=68f8310415b1984596118b40976cdd36</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2208%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DKurtzberg%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMatsushima%26aufirst%3DG.%2BK.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DLiang%26aufirst%3DX.%2BY.%26aulast%3DLovell%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BL.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DAnwar%26aufirst%3DA.%2BA.%26aulast%3DSnodgrass%26aufirst%3DH.%2BR.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26atitle%3DEctopic%2520Expression%2520of%2520the%2520Proto-Oncogene%2520Mer%2520in%2520Pediatric%2520T-Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26issue%3D9%26spage%3D2662%26epage%3D2669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lee-Sherick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGary, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsucker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Aberrant Mer Receptor Tyrosine Kinase Expression Contributes to Leukemogenesis in Acute Myeloid Leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5359</span><span class="NLM_x">–</span> <span class="NLM_lpage">5368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=5359-5368&author=A.+Lee-Sherickauthor=K.+Eisenmanauthor=S.+Satherauthor=A.+McGranahanauthor=P.+Armisteadauthor=C.+McGaryauthor=S.+Hunsuckerauthor=J.+Schlegelauthor=H.+Martinsonauthor=C.+Cannonauthor=A.+K.+Keatingauthor=H.+S.+Earpauthor=X.+Liangauthor=D.+DeRyckereauthor=D.+K.+Graham&title=Aberrant+Mer+Receptor+Tyrosine+Kinase+Expression+Contributes+to+Leukemogenesis+in+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee-Sherick%26aufirst%3DA.%26aulast%3DEisenman%26aufirst%3DK.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DArmistead%26aufirst%3DP.%26aulast%3DMcGary%26aufirst%3DC.%26aulast%3DHunsucker%26aufirst%3DS.%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DMartinson%26aufirst%3DH.%26aulast%3DCannon%26aufirst%3DC.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DAberrant%2520Mer%2520Receptor%2520Tyrosine%2520Kinase%2520Expression%2520Contributes%2520to%2520Leukemogenesis%2520in%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D5359%26epage%3D5368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Linger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migdall-Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedlicka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heasley, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=3420-3431&author=R.+M.+Lingerauthor=R.+A.+Cohenauthor=C.+T.+Cummingsauthor=S.+Satherauthor=J.+Migdall-Wilsonauthor=D.+H.+Middletonauthor=X.+Luauthor=A.+E.+Baronauthor=W.+A.+Franklinauthor=D.+T.+Merrickauthor=P.+Jedlickaauthor=D.+Deryckereauthor=L.+E.+Heasleyauthor=D.+K.+Graham&title=Mer+or+Axl+Receptor+Tyrosine+Kinase+Inhibition+Promotes+Apoptosis%2C+Blocks+Growth+and+Enhances+Chemosensitivity+of+Human+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DR.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMigdall-Wilson%26aufirst%3DJ.%26aulast%3DMiddleton%26aufirst%3DD.%2BH.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBaron%26aufirst%3DA.%2BE.%26aulast%3DFranklin%26aufirst%3DW.%2BA.%26aulast%3DMerrick%26aufirst%3DD.%2BT.%26aulast%3DJedlicka%26aufirst%3DP.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DHeasley%26aufirst%3DL.%2BE.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMer%2520or%2520Axl%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibition%2520Promotes%2520Apoptosis%252C%2520Blocks%2520Growth%2520and%2520Enhances%2520Chemosensitivity%2520of%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D3420%26epage%3D3431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambade, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschos, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembath, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaishvili-Feinberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midkiff, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">MERTK Receptor Tyrosine Kinase Is a Therapeutic Target in Melanoma</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2257</span><span class="NLM_x">–</span> <span class="NLM_lpage">2267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2257-2267&issue=5&author=J.+Schlegelauthor=M.+J.+Sambadeauthor=S.+Satherauthor=S.+J.+Moschosauthor=A.+C.+Tanauthor=A.+Wingesauthor=D.+Deryckereauthor=C.+C.+Carsonauthor=D.+G.+Trembathauthor=J.+J.+Tentlerauthor=S.+G.+Eckhardtauthor=P.+F.+Kuanauthor=R.+L.+Hamiltonauthor=L.+M.+Duncanauthor=C.+R.+Millerauthor=N.+Nikolaishvili-Feinbergauthor=B.+R.+Midkiffauthor=J.+Liuauthor=W.+Zhangauthor=C.+Yangauthor=X.+Wangauthor=S.+V.+Fryeauthor=H.+S.+Earpauthor=J.+M.+Shieldsauthor=D.+K.+Graham&title=MERTK+Receptor+Tyrosine+Kinase+Is+a+Therapeutic+Target+in+Melanoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DSambade%26aufirst%3DM.%2BJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMoschos%26aufirst%3DS.%2BJ.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DCarson%26aufirst%3DC.%2BC.%26aulast%3DTrembath%26aufirst%3DD.%2BG.%26aulast%3DTentler%26aufirst%3DJ.%2BJ.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DKuan%26aufirst%3DP.%2BF.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DDuncan%26aufirst%3DL.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BR.%26aulast%3DNikolaishvili-Feinberg%26aufirst%3DN.%26aulast%3DMidkiff%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DShields%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMERTK%2520Receptor%2520Tyrosine%2520Kinase%2520Is%2520a%2520Therapeutic%2520Target%2520in%2520Melanoma%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26issue%3D5%26spage%3D2257%26epage%3D2267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tworkoski, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchiocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. F.</span><span> </span><span class="NLM_article-title">MERTK Controls Melanoma Cell Migration and Survival and Differentially Regulates Cell Behavior Relative to AXL</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1111%2Fpcmr.12110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=23617806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlalsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=527-541&issue=4&author=K.+A.+Tworkoskiauthor=J.+T.+Plattauthor=A.+Bacchiocchiauthor=M.+Bosenbergauthor=T.+J.+Boggonauthor=D.+F.+Stern&title=MERTK+Controls+Melanoma+Cell+Migration+and+Survival+and+Differentially+Regulates+Cell+Behavior+Relative+to+AXL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL</span></div><div class="casAuthors">Tworkoski, Kathryn A.; Platt, James T.; Bacchiocchi, Antonella; Bosenberg, Marcus; Boggon, Titus J.; Stern, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-541</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The receptor tyrosine kinase AXL regulates melanoma cell proliferation and migration.  We now demonstrate that AXL and the related kinase MERTK are alternately expressed in melanoma and are assocd. with different transcriptional signatures.  MERTK-pos. melanoma cells are more proliferative and less migratory than AXL-pos. melanoma cells and overexpression of AXL increases cell motility relative to MERTK.  MERTK is expressed in up to 50% of melanoma cells and shRNA-mediated knockdown of MERTK reduces colony formation and cell migration in a CDC42-dependent fashion.  Targeting MERTK also decreases cell survival and proliferation in an AKT-dependent manner.  Finally, we identify a novel mutation in the kinase domain of MERTK, MERTKP802S, that increases the motility of melanoma cells relative to wild-type MERTK.  Together, these data demonstrate that MERTK is a possible therapeutic target in melanoma, that AXL and MERTK are assocd. with differential cell behaviors, and that mutations in MERTK may contribute to melanoma pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNyjI7PbukObVg90H21EOLACvtfcHk0lgQey2SU2uHAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlalsLjE&md5=1207422adb7d06e7380fe02700e5634f</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1111%2Fpcmr.12110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcmr.12110%26sid%3Dliteratum%253Aachs%26aulast%3DTworkoski%26aufirst%3DK.%2BA.%26aulast%3DPlatt%26aufirst%3DJ.%2BT.%26aulast%3DBacchiocchi%26aufirst%3DA.%26aulast%3DBosenberg%26aufirst%3DM.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DStern%26aufirst%3DD.%2BF.%26atitle%3DMERTK%2520Controls%2520Melanoma%2520Cell%2520Migration%2520and%2520Survival%2520and%2520Differentially%2520Regulates%2520Cell%2520Behavior%2520Relative%2520to%2520AXL%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2013%26volume%3D26%26issue%3D4%26spage%3D527%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzmil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lino, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement-Schatlo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Promotes Invasion and Survival in Glioblastoma Multiforme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">872</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=872-882&issue=7&author=Y.+Wangauthor=G.+Moncayoauthor=P.+Morinauthor=G.+Xueauthor=M.+Grzmilauthor=M.+M.+Linoauthor=V.+Clement-Schatloauthor=S.+Frankauthor=A.+Merloauthor=B.+A.+Hemmings&title=Mer+Receptor+Tyrosine+Kinase+Promotes+Invasion+and+Survival+in+Glioblastoma+Multiforme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DClement-Schatlo%26aufirst%3DV.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Promotes%2520Invasion%2520and%2520Survival%2520in%2520Glioblastoma%2520Multiforme%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D7%26spage%3D872%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rogers, A. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Inhibition Impedes Glioblastoma Multiforme Migration and Alters Cellular Morphology</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">4171</span><span class="NLM_x">–</span> <span class="NLM_lpage">4181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=4171-4181&issue=38&author=A.+E.+J.+Rogersauthor=J.+P.+Leauthor=S.+Satherauthor=B.+M.+Pernuauthor=D.+K.+Grahamauthor=A.+M.+Pierceauthor=A.+K.+Keating&title=Mer+Receptor+Tyrosine+Kinase+Inhibition+Impedes+Glioblastoma+Multiforme+Migration+and+Alters+Cellular+Morphology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DA.%2BE.%2BJ.%26aulast%3DLe%26aufirst%3DJ.%2BP.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DPernu%26aufirst%3DB.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DPierce%26aufirst%3DA.%2BM.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibition%2520Impedes%2520Glioblastoma%2520Multiforme%2520Migration%2520and%2520Alters%2520Cellular%2520Morphology%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26issue%3D38%26spage%3D4171%26epage%3D4181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickoloff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczyn, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran-Everett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGavran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltesen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Lymphoblastic Leukemia/Lymphoma in Mice Overexpressing the Mer (MerTK) Receptor Tyrosine Kinase</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">6092</span><span class="NLM_x">–</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=6092-6100&issue=45&author=A.+K.+Keatingauthor=D.+B.+Salzbergauthor=S.+Satherauthor=X.+Liangauthor=S.+Nickoloffauthor=A.+Anwarauthor=D.+Deryckereauthor=K.+Hillauthor=D.+Joungauthor=K.+K.+Sawczynauthor=J.+Parkauthor=D.+Curran-Everettauthor=L.+McGavranauthor=L.+Meltesenauthor=L.+Goreauthor=G.+L.+Johnsonauthor=D.+K.+Graham&title=Lymphoblastic+Leukemia%2FLymphoma+in+Mice+Overexpressing+the+Mer+%28MerTK%29+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DNickoloff%26aufirst%3DS.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DHill%26aufirst%3DK.%26aulast%3DJoung%26aufirst%3DD.%26aulast%3DSawczyn%26aufirst%3DK.%2BK.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCurran-Everett%26aufirst%3DD.%26aulast%3DMcGavran%26aufirst%3DL.%26aulast%3DMeltesen%26aufirst%3DL.%26aulast%3DGore%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DLymphoblastic%2520Leukemia%252FLymphoma%2520in%2520Mice%2520Overexpressing%2520the%2520Mer%2520%2528MerTK%2529%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26issue%3D45%26spage%3D6092%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulcahy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1298</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1535-7163.MCT-09-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=20423999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslektrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1298-1307&issue=5&author=A.+K.+Keatingauthor=G.+K.+Kimauthor=A.+E.+Jonesauthor=A.+M.+Donsonauthor=K.+Wareauthor=J.+M.+Mulcahyauthor=D.+B.+Salzbergauthor=N.+K.+Foremanauthor=X.+Liangauthor=A.+Thorburnauthor=D.+K.+Graham&title=Inhibition+of+Mer+and+Axl+Receptor+Tyrosine+Kinases+in+Astrocytoma+Cells+Leads+to+Increased+Apoptosis+and+Improved+Chemosensitivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity</span></div><div class="casAuthors">Keating, Amy K.; Kim, Grace K.; Jones, Ashley E.; Donson, Andrew M.; Ware, Kathryn; Mulcahy, Jean M.; Salzberg, Dana B.; Foreman, Nicholas K.; Liang, Xiayuan; Thorburn, Andrew; Graham, Douglas K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1298-1307</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Astrocytomas account for the majority of malignant brain tumors diagnosed in both adult and pediatric patients.  The therapies available to treat these neoplasms are limited, and the prognosis assocd. with high-grade lesions is extremely poor.  Mer (MerTK) and Axl receptor tyrosine kinases (RTK) are expressed at abnormally high levels in a variety of malignancies, and these receptors are known to activate strong antiapoptotic signaling pathways that promote oncogenesis.  In this study, the authors found that Mer and Axl mRNA transcript and protein expression were elevated in astrocytic patient samples and cell lines.  ShRNA-mediated knockdown of Mer and Axl RTK expression led to an increase in apoptosis in astrocytoma cells.  Apoptotic signaling pathways including Akt and extracellular signal-regulated kinase 1/2, which have been shown to be activated in resistant astrocytomas, were downregulated with Mer and Axl inhibition, whereas poly(ADP-ribose) polymerase cleavage was increased.  Furthermore, Mer and Axl shRNA knockdown led to a profound decrease of astrocytoma cell proliferation in soft agar and a significant increase in chemosensitivity in response to temozolomide, carboplatin, and vincristine treatment.  The authors' results suggest Mer and Axl RTK inhibition as a novel method to improve apoptotic response and chemosensitivity in astrocytoma and provide support for these oncogenes as attractive biol. targets for astrocytoma drug development.  Mol Cancer Ther; 9(5); 1298-307.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPZlqtANWfZbVg90H21EOLACvtfcHk0lgQey2SU2uHAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslektrY%253D&md5=04e8a0c70eba12c28f58a989131ab885</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0707%26sid%3Dliteratum%253Aachs%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DKim%26aufirst%3DG.%2BK.%26aulast%3DJones%26aufirst%3DA.%2BE.%26aulast%3DDonson%26aufirst%3DA.%2BM.%26aulast%3DWare%26aufirst%3DK.%26aulast%3DMulcahy%26aufirst%3DJ.%2BM.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DForeman%26aufirst%3DN.%2BK.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DInhibition%2520of%2520Mer%2520and%2520Axl%2520Receptor%2520Tyrosine%2520Kinases%2520in%2520Astrocytoma%2520Cells%2520Leads%2520to%2520Increased%2520Apoptosis%2520and%2520Improved%2520Chemosensitivity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D5%26spage%3D1298%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brandao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migdall-Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span> </span><span class="NLM_article-title">Inhibition of MerTK Increases Chemosensitivity and Decreases Oncogenic Potential in T-Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Blood Cancer Journal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e101&issue=1&author=L.+Brandaoauthor=A.+Wingesauthor=S.+Christophauthor=S.+Satherauthor=J.+Migdall-Wilsonauthor=J.+Schlegelauthor=A.+McGranahanauthor=D.+Gaoauthor=X.+Liangauthor=D.+DeRyckere&title=Inhibition+of+MerTK+Increases+Chemosensitivity+and+Decreases+Oncogenic+Potential+in+T-Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrandao%26aufirst%3DL.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DChristoph%26aufirst%3DS.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMigdall-Wilson%26aufirst%3DJ.%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DDeRyckere%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520MerTK%2520Increases%2520Chemosensitivity%2520and%2520Decreases%2520Oncogenic%2520Potential%2520in%2520T-Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DBlood%2520Cancer%2520Journal%26date%3D2013%26volume%3D3%26issue%3D1%26spage%3De101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Linger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Sherick, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczyn, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Is a Therapeutic Target in Pre-B Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1599-1609&author=R.+M.+Lingerauthor=A.+B.+Lee-Sherickauthor=D.+Deryckereauthor=R.+A.+Cohenauthor=K.+M.+Jacobsenauthor=A.+McGranahanauthor=L.+Brand%C3%A3oauthor=A.+Wingesauthor=K.+K.+Sawczynauthor=X.+Liangauthor=A.+K.+Keatingauthor=A.+C.+Tanauthor=H.+S.+Earpauthor=D.+K.+Graham&title=Mer+Receptor+Tyrosine+Kinase+Is+a+Therapeutic+Target+in+Pre-B+Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%26aulast%3DLee-Sherick%26aufirst%3DA.%2BB.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DR.%2BA.%26aulast%3DJacobsen%26aufirst%3DK.%2BM.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DBrand%25C3%25A3o%26aufirst%3DL.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DSawczyn%26aufirst%3DK.%2BK.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Is%2520a%2520Therapeutic%2520Target%2520in%2520Pre-B%2520Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1599%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Knubel, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span> </span><span class="NLM_article-title">MerTK Inhibition is a Novel Therapeutic Approach for Glioblastoma Multiforme</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1338-1351&issue=5&author=K.+H.+Knubelauthor=B.+M.+Pernuauthor=A.+Sufitauthor=S.+Nelsonauthor=A.+M.+Pierceauthor=A.+K.+Keating&title=MerTK+Inhibition+is+a+Novel+Therapeutic+Approach+for+Glioblastoma+Multiforme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnubel%26aufirst%3DK.%2BH.%26aulast%3DPernu%26aufirst%3DB.%2BM.%26aulast%3DSufit%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DA.%2BM.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26atitle%3DMerTK%2520Inhibition%2520is%2520a%2520Novel%2520Therapeutic%2520Approach%2520for%2520Glioblastoma%2520Multiforme%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D1338%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abu-Duhier, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodeve, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gari, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peake, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winship, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. T.</span><span> </span><span class="NLM_article-title">FLT3 Internal Tandem Duplication Mutations in Adult Acute Myeloid Leukaemia Define a High-Risk Group</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1046%2Fj.1365-2141.2000.02317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=11091200" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2000&pages=190-195&issue=1&author=F.+M.+Abu-Duhierauthor=A.+C.+Goodeveauthor=G.+A.+Wilsonauthor=M.+A.+Gariauthor=I.+R.+Peakeauthor=D.+C.+Reesauthor=E.+A.+Vandenbergheauthor=P.+R.+Winshipauthor=J.+T.+Reilly&title=FLT3+Internal+Tandem+Duplication+Mutations+in+Adult+Acute+Myeloid+Leukaemia+Define+a+High-Risk+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2000.02317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2000.02317.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbu-Duhier%26aufirst%3DF.%2BM.%26aulast%3DGoodeve%26aufirst%3DA.%2BC.%26aulast%3DWilson%26aufirst%3DG.%2BA.%26aulast%3DGari%26aufirst%3DM.%2BA.%26aulast%3DPeake%26aufirst%3DI.%2BR.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DVandenberghe%26aufirst%3DE.%2BA.%26aulast%3DWinship%26aufirst%3DP.%2BR.%26aulast%3DReilly%26aufirst%3DJ.%2BT.%26atitle%3DFLT3%2520Internal%2520Tandem%2520Duplication%2520Mutations%2520in%2520Adult%2520Acute%2520Myeloid%2520Leukaemia%2520Define%2520a%2520High-Risk%2520Group%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2000%26volume%3D111%26issue%3D1%26spage%3D190%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kottaridis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frew, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langabeer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstone, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linch, D. C.</span><span> </span><span class="NLM_article-title">The Presence of a FLT3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia (AML) Adds Important Prognostic Information to Cytogenetic Risk Group and Response to the First Cycle of Chemotherapy: Analysis of 854 Patients from the United Kingdom Medical Research Council AML 10 and 12 Trials</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=1752-1759&issue=6&author=P.+D.+Kottaridisauthor=R.+E.+Galeauthor=M.+E.+Frewauthor=G.+Harrisonauthor=S.+E.+Langabeerauthor=A.+A.+Beltonauthor=H.+Walkerauthor=K.+Wheatleyauthor=D.+T.+Bowenauthor=A.+K.+Burnettauthor=A.+H.+Goldstoneauthor=D.+C.+Linch&title=The+Presence+of+a+FLT3+Internal+Tandem+Duplication+in+Patients+with+Acute+Myeloid+Leukemia+%28AML%29+Adds+Important+Prognostic+Information+to+Cytogenetic+Risk+Group+and+Response+to+the+First+Cycle+of+Chemotherapy%3A+Analysis+of+854+Patients+from+the+United+Kingdom+Medical+Research+Council+AML+10+and+12+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKottaridis%26aufirst%3DP.%2BD.%26aulast%3DGale%26aufirst%3DR.%2BE.%26aulast%3DFrew%26aufirst%3DM.%2BE.%26aulast%3DHarrison%26aufirst%3DG.%26aulast%3DLangabeer%26aufirst%3DS.%2BE.%26aulast%3DBelton%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DH.%26aulast%3DWheatley%26aufirst%3DK.%26aulast%3DBowen%26aufirst%3DD.%2BT.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DGoldstone%26aufirst%3DA.%2BH.%26aulast%3DLinch%26aufirst%3DD.%2BC.%26atitle%3DThe%2520Presence%2520of%2520a%2520FLT3%2520Internal%2520Tandem%2520Duplication%2520in%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520%2528AML%2529%2520Adds%2520Important%2520Prognostic%2520Information%2520to%2520Cytogenetic%2520Risk%2520Group%2520and%2520Response%2520to%2520the%2520First%2520Cycle%2520of%2520Chemotherapy%253A%2520Analysis%2520of%2520854%2520Patients%2520from%2520the%2520United%2520Kingdom%2520Medical%2520Research%2520Council%2520AML%252010%2520and%252012%2520Trials%26jtitle%3DBlood%26date%3D2001%26volume%3D98%26issue%3D6%26spage%3D1752%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span> </span><span class="NLM_article-title">Patients with Acute Myeloid Leukemia and an Activating Mutation in FLT3 Respond to a Small-Molecule FLT3 Tyrosine Kinase Inhibitor, PKC412</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=54-60&issue=1&author=R.+M.+Stoneauthor=D.+J.+DeAngeloauthor=V.+Klimekauthor=I.+Galinskyauthor=E.+Esteyauthor=S.+D.+Nimerauthor=W.+Grandinauthor=D.+Lebwohlauthor=Y.+Wangauthor=P.+Cohenauthor=E.+A.+Foxauthor=D.+Neubergauthor=J.+Clarkauthor=D.+G.+Gillilandauthor=J.+D.+Griffin&title=Patients+with+Acute+Myeloid+Leukemia+and+an+Activating+Mutation+in+FLT3+Respond+to+a+Small-Molecule+FLT3+Tyrosine+Kinase+Inhibitor%2C+PKC412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKlimek%26aufirst%3DV.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DEstey%26aufirst%3DE.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DGrandin%26aufirst%3DW.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DFox%26aufirst%3DE.%2BA.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DPatients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520and%2520an%2520Activating%2520Mutation%2520in%2520FLT3%2520Respond%2520to%2520a%2520Small-Molecule%2520FLT3%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520PKC412%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D1%26spage%3D54%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klisovic, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecerf, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karol, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span> </span><span class="NLM_article-title">Phase 1 Clinical Results with Tandutinib (MLN518), a Novel FLT3 Antagonist, In Patients with Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome: Safety, Pharmacokinetics, And Pharmacodynamics</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3674-3681&issue=12&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=M.+L.+Heaneyauthor=S.+D.+Nimerauthor=R.+L.+Paquetteauthor=R.+B.+Klisovicauthor=M.+A.+Caligiuriauthor=M.+R.+Cooperauthor=J.+M.+Lecerfauthor=M.+D.+Karolauthor=S.+Shengauthor=N.+Holfordauthor=P.+T.+Curtinauthor=B.+J.+Drukerauthor=M.+C.+Heinrich&title=Phase+1+Clinical+Results+with+Tandutinib+%28MLN518%29%2C+a+Novel+FLT3+Antagonist%2C+In+Patients+with+Acute+Myelogenous+Leukemia+or+High-Risk+Myelodysplastic+Syndrome%3A+Safety%2C+Pharmacokinetics%2C+And+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DHeaney%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKlisovic%26aufirst%3DR.%2BB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DLecerf%26aufirst%3DJ.%2BM.%26aulast%3DKarol%26aufirst%3DM.%2BD.%26aulast%3DSheng%26aufirst%3DS.%26aulast%3DHolford%26aufirst%3DN.%26aulast%3DCurtin%26aufirst%3DP.%2BT.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DPhase%25201%2520Clinical%2520Results%2520with%2520Tandutinib%2520%2528MLN518%2529%252C%2520a%2520Novel%2520FLT3%2520Antagonist%252C%2520In%2520Patients%2520with%2520Acute%2520Myelogenous%2520Leukemia%2520or%2520High-Risk%2520Myelodysplastic%2520Syndrome%253A%2520Safety%252C%2520Pharmacokinetics%252C%2520And%2520Pharmacodynamics%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26issue%3D12%26spage%3D3674%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knapper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kell, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">A Phase 2 Trial of the FLT3 Inhibitor Lestaurtinib (CEP701) as First-Line Treatment for Older Patients with Acute Myeloid Leukemia Not Considered Fit for Intensive Chemotherapy</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3262</span><span class="NLM_x">–</span> <span class="NLM_lpage">3270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3262-3270&issue=10&author=S.+Knapperauthor=A.+K.+Burnettauthor=T.+Littlewoodauthor=W.+J.+Kellauthor=S.+Agrawalauthor=R.+Chopraauthor=R.+Clarkauthor=M.+J.+Levisauthor=D.+Small&title=A+Phase+2+Trial+of+the+FLT3+Inhibitor+Lestaurtinib+%28CEP701%29+as+First-Line+Treatment+for+Older+Patients+with+Acute+Myeloid+Leukemia+Not+Considered+Fit+for+Intensive+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnapper%26aufirst%3DS.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DLittlewood%26aufirst%3DT.%26aulast%3DKell%26aufirst%3DW.%2BJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DA%2520Phase%25202%2520Trial%2520of%2520the%2520FLT3%2520Inhibitor%2520Lestaurtinib%2520%2528CEP701%2529%2520as%2520First-Line%2520Treatment%2520for%2520Older%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520Not%2520Considered%2520Fit%2520for%2520Intensive%2520Chemotherapy%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26issue%3D10%26spage%3D3262%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pratz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, S. M.</span><span> </span><span class="NLM_article-title">Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?</span> <span class="citation_source-journal">Curr. Opin. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1097%2FMOH.0000000000000022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=24468836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=72-78&issue=2&author=K.+W.+Pratzauthor=S.+M.+Luger&title=Will+FLT3+inhibitors+fulfill+their+promise+in+acute+meyloid+leukemia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?</span></div><div class="casAuthors">Pratz, Keith W.; Luger, Selina M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Hematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-78</span>CODEN:
                <span class="NLM_cas:coden">COHEF4</span>;
        ISSN:<span class="NLM_cas:issn">1065-6251</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: 'FMS'-like tyrosine kinase 3 (FLT3) mutations in acute myeloid leukemia (AML) have been brought from discovery in the early 1990s to clin. targeting in the past 10 years.  Despite several promising leads in preclin. models, no agent has yet been approved for clin. use.  Here we will review the development of novel therapies for AML with FLT3 mutations.  Recent findings: Initial clin. development focused on broad kinase inhibitors which were found to have limited clin. activity due to insufficient kinase inhibitory activity and high toxicity.  Subsequent development has brought forth narrow-spectrum inhibitors with potent in-vivo activity and reasonable clin. tolerance, but many patients still progress with prolonged use.  Summary: The optimal role for targeting FLT3 may depend on multimodality therapy and will likely require hematopoietic transplant.  The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clin. care.  Strategies incorporating FLT3-targeted agents into AML therapy are ongoing, but challenges in trial design, clin. heterogeneity and need for long-term follow-up make these investigations complicated in design and implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhd0WIK8avjbVg90H21EOLACvtfcHk0lgfSt6jBSYZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qt74%253D&md5=ab564d98a69f62226f0775c88e2eb106</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FMOH.0000000000000022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOH.0000000000000022%26sid%3Dliteratum%253Aachs%26aulast%3DPratz%26aufirst%3DK.%2BW.%26aulast%3DLuger%26aufirst%3DS.%2BM.%26atitle%3DWill%2520FLT3%2520inhibitors%2520fulfill%2520their%2520promise%2520in%2520acute%2520meyloid%2520leukemia%253F%26jtitle%3DCurr.%2520Opin.%2520Hematol.%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D72%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korboukh, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200239k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=129-134&author=J.+Liuauthor=C.+Yangauthor=C.+Simpsonauthor=D.+DeRyckereauthor=D.+A.+Vanauthor=M.+J.+Mileyauthor=D.+Kireevauthor=J.+Norris-Drouinauthor=S.+Satherauthor=D.+Hunterauthor=V.+K.+Korboukhauthor=H.+S.+Patelauthor=W.+P.+Janzenauthor=M.+Machiusauthor=G.+L.+Johnsonauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Discovery+of+Small+Molecule+Mer+Kinase+Inhibitors+for+the+Treatment+of+Pediatric+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fml200239k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200239k%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSimpson%26aufirst%3DC.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DVan%26aufirst%3DD.%2BA.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKorboukh%26aufirst%3DV.%2BK.%26aulast%3DPatel%26aufirst%3DH.%2BS.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Small%2520Molecule%2520Mer%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pediatric%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakody, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">UNC1062, a New and Potent Mer Inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=83-93&author=J.+Liuauthor=W.+Zhangauthor=M.+A.+Stashkoauthor=D.+DeRyckereauthor=C.+T.+Cummingsauthor=D.+Hunterauthor=C.+Yangauthor=C.+N.+Jayakodyauthor=N.+Chengauthor=C.+Simpsonauthor=J.+Norris-Drouinauthor=S.+Satherauthor=D.+Kireevauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=UNC1062%2C+a+New+and+Potent+Mer+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DJayakody%26aufirst%3DC.%2BN.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DSimpson%26aufirst%3DC.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DUNC1062%252C%2520a%2520New%2520and%2520Potent%2520Mer%2520Inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D65%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">9683</span><span class="NLM_x">–</span> <span class="NLM_lpage">9692</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401387j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9683-9692&issue=23&author=W.+Zhangauthor=D.+Zhangauthor=M.+A.+Stashkoauthor=D.+DeRyckereauthor=D.+Hunterauthor=D.+Kireevauthor=M.+J.+Mileyauthor=C.+Cummingsauthor=M.+Leeauthor=J.+Norris-Drouinauthor=W.+M.+Stewartauthor=S.+Satherauthor=Y.+Zhouauthor=G.+Kirkpatrickauthor=M.+Machiusauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Pseudo-Cyclization+through+Intramolecular+Hydrogen+Bond+Enables+Discovery+of+Pyridine+Substituted+Pyrimidines+as+New+Mer+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm401387j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401387j%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DCummings%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DW.%2BM.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKirkpatrick%26aufirst%3DG.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPseudo-Cyclization%2520through%2520Intramolecular%2520Hydrogen%2520Bond%2520Enables%2520Discovery%2520of%2520Pyridine%2520Substituted%2520Pyrimidines%2520as%2520New%2520Mer%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9683%26epage%3D9692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIver, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchford, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paola, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Discovery of mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">9693</span><span class="NLM_x">–</span> <span class="NLM_lpage">9700</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4013888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9693-9700&issue=23&author=W.+Zhangauthor=A.+L.+McIverauthor=M.+A.+Stashkoauthor=D.+Deryckereauthor=B.+R.+Branchfordauthor=D.+Hunterauthor=D.+Kireevauthor=M.+J.+Mileyauthor=J.+Norris-Drouinauthor=W.+M.+Stewartauthor=M.+Leeauthor=S.+Satherauthor=Y.+Zhouauthor=J.+A.+Di+Paolaauthor=M.+Machiusauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Discovery+of+mer+Specific+Tyrosine+Kinase+Inhibitors+for+the+Treatment+and+Prevention+of+Thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm4013888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4013888%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcIver%26aufirst%3DA.%2BL.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DBranchford%26aufirst%3DB.%2BR.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DW.%2BM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDi%2BPaola%26aufirst%3DJ.%2BA.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520mer%2520Specific%2520Tyrosine%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520and%2520Prevention%2520of%2520Thrombosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9693%26epage%3D9700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler-Cole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span> </span><span class="NLM_article-title">Structural Insights into the Inhibited States of the Mer Receptor Tyrosine Kinase</span> <span class="citation_source-journal">J. Struct Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2009&pages=88-96&issue=2&author=X.+Huangauthor=P.+Finertyauthor=J.+R.+Walkerauthor=C.+Butler-Coleauthor=M.+Vedadiauthor=M.+Schapiraauthor=S.+A.+Parkerauthor=B.+E.+Turkauthor=D.+A.+Thompsonauthor=S.+Dhe-Paganon&title=Structural+Insights+into+the+Inhibited+States+of+the+Mer+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DButler-Cole%26aufirst%3DC.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DS.%2BA.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26atitle%3DStructural%2520Insights%2520into%2520the%2520Inhibited%2520States%2520of%2520the%2520Mer%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Struct%2520Biol.%26date%3D2009%26volume%3D165%26issue%3D2%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span> </span><span class="NLM_article-title">Molecular Target Class Is Predictive of In vitro Response Profile</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3677</span><span class="NLM_x">–</span> <span class="NLM_lpage">3686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3677-3686&issue=9&author=J.+Greshockauthor=K.+E.+Bachmanauthor=Y.+Y.+Degenhardtauthor=J.+Jingauthor=Y.+H.+Wenauthor=S.+Eastmanauthor=E.+McNeilauthor=C.+Moyauthor=R.+Wegrzynauthor=K.+Augerauthor=M.+A.+Hardwickeauthor=R.+Wooster&title=Molecular+Target+Class+Is+Predictive+of+In+vitro+Response+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DDegenhardt%26aufirst%3DY.%2BY.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DY.%2BH.%26aulast%3DEastman%26aufirst%3DS.%26aulast%3DMcNeil%26aufirst%3DE.%26aulast%3DMoy%26aufirst%3DC.%26aulast%3DWegrzyn%26aufirst%3DR.%26aulast%3DAuger%26aufirst%3DK.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMolecular%2520Target%2520Class%2520Is%2520Predictive%2520of%2520In%2520vitro%2520Response%2520Profile%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D9%26spage%3D3677%26epage%3D3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Howard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800984v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=379-388&issue=2&author=S.+Howardauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=J.+Curryauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=L.+Fazalauthor=A.+L.+Gillauthor=M.+Heathcoteauthor=S.+Mamanauthor=J.+E.+Matthewsauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=D.+C.+Reesauthor=M.+Reuleauthor=D.+Tisiauthor=G.+Williamsauthor=M.+Vinkovicauthor=P.+G.+Wyatt&title=Fragment-Based+Discovery+of+the+Pyrazol-4-yl+urea+%28AT9283%29%2C+a+Multitargeted+Kinase+Inhibitor+with+Potent+Aurora+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm800984v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800984v%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DHeathcote%26aufirst%3DM.%26aulast%3DMaman%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DJ.%2BE.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DFragment-Based%2520Discovery%2520of%2520the%2520Pyrazol-4-yl%2520urea%2520%2528AT9283%2529%252C%2520a%2520Multitargeted%2520Kinase%2520Inhibitor%2520with%2520Potent%2520Aurora%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D379%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&issue=5&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+Selective+and+Orally+Efficacious+Inhibitor+of+the+Met+Kinase+Superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520Selective%2520and%2520Orally%2520Efficacious%2520Inhibitor%2520of%2520the%2520Met%2520Kinase%2520Superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D5%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funakoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span> </span><span class="NLM_article-title">Foretinib (GSK1363089), a Multi-Kinase Inhibitor of MET and VEGFRs, Inhibits Growth of Gastric Cancer Cell Lines by Blocking Inter-Receptor Tyrosine Kinase Networks</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1352-1360&issue=4&author=Y.+Kataokaauthor=T.+Mukoharaauthor=H.+Tomiokaauthor=Y.+Funakoshiauthor=N.+Kiyotaauthor=Y.+Fujiwaraauthor=M.+Yashiroauthor=K.+Hirakawaauthor=M.+Hiraiauthor=H.+Minami&title=Foretinib+%28GSK1363089%29%2C+a+Multi-Kinase+Inhibitor+of+MET+and+VEGFRs%2C+Inhibits+Growth+of+Gastric+Cancer+Cell+Lines+by+Blocking+Inter-Receptor+Tyrosine+Kinase+Networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DMukohara%26aufirst%3DT.%26aulast%3DTomioka%26aufirst%3DH.%26aulast%3DFunakoshi%26aufirst%3DY.%26aulast%3DKiyota%26aufirst%3DN.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DYashiro%26aufirst%3DM.%26aulast%3DHirakawa%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DMinami%26aufirst%3DH.%26atitle%3DForetinib%2520%2528GSK1363089%2529%252C%2520a%2520Multi-Kinase%2520Inhibitor%2520of%2520MET%2520and%2520VEGFRs%252C%2520Inhibits%2520Growth%2520of%2520Gastric%2520Cancer%2520Cell%2520Lines%2520by%2520Blocking%2520Inter-Receptor%2520Tyrosine%2520Kinase%2520Networks%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26issue%3D4%26spage%3D1352%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Yan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peek, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajamie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konicek, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walgren, R. A.</span><span> </span><span class="NLM_article-title">LY2801653 is an Orally Bioavailable Multi-Kinase Inhibitor with Potent Activity against MET, MST1R, and Other Oncoproteins, And Displays Anti-Tumor Activities in Mouse Xenograft Models</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=833-844&issue=4&author=S.+B.+Yanauthor=V.+L.+Peekauthor=R.+Ajamieauthor=S.+G.+Buchananauthor=J.+R.+Graffauthor=S.+A.+Heidlerauthor=Y.+H.+Huiauthor=K.+L.+Hussauthor=B.+W.+Konicekauthor=J.+R.+Manroauthor=C.+Shihauthor=J.+A.+Stewartauthor=T.+R.+Stewartauthor=S.+L.+Stoutauthor=M.+T.+Uhlikauthor=S.+L.+Umauthor=Y.+Wangauthor=W.+Wuauthor=L.+Yanauthor=W.+J.+Yangauthor=B.+Zhongauthor=R.+A.+Walgren&title=LY2801653+is+an+Orally+Bioavailable+Multi-Kinase+Inhibitor+with+Potent+Activity+against+MET%2C+MST1R%2C+and+Other+Oncoproteins%2C+And+Displays+Anti-Tumor+Activities+in+Mouse+Xenograft+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BB.%26aulast%3DPeek%26aufirst%3DV.%2BL.%26aulast%3DAjamie%26aufirst%3DR.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DHeidler%26aufirst%3DS.%2BA.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DHuss%26aufirst%3DK.%2BL.%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DJ.%2BA.%26aulast%3DStewart%26aufirst%3DT.%2BR.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DUhlik%26aufirst%3DM.%2BT.%26aulast%3DUm%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%2BJ.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DWalgren%26aufirst%3DR.%2BA.%26atitle%3DLY2801653%2520is%2520an%2520Orally%2520Bioavailable%2520Multi-Kinase%2520Inhibitor%2520with%2520Potent%2520Activity%2520against%2520MET%252C%2520MST1R%252C%2520and%2520Other%2520Oncoproteins%252C%2520And%2520Displays%2520Anti-Tumor%2520Activities%2520in%2520Mouse%2520Xenograft%2520Models%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26issue%3D4%26spage%3D833%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Katz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarda, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soisson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span> </span><span class="NLM_article-title">Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200112k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4092-4108&issue=12&author=J.+D.+Katzauthor=J.+P.+Jewellauthor=D.+J.+Guerinauthor=J.+Limauthor=C.+J.+Dinsmoreauthor=S.+V.+Deshmukhauthor=B.+S.+Panauthor=C.+G.+Marshallauthor=W.+Luauthor=M.+D.+Altmanauthor=W.+K.+Dahlbergauthor=L.+Davisauthor=D.+Falconeauthor=A.+E.+Gabardaauthor=G.+Hangauthor=H.+Hatchauthor=R.+Holmesauthor=K.+Kuniiauthor=K.+J.+Lumbauthor=B.+Lutterbachauthor=R.+Mathvinkauthor=N.+Nazefauthor=S.+B.+Patelauthor=X.+Quauthor=J.+F.+Reillyauthor=K.+W.+Rickertauthor=C.+Rosensteinauthor=S.+M.+Soissonauthor=K.+B.+Spencerauthor=A.+A.+Szewczakauthor=D.+Walkerauthor=W.+Wangauthor=J.+Youngauthor=Q.+Zeng&title=Discovery+of+a+5H-Benzo%5B4%2C5%5Dcyclohepta%5B1%2C2-b%5Dpyridin-5-one+%28MK-2461%29+Inhibitor+of+c-Met+Kinase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1021%2Fjm200112k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200112k%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DJewell%26aufirst%3DJ.%2BP.%26aulast%3DGuerin%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DFalcone%26aufirst%3DD.%26aulast%3DGabarda%26aufirst%3DA.%2BE.%26aulast%3DHang%26aufirst%3DG.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DReilly%26aufirst%3DJ.%2BF.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DSpencer%26aufirst%3DK.%2BB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520a%25205H-Benzo%255B4%252C5%255Dcyclohepta%255B1%252C2-b%255Dpyridin-5-one%2520%2528MK-2461%2529%2520Inhibitor%2520of%2520c-Met%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D12%26spage%3D4092%26epage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Frye, S. V.</span><span> </span><span class="NLM_article-title">The Art of the Chemical Probe</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1038%2Fnchembio.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=20154659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=159-161&issue=3&author=S.+V.+Frye&title=The+Art+of+the+Chemical+Probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The art of the chemical probe</span></div><div class="casAuthors">Frye, Stephen V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-161</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. biologists frequently aim to create small-mol. probes that interact with a specific protein in vitro in order to explore the role of the protein in a broader biol. context (cells or organisms), but a common understanding of what makes a high-quality probe is lacking.  Here I propose a set of principles to guide probe qualification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7vDfsTLhqWrVg90H21EOLACvtfcHk0lhxgv6bAWdDIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbg%253D&md5=b7b48c591a611b8686e11b3fc4f1b85c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.296%26sid%3Dliteratum%253Aachs%26aulast%3DFrye%26aufirst%3DS.%2BV.%26atitle%3DThe%2520Art%2520of%2520the%2520Chemical%2520Probe%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D159%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Microwave-Assisted, Divergent Solution-Phase Synthesis of 1,3,6-Trisubstituted Pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/doi/10.1021/co200039k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=414-420&issue=4&author=J.+Liuauthor=X.+Wang&title=Microwave-Assisted%2C+Divergent+Solution-Phase+Synthesis+of+1%2C3%2C6-Trisubstituted+Pyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted, Divergent Solution-Phase Synthesis of 1,3,6-Trisubstituted Pyrazolo[3,4-d]pyrimidines</span></div><div class="casAuthors">Liu, Jing; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">414-420</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A concise and highly divergent synthetic route has been developed to rapidly access 1,3,6-trisubstituted pyrazolopyrimidines.  The synthesis features a microwave assisted one-pot N1-alkylation/Suzuki-Miyaura reaction as the key step.  The sequence of the synthetic scheme can be varied to selectively modify the N1, C3, or C6 position at a late synthetic stage, thereby providing a highly efficient approach to explore the structure-activity relationships of pyrazolopyrimidine derivs.  The scope of these reactions has also been explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Nc3Hpg5qpLVg90H21EOLACvtfcHk0lhxgv6bAWdDIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVSks7g%253D&md5=3d18c62b7d30fa69acfba01324fdbc44</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fco200039k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco200039k%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMicrowave-Assisted%252C%2520Divergent%2520Solution-Phase%2520Synthesis%2520of%25201%252C3%252C6-Trisubstituted%2520Pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3D414%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Palmer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Mourik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, M. V.</span><span> </span><span class="NLM_article-title">First-Principles Calculation of the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3322</span><span class="NLM_x">–</span> <span class="NLM_lpage">3337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ct300345m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3322-3337&issue=9&author=D.+S.+Palmerauthor=J.+L.+McDonaghauthor=J.+B.+Mitchellauthor=T.+van+Mourikauthor=M.+V.+Fedorov&title=First-Principles+Calculation+of+the+Intrinsic+Aqueous+Solubility+of+Crystalline+Druglike+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">First-Principles Calculation of the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules</span></div><div class="casAuthors">Palmer, David S.; McDonagh, James L.; Mitchell, John B. O.; van Mourik, Tanja; Fedorov, Maxim V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3322-3337</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate that the intrinsic aq. soly. of cryst. druglike mols. can be estd. with reasonable accuracy from sublimation free energies calcd. using crystal lattice simulations and hydration free energies calcd. using the 3D Ref. Interaction Site Model (3D-RISM) of the Integral Equation Theory of Mol. Liqs. (IET).  The solubilities of 25 cryst. druglike mols. taken from different chem. classes are predicted by the model with a correlation coeff. of R = 0.85 and a root mean square error (RMSE) equal to 1.45 log10S units, which is significantly more accurate than results obtained using implicit continuum solvent models.  The method is not directly parametrized against exptl. soly. data, and it offers a full computational characterization of the thermodn. of transfer of the drug mol. from crystal phase to gas phase to dil. aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo2R_l3phcErVg90H21EOLACvtfcHk0li4C4j68IuNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsrnE&md5=fbcfafe07e5f8ccb8acc2414bdb3a021</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fct300345m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300345m%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DD.%2BS.%26aulast%3DMcDonagh%26aufirst%3DJ.%2BL.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26aulast%3Dvan%2BMourik%26aufirst%3DT.%26aulast%3DFedorov%26aufirst%3DM.%2BV.%26atitle%3DFirst-Principles%2520Calculation%2520of%2520the%2520Intrinsic%2520Aqueous%2520Solubility%2520of%2520Crystalline%2520Druglike%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D3322%26epage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Veith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fayne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artemenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span> </span><span class="NLM_article-title">Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity Across Chemical Libraries</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1050</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1050-1055&issue=11&author=H.+Veithauthor=N.+Southallauthor=R.+Huangauthor=T.+Jamesauthor=D.+Fayneauthor=N.+Artemenkoauthor=M.+Shenauthor=J.+Ingleseauthor=C.+P.+Austinauthor=D.+G.+Lloydauthor=D.+S.+Auld&title=Comprehensive+Characterization+of+Cytochrome+P450+Isozyme+Selectivity+Across+Chemical+Libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeith%26aufirst%3DH.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DJames%26aufirst%3DT.%26aulast%3DFayne%26aufirst%3DD.%26aulast%3DArtemenko%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DComprehensive%2520Characterization%2520of%2520Cytochrome%2520P450%2520Isozyme%2520Selectivity%2520Across%2520Chemical%2520Libraries%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26issue%3D11%26spage%3D1050%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Diana, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutko, F. J.</span><span> </span><span class="NLM_article-title">Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00008a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1355-1371&issue=8&author=G.+D.+Dianaauthor=P.+Rudewiczauthor=D.+C.+Pevearauthor=T.+J.+Nitzauthor=S.+C.+Aldousauthor=D.+J.+Aldousauthor=D.+T.+Robinsonauthor=T.+Draperauthor=F.+J.+Dutko&title=Picornavirus+Inhibitors%3A+Trifluoromethyl+Substitution+Provides+a+Global+Protective+Effect+against+Hepatic+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm00008a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00008a014%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DD.%2BT.%26aulast%3DDraper%26aufirst%3DT.%26aulast%3DDutko%26aufirst%3DF.%2BJ.%26atitle%3DPicornavirus%2520Inhibitors%253A%2520Trifluoromethyl%2520Substitution%2520Provides%2520a%2520Global%2520Protective%2520Effect%2520against%2520Hepatic%2520Metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26issue%3D8%26spage%3D1355%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0li4C4j68IuNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bach, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitrenko, O.</span><span> </span><span class="NLM_article-title">Strain Energy of Small Ring Hydrocarbons. Influence of C-H Bond Dissociation Energies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4444</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja036309a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=4444-4452&issue=13&author=R.+D.+Bachauthor=O.+Dmitrenko&title=Strain+Energy+of+Small+Ring+Hydrocarbons.+Influence+of+C-H+Bond+Dissociation+Energies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja036309a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja036309a%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DR.%2BD.%26aulast%3DDmitrenko%26aufirst%3DO.%26atitle%3DStrain%2520Energy%2520of%2520Small%2520Ring%2520Hydrocarbons.%2520Influence%2520of%2520C-H%2520Bond%2520Dissociation%2520Energies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D13%26spage%3D4444%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahrendt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, G.</span><span> </span><span class="NLM_article-title">Pyrazolopyridine Inhibitors of B-Raf <sup>V600E</sup>. Part 3: An Increase in Aqueous Solubility via the Disruption of Crystal Packing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=912-915&issue=2&author=S.+Wenglowskyauthor=D.+Morenoauthor=J.+Rudolphauthor=Y.+Ranauthor=K.+A.+Ahrendtauthor=A.+Arrigoauthor=B.+Colsonauthor=S.+L.+Gloorauthor=G.+Hastings&title=Pyrazolopyridine+Inhibitors+of+B-Raf+V600E.+Part+3%3A+An+Increase+in+Aqueous+Solubility+via+the+Disruption+of+Crystal+Packing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DAhrendt%26aufirst%3DK.%2BA.%26aulast%3DArrigo%26aufirst%3DA.%26aulast%3DColson%26aufirst%3DB.%26aulast%3DGloor%26aufirst%3DS.%2BL.%26aulast%3DHastings%26aufirst%3DG.%26atitle%3DPyrazolopyridine%2520Inhibitors%2520of%2520B-Raf%2520V600E.%2520Part%25203%253A%2520An%2520Increase%2520in%2520Aqueous%2520Solubility%2520via%2520the%2520Disruption%2520of%2520Crystal%2520Packing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D912%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Schuürer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskal, S. M.</span><span> </span><span class="NLM_article-title">Kinome-Wide Activity Modeling from Diverse Public High-Quality Data Sets</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300403k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=27-38&issue=1&author=S.+C.+Schu%C3%BCrerauthor=S.+M.+Muskal&title=Kinome-Wide+Activity+Modeling+from+Diverse+Public+High-Quality+Data+Sets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fci300403k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300403k%26sid%3Dliteratum%253Aachs%26aulast%3DSchu%25C3%25BCrer%26aufirst%3DS.%2BC.%26aulast%3DMuskal%26aufirst%3DS.%2BM.%26atitle%3DKinome-Wide%2520Activity%2520Modeling%2520from%2520Diverse%2520Public%2520High-Quality%2520Data%2520Sets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26issue%3D1%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kitagawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiwaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirii, Y.</span><span> </span><span class="NLM_article-title">Activity-Based Kinase Profiling of Approved Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1111%2Fgtc.12022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=23279183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlajurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=110-122&issue=2&author=D.+Kitagawaauthor=K.+Yokotaauthor=M.+Goudaauthor=Y.+Narumiauthor=H.+Ohmotoauthor=E.+Nishiwakiauthor=K.+Akitaauthor=Y.+Kirii&title=Activity-Based+Kinase+Profiling+of+Approved+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based kinase profiling of approved tyrosine kinase inhibitors</span></div><div class="casAuthors">Kitagawa, Daisuke; Yokota, Koichi; Gouda, Masaki; Narumi, Yugo; Ohmoto, Hiroshi; Nishiwaki, Eiji; Akita, Kensaku; Kirii, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The specificities of nine approved tyrosine kinase inhibitors (imatinib, dasatinib, nilotinib, gefitinib, erlotinib, lapatinib, sorafenib, sunitinib, and pazopanib) were detd. by activity-based kinase profiling using a large panel of human recombinant active kinases.  This panel consisted of 79 tyrosine kinases, 199 serine/threonine kinases, three lipid kinases, and 29 disease-relevant mutant kinases.  Many potential targets of each inhibitor were identified by kinase profiling at the Km for ATP.  In addn., profiling at a physiol. ATP concn. (1 mm) was carried out, and the IC50 values of the inhibitors against each kinase were compared with the estd. plasma-free concn. (calcd. from published pharmacokinetic parameters of plasma Ctrough and Cmax values).  This anal. revealed that the approved kinase inhibitors were well optimized for their target kinases.  This profiling also implicates activity at particular off-target kinases in drug side effects.  Thus, large-scale kinase profiling at both Km and physiol. ATP concns. could be useful in characterizing the targets and off-targets of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUe0U00YKTHbVg90H21EOLACvtfcHk0lhsgKFuFA3nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlajurs%253D&md5=a30fd15aa57d46e7d6d461a80907e0e2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12022%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DD.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DGouda%26aufirst%3DM.%26aulast%3DNarumi%26aufirst%3DY.%26aulast%3DOhmoto%26aufirst%3DH.%26aulast%3DNishiwaki%26aufirst%3DE.%26aulast%3DAkita%26aufirst%3DK.%26aulast%3DKirii%26aufirst%3DY.%26atitle%3DActivity-Based%2520Kinase%2520Profiling%2520of%2520Approved%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DGenes%2520Cells%26date%3D2013%26volume%3D18%26issue%3D2%26spage%3D110%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&issue=11&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lhsgKFuFA3nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1039%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the Reversible Inhibition of Enzyme-Catalysed Reactions by Tight-Binding Inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&issue=2&author=J.+F.+Morrison&title=Kinetics+of+the+Reversible+Inhibition+of+Enzyme-Catalysed+Reactions+by+Tight-Binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lhsgKFuFA3nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520Reversible%2520Inhibition%2520of%2520Enzyme-Catalysed%2520Reactions%2520by%2520Tight-Binding%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26issue%3D2%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of Enzyme Inhibitors in Drug Discovery. A guide for Medicinal Chemists and Pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=178-189&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery.+A+guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery.%2520A%2520guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D178%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&issue=6&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.+D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+Situ+Kinase+Profiling+Reveals+Functionally+Relevant+Properties+of+Native+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0li5ZLnxIEIdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520Situ%2520Kinase%2520Profiling%2520Reveals%2520Functionally%2520Relevant%2520Properties%2520of%2520Native%2520Kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D6%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Walters, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffregen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">RNAi-Induced down-Regulation of FLT3 Expression in AML Cell Lines Increases Sensitivity to MLN518</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2952</span><span class="NLM_x">–</span> <span class="NLM_lpage">2954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2952-2954&issue=7&author=D.+K.+Waltersauthor=E.+P.+Stoffregenauthor=M.+C.+Heinrichauthor=M.+W.+Deiningerauthor=B.+J.+Druker&title=RNAi-Induced+down-Regulation+of+FLT3+Expression+in+AML+Cell+Lines+Increases+Sensitivity+to+MLN518"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DD.%2BK.%26aulast%3DStoffregen%26aufirst%3DE.%2BP.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DRNAi-Induced%2520down-Regulation%2520of%2520FLT3%2520Expression%2520in%2520AML%2520Cell%2520Lines%2520Increases%2520Sensitivity%2520to%2520MLN518%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D7%26spage%3D2952%26epage%3D2954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c','cit15d'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f','cit16g'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 76 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Muhammad Faisal, Jae Ho Kim, Kyung Ho Yoo, Eun Joo Roh, Soon Sun Hong, <span class="NLM_string-name hlFld-ContribAuthor">So Ha Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Therapeutic Potential of NUAKs Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 2-25. <a href="https://doi.org/10.1021/acs.jmedchem.0c00533" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00533%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252BTherapeutic%252BPotential%252Bof%252BNUAKs%252BInhibitors%26aulast%3DFaisal%26aufirst%3DMuhammad%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01042020%26date%3D24122020%26volume%3D64%26issue%3D1%26spage%3D2%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yue Zhong, Run-Ze Qiu, Shan-Liang Sun, Chao Zhao, Tian-Yuan Fan, Min Chen, Nian-Guang Li, <span class="NLM_string-name hlFld-ContribAuthor">Zhi-Hao Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12403-12428. <a href="https://doi.org/10.1021/acs.jmedchem.0c00696" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BFms-like%252BTyrosine%252BKinase%252B3%252BInhibitors%25253A%252BAn%252BAttractive%252Band%252BEfficient%252BMethod%252Bfor%252Bthe%252BTreatment%252Bof%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DZhong%26aufirst%3DYue%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26042020%26date%3D21072020%26date%3D13072020%26volume%3D63%26issue%3D21%26spage%3D12403%26epage%3D12428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tigran M. Abramyan, Yi An, <span class="NLM_string-name hlFld-ContribAuthor">Dmitri Kireev</span>. </span><span class="cited-content_cbyCitation_article-title">Off-Pocket Activity Cliffs: A Puzzling Facet of Molecular Recognition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (1)
                                     , 152-161. <a href="https://doi.org/10.1021/acs.jcim.9b00731" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00731%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DOff-Pocket%252BActivity%252BCliffs%25253A%252BA%252BPuzzling%252BFacet%252Bof%252BMolecular%252BRecognition%26aulast%3DAbramyan%26aufirst%3DTigran%2BM.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D31082019%26date%3D16122019%26date%3D02122019%26volume%3D60%26issue%3D1%26spage%3D152%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chenxiao Da, Dehui Zhang, Michael Stashko, Eleana Vasileiadi, Rebecca E. Parker, Katherine A. Minson, Madeline G. Huey, Justus M. Huelse, Debra Hunter, Thomas S. K. Gilbert, Jacqueline Norris-Drouin, Michael Miley, Laura E. Herring, Lee M. Graves, Deborah DeRyckere, H. Shelton Earp, Douglas K. Graham, Stephen V. Frye, Xiaodong Wang, <span class="NLM_string-name hlFld-ContribAuthor">Dmitri Kireev</span>. </span><span class="cited-content_cbyCitation_article-title">Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (39)
                                     , 15700-15709. <a href="https://doi.org/10.1021/jacs.9b08660" title="DOI URL">https://doi.org/10.1021/jacs.9b08660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08660%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DData-Driven%252BConstruction%252Bof%252BAntitumor%252BAgents%252Bwith%252BControlled%252BPolypharmacology%26aulast%3DDa%26aufirst%3DChenxiao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10082019%26date%3D20092019%26date%3D09092019%26volume%3D141%26issue%3D39%26spage%3D15700%26epage%3D15709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xue Yuan, Yong Chen, Wanhua Zhang, Jun He, Lei Lei, Minghai Tang, Jiang Liu, Muzhou Li, Caixia Dou, Tao Yang, Linyu Yang, Shengyong Yang, Yuquan Wei, Aihua Peng, Ting Niu, Mingli Xiang, Haoyu Ye, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Pyrrolo[2,3-d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 4158-4173. <a href="https://doi.org/10.1021/acs.jmedchem.9b00223" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-Based%252BDerivatives%252Bas%252BPotent%252Band%252BOrally%252BEffective%252BFms-like%252BTyrosine%252BReceptor%252BKinase%252B3%252B%252528FLT3%252529%252BInhibitors%252Bfor%252BTreating%252BAcute%252BMyelogenous%252BLeukemia%26aulast%3DYuan%26aufirst%3DXue%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02022019%26date%3D15042019%26date%3D02042019%26volume%3D62%26issue%3D8%26spage%3D4158%26epage%3D4173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jichen Zhao, Dehui Zhang, Weihe Zhang, Michael A. Stashko, Deborah DeRyckere, Eleana Vasileiadi, Rebecca E. Parker, Debra Hunter, Qingyang Liu, Yuewei Zhang, Jacqueline Norris-Drouin, Bing Li, David H. Drewry, Dmitri Kireev, Douglas K. Graham, Henry Shelton Earp, Stephen V. Frye, <span class="NLM_string-name hlFld-ContribAuthor">Xiaodong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10242-10254. <a href="https://doi.org/10.1021/acs.jmedchem.8b01229" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSelective%252BMERTK%252BInhibitors%252BAchieved%252Bby%252Ba%252BSingle%252BMethyl%252BGroup%26aulast%3DZhao%26aufirst%3DJichen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10092018%26date%3D05112018%26date%3D22102018%26volume%3D61%26issue%3D22%26spage%3D10242%26epage%3D10254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">James  Nichols</span>, <span class="hlFld-ContribAuthor ">Michael J.  Miley</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Norris-Drouin</span>, <span class="hlFld-ContribAuthor ">Zhilong  Chen</span>, <span class="hlFld-ContribAuthor ">Mischa  Machius</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Edgar  Wood</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, and <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 1044-1049. <a href="https://doi.org/10.1021/acsmedchemlett.6b00221" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00221%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BMacrocyclic%252BMer%252BTyrosine%252BKinase%252BInhibitors%26aulast%3DWang%26aufirst%3DXiaodong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26052016%26date%3D13092016%26date%3D21092016%26date%3D08122016%26date%3D13092016%26volume%3D7%26issue%3D12%26spage%3D1044%26epage%3D1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel H.  Myers</span>, <span class="hlFld-ContribAuthor ">Valerie G.  Brunton</span>, and <span class="hlFld-ContribAuthor ">Asier  Unciti-Broceta</span>  . </span><span class="cited-content_cbyCitation_article-title">AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3593-3608. <a href="https://doi.org/10.1021/acs.jmedchem.5b01273" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAXL%252BInhibitors%252Bin%252BCancer%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DMyers%26aufirst%3DSamuel%2BH.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D14082015%26date%3D20112015%26date%3D28042016%26date%3D10112015%26volume%3D59%26issue%3D8%26spage%3D3593%26epage%3D3608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xixiang  Li</span>, <span class="hlFld-ContribAuthor ">Aoli  Wang</span>, <span class="hlFld-ContribAuthor ">Kailin  Yu</span>, <span class="hlFld-ContribAuthor ">Ziping  Qi</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Wenchao  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Hu</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Jiaxin  Wu</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Juan  Liu</span>, <span class="hlFld-ContribAuthor ">Fengming  Zou</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Beilei  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Shanchun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, and <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a Potent and Orally Available FLT3 Kinase Inhibitor for FLT3-ITD Positive Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (24)
                                     , 9625-9638. <a href="https://doi.org/10.1021/acs.jmedchem.5b01611" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01611%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%252529-1-%2525283-%2525284-Amino-3-%2525284-phenoxyphenyl%252529-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-1-yl%252529piperidin-1-yl%252529-2-%252528dimethylamino%252529ethanone%252B%252528CHMFL-FLT3-122%252529%252Bas%252Ba%252BPotent%252Band%252BOrally%252BAvailable%252BFLT3%252BKinase%252BInhibitor%252Bfor%252BFLT3-ITD%252BPositive%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DLi%26aufirst%3DXixiang%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05082015%26date%3D14122015%26date%3D24122015%26date%3D02122015%26volume%3D58%26issue%3D24%26spage%3D9625%26epage%3D9638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>  . </span><span class="cited-content_cbyCitation_article-title">Screening-Based Translation of Public Research Encounters Painful Problems. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 229-234. <a href="https://doi.org/10.1021/acsmedchemlett.5b00032" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00032%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScreening-Based%252BTranslation%252Bof%252BPublic%252BResearch%252BEncounters%252BPainful%252BProblems%26aulast%3DBaell%26aufirst%3DJonathan%2BB.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D03022015%26date%3D23012015%26date%3D09022015%26date%3D12032015%26volume%3D6%26issue%3D3%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amir  Tajbakhsh</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Gheibi hayat</span>, <span class="hlFld-ContribAuthor ">Ahmad  Movahedpour</span>, <span class="hlFld-ContribAuthor ">Amir  Savardashtaki</span>, <span class="hlFld-ContribAuthor ">Reid  Loveless</span>, <span class="hlFld-ContribAuthor ">George E.  Barreto</span>, <span class="hlFld-ContribAuthor ">Yong  Teng</span>, <span class="hlFld-ContribAuthor ">Amirhossein  Sahebkar</span>. </span><span class="cited-content_cbyCitation_article-title">The complex roles of efferocytosis in cancer development, metastasis, and treatment. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2021,</strong> <em>140 </em>, 111776. <a href="https://doi.org/10.1016/j.biopha.2021.111776" title="DOI URL">https://doi.org/10.1016/j.biopha.2021.111776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2021.111776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2021.111776%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DThe%252Bcomplex%252Broles%252Bof%252Befferocytosis%252Bin%252Bcancer%252Bdevelopment%25252C%252Bmetastasis%25252C%252Band%252Btreatment%26aulast%3DTajbakhsh%26aufirst%3DAmir%26date%3D2021%26volume%3D140%26spage%3D111776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongchao  Zheng</span>, <span class="hlFld-ContribAuthor ">Jichen  Zhao</span>, <span class="hlFld-ContribAuthor ">Bing  Li</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Minson</span>, <span class="hlFld-ContribAuthor ">Madeline G.  Huey</span>, <span class="hlFld-ContribAuthor ">Yubai  Zhou</span>, <span class="hlFld-ContribAuthor ">Henry Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">UNC5293, a potent, orally available and highly MERTK-selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113534. <a href="https://doi.org/10.1016/j.ejmech.2021.113534" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113534%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUNC5293%25252C%252Ba%252Bpotent%25252C%252Borally%252Bavailable%252Band%252Bhighly%252BMERTK-selective%252Binhibitor%26aulast%3DZheng%26aufirst%3DHongchao%26date%3D2021%26volume%3D220%26spage%3D113534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Bistrović Popov</span>, <span class="hlFld-ContribAuthor ">Robert  Vianelo</span>, <span class="hlFld-ContribAuthor ">Petra  Grbčić</span>, <span class="hlFld-ContribAuthor ">Mirela  Sedić</span>, <span class="hlFld-ContribAuthor ">Sandra Kraljević  Pavelić</span>, <span class="hlFld-ContribAuthor ">Krešimir  Pavelić</span>, <span class="hlFld-ContribAuthor ">Silvana  Raić-Malić</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3334. <a href="https://doi.org/10.3390/molecules26113334" title="DOI URL">https://doi.org/10.3390/molecules26113334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113334%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BBis-%252Band%252BMono-Pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Band%252BPurine%252BDerivatives%25253A%252BSynthesis%25252C%252BComputational%252BAnalysis%252Band%252BAntiproliferative%252BEvaluation%26aulast%3DBistrovi%25C4%2587%2BPopov%26aufirst%3DAndrea%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Siu  Wai Wong</span>, <span class="hlFld-ContribAuthor ">Ariadna  Recasens</span>, <span class="hlFld-ContribAuthor ">Ramzi  Abbassi</span>, <span class="hlFld-ContribAuthor ">Nghi  Nguyen</span>, <span class="hlFld-ContribAuthor ">Dehui  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen  Frye</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Jonathan  Baell</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>. </span><span class="cited-content_cbyCitation_article-title">MerTK activity is not necessary for the proliferation of glioblastoma stem cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>186 </em>, 114437. <a href="https://doi.org/10.1016/j.bcp.2021.114437" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114437%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMerTK%252Bactivity%252Bis%252Bnot%252Bnecessary%252Bfor%252Bthe%252Bproliferation%252Bof%252Bglioblastoma%252Bstem%252Bcells%26aulast%3DHoque%26aufirst%3DMonira%26date%3D2021%26volume%3D186%26spage%3D114437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuefei  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiangrui  Liu</span>, <span class="hlFld-ContribAuthor ">Leaf  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention. </span><span class="cited-content_cbyCitation_journal-name">Advanced Functional Materials</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 2006220. <a href="https://doi.org/10.1002/adfm.202006220" title="DOI URL">https://doi.org/10.1002/adfm.202006220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adfm.202006220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadfm.202006220%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Functional%2520Materials%26atitle%3DMacrophage%2525E2%252580%252590Mediated%252BTumor%252BCell%252BPhagocytosis%25253A%252BOpportunity%252Bfor%252BNanomedicine%252BIntervention%26aulast%3DZhou%26aufirst%3DXuefei%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D5%26spage%3D2006220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rossella  Di Stasi</span>, <span class="hlFld-ContribAuthor ">Lucia  De Rosa</span>, <span class="hlFld-ContribAuthor ">Luca D.  D’Andrea</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic aspects of the Axl/Gas6 molecular system. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2130-2148. <a href="https://doi.org/10.1016/j.drudis.2020.09.022" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.09.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.09.022%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTherapeutic%252Baspects%252Bof%252Bthe%252BAxl%25252FGas6%252Bmolecular%252Bsystem%26aulast%3DDi%2BStasi%26aufirst%3DRossella%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2130%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jenna L.  Carter</span>, <span class="hlFld-ContribAuthor ">Katie  Hege</span>, <span class="hlFld-ContribAuthor ">Jay  Yang</span>, <span class="hlFld-ContribAuthor ">Hasini A.  Kalpage</span>, <span class="hlFld-ContribAuthor ">Yongwei  Su</span>, <span class="hlFld-ContribAuthor ">Holly  Edwards</span>, <span class="hlFld-ContribAuthor ">Maik  Hüttemann</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Taub</span>, <span class="hlFld-ContribAuthor ">Yubin  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00361-x" title="DOI URL">https://doi.org/10.1038/s41392-020-00361-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00361-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00361-x%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DTargeting%252Bmultiple%252Bsignaling%252Bpathways%25253A%252Bthe%252Bnew%252Bapproach%252Bto%252Bacute%252Bmyeloid%252Bleukemia%252Btherapy%26aulast%3DCarter%26aufirst%3DJenna%2BL.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaoyu  Chen</span>, <span class="hlFld-ContribAuthor ">Margaret  Favata</span>, <span class="hlFld-ContribAuthor ">Michelle  Pusey</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Yvonne  Lo</span>, <span class="hlFld-ContribAuthor ">Min  Ye</span>, <span class="hlFld-ContribAuthor ">Richard  Wynn</span>, <span class="hlFld-ContribAuthor ">Xiaozhao  Wang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Yao</span>, <span class="hlFld-ContribAuthor ">Yingnan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of pAKT as a pharmacodynamic marker for MER kinase in human melanoma G361 cells. </span><span class="cited-content_cbyCitation_journal-name">Biomarker Research</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40364-020-0184-9" title="DOI URL">https://doi.org/10.1186/s40364-020-0184-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40364-020-0184-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40364-020-0184-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomarker%2520Research%26atitle%3DIdentification%252Bof%252BpAKT%252Bas%252Ba%252Bpharmacodynamic%252Bmarker%252Bfor%252BMER%252Bkinase%252Bin%252Bhuman%252Bmelanoma%252BG361%252Bcells%26aulast%3DChen%26aufirst%3DYaoyu%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenchen  Zhao</span>, <span class="hlFld-ContribAuthor ">Jianjia  Fan</span>, <span class="hlFld-ContribAuthor ">Iva  Kulic</span>, <span class="hlFld-ContribAuthor ">Cheryl  Koh</span>, <span class="hlFld-ContribAuthor ">Amanda  Clark</span>, <span class="hlFld-ContribAuthor ">Johan  Meuller</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>, <span class="hlFld-ContribAuthor ">Samantha  Barichievy</span>, <span class="hlFld-ContribAuthor ">Carina  Raynoschek</span>, <span class="hlFld-ContribAuthor ">Ryan  Hicks</span>, <span class="hlFld-ContribAuthor ">Marcello  Maresca</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Dean G.  Brown</span>, <span class="hlFld-ContribAuthor ">Alvin  Lok</span>, <span class="hlFld-ContribAuthor ">Cameron  Parro</span>, <span class="hlFld-ContribAuthor ">Jerome  Robert</span>, <span class="hlFld-ContribAuthor ">Hsien-Ya  Chou</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Zuhl</span>, <span class="hlFld-ContribAuthor ">Michael W.  Wood</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Brandon</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Wellington</span>. </span><span class="cited-content_cbyCitation_article-title">Axl receptor tyrosine kinase is a regulator of apolipoprotein E. </span><span class="cited-content_cbyCitation_journal-name">Molecular Brain</span><span> <strong>2020,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13041-020-00609-1" title="DOI URL">https://doi.org/10.1186/s13041-020-00609-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13041-020-00609-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13041-020-00609-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Brain%26atitle%3DAxl%252Breceptor%252Btyrosine%252Bkinase%252Bis%252Ba%252Bregulator%252Bof%252Bapolipoprotein%252BE%26aulast%3DZhao%26aufirst%3DWenchen%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Pflug</span>, <span class="hlFld-ContribAuthor ">Marianne  Schimpl</span>, <span class="hlFld-ContribAuthor ">J. Willem M.  Nissink</span>, <span class="hlFld-ContribAuthor ">Ross C.  Overman</span>, <span class="hlFld-ContribAuthor ">Philip B.  Rawlins</span>, <span class="hlFld-ContribAuthor ">Caroline  Truman</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Underwood</span>, <span class="hlFld-ContribAuthor ">Juli  Warwicker</span>, <span class="hlFld-ContribAuthor ">Jon  Winter-Holt</span>, <span class="hlFld-ContribAuthor ">William  McCoull</span>. </span><span class="cited-content_cbyCitation_article-title">A-loop interactions in Mer tyrosine kinase give rise to inhibitors with two-step mechanism and long residence time of binding. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (22)
                                     , 4443-4452. <a href="https://doi.org/10.1042/BCJ20200735" title="DOI URL">https://doi.org/10.1042/BCJ20200735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200735%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DA-loop%252Binteractions%252Bin%252BMer%252Btyrosine%252Bkinase%252Bgive%252Brise%252Bto%252Binhibitors%252Bwith%252Btwo-step%252Bmechanism%252Band%252Blong%252Bresidence%252Btime%252Bof%252Bbinding%26aulast%3DPflug%26aufirst%3DAlexander%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D22%26spage%3D4443%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tae Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Seung-Hyun  Bae</span>, <span class="hlFld-ContribAuthor ">Seoung Min  Bong</span>, <span class="hlFld-ContribAuthor ">Seong Eon  Ryu</span>, <span class="hlFld-ContribAuthor ">Hyonchol  Jang</span>, <span class="hlFld-ContribAuthor ">Byung Il  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structure of the Kinase Domain of MerTK in Complex with AZD7762 Provides Clues for Structure-Based Drug Development. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 7878. <a href="https://doi.org/10.3390/ijms21217878" title="DOI URL">https://doi.org/10.3390/ijms21217878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21217878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21217878%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCrystal%252BStructure%252Bof%252Bthe%252BKinase%252BDomain%252Bof%252BMerTK%252Bin%252BComplex%252Bwith%252BAZD7762%252BProvides%252BClues%252Bfor%252BStructure-Based%252BDrug%252BDevelopment%26aulast%3DPark%26aufirst%3DTae%2BHyun%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D7878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Baillache</span>, <span class="hlFld-ContribAuthor ">Asier  Unciti-Broceta</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-
              d
              ]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1112-1135. <a href="https://doi.org/10.1039/D0MD00227E" title="DOI URL">https://doi.org/10.1039/D0MD00227E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00227E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00227E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bin%252Banticancer%252Bkinase%252Binhibitors%252Bbased%252Bon%252Bthe%252Bpyrazolo%25255B3%25252C4-%252Bd%252B%25255Dpyrimidine%252Bscaffold%26aulast%3DBaillache%26aufirst%3DDaniel%2BJ.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D10%26spage%3D1112%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Giroud</span>, <span class="hlFld-ContribAuthor ">Sarah  Renaudineau</span>, <span class="hlFld-ContribAuthor ">Laura  Gudefin</span>, <span class="hlFld-ContribAuthor ">Alexandre  Calcei</span>, <span class="hlFld-ContribAuthor ">Thierry  Menguy</span>, <span class="hlFld-ContribAuthor ">Caroline  Rozan</span>, <span class="hlFld-ContribAuthor ">Jacques  Mizrahi</span>, <span class="hlFld-ContribAuthor ">Christophe  Caux</span>, <span class="hlFld-ContribAuthor ">Vanessa  Duong</span>, <span class="hlFld-ContribAuthor ">Jenny  Valladeau-Guilemond</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fimmu.2020.564133" title="DOI URL">https://doi.org/10.3389/fimmu.2020.564133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2020.564133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2020.564133%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DExpression%252Bof%252BTAM-R%252Bin%252BHuman%252BImmune%252BCells%252Band%252BUnique%252BRegulatory%252BFunction%252Bof%252BMerTK%252Bin%252BIL-10%252BProduction%252Bby%252BTolerogenic%252BDC%26aulast%3DGiroud%26aufirst%3DPaul%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justus M.  Huelse</span>, <span class="hlFld-ContribAuthor ">Diana M.  Fridlyand</span>, <span class="hlFld-ContribAuthor ">Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>213 </em>, 107577. <a href="https://doi.org/10.1016/j.pharmthera.2020.107577" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107577%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMERTK%252Bin%252Bcancer%252Btherapy%25253A%252BTargeting%252Bthe%252Breceptor%252Btyrosine%252Bkinase%252Bin%252Btumor%252Bcells%252Band%252Bthe%252Bimmune%252Bsystem%26aulast%3DHuelse%26aufirst%3DJustus%2BM.%26date%3D2020%26volume%3D213%26spage%3D107577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dennis  Kobelt</span>, <span class="hlFld-ContribAuthor ">Mathias  Dahlmann</span>, <span class="hlFld-ContribAuthor ">Malti  Dumbani</span>, <span class="hlFld-ContribAuthor ">Nazli  Güllü</span>, <span class="hlFld-ContribAuthor ">Benedikt  Kortüm</span>, <span class="hlFld-ContribAuthor ">Miguel E. Alberto  Vílchez</span>, <span class="hlFld-ContribAuthor ">Ulrike  Stein</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Walther</span>. </span><span class="cited-content_cbyCitation_article-title">Small Ones to Fight a Big Problem—Intervention of Cancer Metastasis by Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1454. <a href="https://doi.org/10.3390/cancers12061454" title="DOI URL">https://doi.org/10.3390/cancers12061454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061454%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSmall%252BOnes%252Bto%252BFight%252Ba%252BBig%252BProblem%2525E2%252580%252594Intervention%252Bof%252BCancer%252BMetastasis%252Bby%252BSmall%252BMolecules%26aulast%3DKobelt%26aufirst%3DDennis%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lexian  Tong</span>, <span class="hlFld-ContribAuthor ">Xuemei  Li</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in FLT3 inhibitors for acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 961-981. <a href="https://doi.org/10.4155/fmc-2019-0365" title="DOI URL">https://doi.org/10.4155/fmc-2019-0365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0365%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252BFLT3%252Binhibitors%252Bfor%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DTong%26aufirst%3DLexian%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D961%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yuqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Shouyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-target kinase drug design: Current strategies and future directions in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 112025. <a href="https://doi.org/10.1016/j.ejmech.2019.112025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.112025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.112025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.112025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-target%252Bkinase%252Bdrug%252Bdesign%25253A%252BCurrent%252Bstrategies%252Band%252Bfuture%252Bdirections%252Bin%252Bcancer%252Btherapy%26aulast%3DSun%26aufirst%3DDejuan%26date%3D2020%26volume%3D188%26spage%3D112025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nellie K.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Samantha R.  Fischbach</span>, <span class="hlFld-ContribAuthor ">Olivia J.  Ondracek</span>, <span class="hlFld-ContribAuthor ">Noah B.  Welke</span>, <span class="hlFld-ContribAuthor ">Mari  Iida</span>, <span class="hlFld-ContribAuthor ">Deric L.  Wheeler</span>. </span><span class="cited-content_cbyCitation_article-title">TAM family proteins and therapy resistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 159-192. <a href="https://doi.org/10.1016/B978-0-12-817868-3.00008-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-817868-3.00008-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817868-3.00008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817868-3.00008-1%26sid%3Dliteratum%253Aachs%26atitle%3DTAM%252Bfamily%252Bproteins%252Band%252Btherapy%252Bresistance%26aulast%3DMcDaniel%26aufirst%3DNellie%2BK.%26date%3D2020%26spage%3D159%26epage%3D192%26pub%3DElsevier%26atitle%3DImproving%252Bthe%252BTherapeutic%252BRatio%252Bin%252BHead%252Band%252BNeck%252BCancer%26date%3D2020%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Varsha  Gadiyar</span>, <span class="hlFld-ContribAuthor ">Gopi  Patel</span>, <span class="hlFld-ContribAuthor ">Viralkumar  Davra</span>. </span><span class="cited-content_cbyCitation_article-title">Immunological role of TAM receptors in the cancer microenvironment. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 57-79. <a href="https://doi.org/10.1016/bs.ircmb.2020.09.011" title="DOI URL">https://doi.org/10.1016/bs.ircmb.2020.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.ircmb.2020.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.ircmb.2020.09.011%26sid%3Dliteratum%253Aachs%26atitle%3DImmunological%252Brole%252Bof%252BTAM%252Breceptors%252Bin%252Bthe%252Bcancer%252Bmicroenvironment%26aulast%3DGadiyar%26aufirst%3DVarsha%26date%3D2020%26spage%3D57%26epage%3D79%26pub%3DElsevier%26atitle%3DTAM%252BReceptors%252Bin%252BHealth%252Band%252BDisease%26date%3D2020%26volume%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kayla V.  Myers</span>, <span class="hlFld-ContribAuthor ">Sarah R.  Amend</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Pienta</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2019,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-019-1022-2" title="DOI URL">https://doi.org/10.1186/s12943-019-1022-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-019-1022-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-019-1022-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DTargeting%252BTyro3%25252C%252BAxl%252Band%252BMerTK%252B%252528TAM%252Breceptors%252529%25253A%252Bimplications%252Bfor%252Bmacrophages%252Bin%252Bthe%252Btumor%252Bmicroenvironment%26aulast%3DMyers%26aufirst%3DKayla%2BV.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenjing  Zhu</span>, <span class="hlFld-ContribAuthor ">Yuquan  Wei</span>, <span class="hlFld-ContribAuthor ">Xiawei  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer</span><span> <strong>2019,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12943-019-1090-3" title="DOI URL">https://doi.org/10.1186/s12943-019-1090-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12943-019-1090-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12943-019-1090-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%26atitle%3DAXL%252Breceptor%252Btyrosine%252Bkinase%252Bas%252Ba%252Bpromising%252Banti-cancer%252Bapproach%25253A%252Bfunctions%25252C%252Bmolecular%252Bmechanisms%252Band%252Bclinical%252Bapplications%26aulast%3DZhu%26aufirst%3DChenjing%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Bearz</span>, <span class="hlFld-ContribAuthor ">Sara  Cecco</span>, <span class="hlFld-ContribAuthor ">Sara  Francescon</span>, <span class="hlFld-ContribAuthor ">Francesco Lo  Re</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Corona</span>, <span class="hlFld-ContribAuthor ">Paolo  Baldo</span>. </span><span class="cited-content_cbyCitation_article-title">Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Recent Patents on Anti-Cancer Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (3)
                                     , 242-257. <a href="https://doi.org/10.2174/1574892814666190726124735" title="DOI URL">https://doi.org/10.2174/1574892814666190726124735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1574892814666190726124735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1574892814666190726124735%26sid%3Dliteratum%253Aachs%26jtitle%3DRecent%2520Patents%2520on%2520Anti-Cancer%2520Drug%2520Discovery%26atitle%3DSafety%252BProfiles%252Band%252BPharmacovigilance%252BConsiderations%252Bfor%252BRecently%252BPatented%252BAnticancer%252BDrugs%25253A%252BLung%252BCancer%26aulast%3DBearz%26aufirst%3DAlessandra%26date%3D2019%26volume%3D14%26issue%3D3%26spage%3D242%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Baowen  Qi</span>, <span class="hlFld-ContribAuthor ">Zhongliang  Jiang</span>, <span class="hlFld-ContribAuthor ">Wenjuan  Dong</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Lan  Bai</span>, <span class="hlFld-ContribAuthor ">Rongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Jiying  Yu</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 468-483. <a href="https://doi.org/10.1016/j.ejmech.2019.06.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BFLT3%252Binhibitors%25253A%252BAgainst%252Bthe%252Bdrug%252Bresistance%252Bof%252Bacute%252Bmyeloid%252Bleukemia%252Bin%252Brecent%252Bdecade%26aulast%3DYuan%26aufirst%3DTing%26date%3D2019%26volume%3D178%26spage%3D468%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason P.  Wong</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Stuhlmiller</span>, <span class="hlFld-ContribAuthor ">Louise C.  Giffin</span>, <span class="hlFld-ContribAuthor ">Carolina  Lin</span>, <span class="hlFld-ContribAuthor ">Rachele  Bigi</span>, <span class="hlFld-ContribAuthor ">Jichen  Zhao</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Ariana G.  Bravo Cruz</span>, <span class="hlFld-ContribAuthor ">Steven I.  Park</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Dirk P.  Dittmer</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Gary L.  Johnson</span>, <span class="hlFld-ContribAuthor ">Blossom  Damania</span>. </span><span class="cited-content_cbyCitation_article-title">Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (33)
                                     , 16541-16550. <a href="https://doi.org/10.1073/pnas.1903991116" title="DOI URL">https://doi.org/10.1073/pnas.1903991116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1903991116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1903991116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DKinome%252Bprofiling%252Bof%252Bnon-Hodgkin%252Blymphoma%252Bidentifies%252BTyro3%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bprimary%252Beffusion%252Blymphoma%26aulast%3DWong%26aufirst%3DJason%2BP.%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D33%26spage%3D16541%26epage%3D16550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seong-Ah  Shin</span>, <span class="hlFld-ContribAuthor ">Sun Young  Moon</span>, <span class="hlFld-ContribAuthor ">Daeho  Park</span>, <span class="hlFld-ContribAuthor ">Jong Bae  Park</span>, <span class="hlFld-ContribAuthor ">Chang Sup  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Apoptotic cell clearance in the tumor microenvironment: a potential cancer therapeutic target. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2019,</strong> <em>42 </em>
                                    (8)
                                     , 658-671. <a href="https://doi.org/10.1007/s12272-019-01169-2" title="DOI URL">https://doi.org/10.1007/s12272-019-01169-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-019-01169-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-019-01169-2%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DApoptotic%252Bcell%252Bclearance%252Bin%252Bthe%252Btumor%252Bmicroenvironment%25253A%252Ba%252Bpotential%252Bcancer%252Btherapeutic%252Btarget%26aulast%3DShin%26aufirst%3DSeong-Ah%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D8%26spage%3D658%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanqiong  Zhang</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Pengda  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond growth signaling: apoptotic sensor MERTK activates AKT by a novel mechanism. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Oncology</span><span> <strong>2019,</strong> <em>6 </em>
                                    (4)
                                     , 1611161. <a href="https://doi.org/10.1080/23723556.2019.1611161" title="DOI URL">https://doi.org/10.1080/23723556.2019.1611161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/23723556.2019.1611161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F23723556.2019.1611161%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Oncology%26atitle%3DBeyond%252Bgrowth%252Bsignaling%25253A%252Bapoptotic%252Bsensor%252BMERTK%252Bactivates%252BAKT%252Bby%252Ba%252Bnovel%252Bmechanism%26aulast%3DZhang%26aufirst%3DYanqiong%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D4%26spage%3D1611161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julhash U.  Kazi</span>, <span class="hlFld-ContribAuthor ">Lars  Rönnstrand</span>. </span><span class="cited-content_cbyCitation_article-title">FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications. </span><span class="cited-content_cbyCitation_journal-name">Physiological Reviews</span><span> <strong>2019,</strong> <em>99 </em>
                                    (3)
                                     , 1433-1466. <a href="https://doi.org/10.1152/physrev.00029.2018" title="DOI URL">https://doi.org/10.1152/physrev.00029.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/physrev.00029.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fphysrev.00029.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Reviews%26atitle%3DFMS-like%252BTyrosine%252BKinase%252B3%25252FFLT3%25253A%252BFrom%252BBasic%252BScience%252Bto%252BClinical%252BImplications%26aulast%3DKazi%26aufirst%3DJulhash%2BU.%26date%3D2019%26volume%3D99%26issue%3D3%26spage%3D1433%26epage%3D1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mirella  Pastore</span>, <span class="hlFld-ContribAuthor ">Stefania  Grimaudo</span>, <span class="hlFld-ContribAuthor ">Rosaria Maria  Pipitone</span>, <span class="hlFld-ContribAuthor ">Giulia  Lori</span>, <span class="hlFld-ContribAuthor ">Chiara  Raggi</span>, <span class="hlFld-ContribAuthor ">Salvatore  Petta</span>, <span class="hlFld-ContribAuthor ">Fabio  Marra</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00604" title="DOI URL">https://doi.org/10.3389/fphar.2019.00604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00604%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DRole%252Bof%252BMyeloid-Epithelial-Reproductive%252BTyrosine%252BKinase%252Band%252BMacrophage%252BPolarization%252Bin%252Bthe%252BProgression%252Bof%252BAtherosclerotic%252BLesions%252BAssociated%252BWith%252BNonalcoholic%252BFatty%252BLiver%252BDisease%26aulast%3DPastore%26aufirst%3DMirella%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Canan  Kasikara</span>, <span class="hlFld-ContribAuthor ">Viralkumar  Davra</span>, <span class="hlFld-ContribAuthor ">David  Calianese</span>, <span class="hlFld-ContribAuthor ">Ke  Geng</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Spires</span>, <span class="hlFld-ContribAuthor ">Michael  Quigley</span>, <span class="hlFld-ContribAuthor ">Michael  Wichroski</span>, <span class="hlFld-ContribAuthor ">Ganapathy  Sriram</span>, <span class="hlFld-ContribAuthor ">Lucia  Suarez-Lopez</span>, <span class="hlFld-ContribAuthor ">Michael B.  Yaffe</span>, <span class="hlFld-ContribAuthor ">Sergei V.  Kotenko</span>, <span class="hlFld-ContribAuthor ">Mariana S.  De Lorenzo</span>, <span class="hlFld-ContribAuthor ">Raymond B.  Birge</span>. </span><span class="cited-content_cbyCitation_article-title">Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (10)
                                     , 2669-2683. <a href="https://doi.org/10.1158/0008-5472.CAN-18-2614" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-2614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-2614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-2614%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DPan-TAM%252BTyrosine%252BKinase%252BInhibitor%252BBMS-777607%252BEnhances%252BAnti%2525E2%252580%252593PD-1%252BmAb%252BEfficacy%252Bin%252Ba%252BMurine%252BModel%252Bof%252BTriple-Negative%252BBreast%252BCancer%26aulast%3DKasikara%26aufirst%3DCanan%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D10%26spage%3D2669%26epage%3D2683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Dufour</span>, <span class="hlFld-ContribAuthor ">Linda  Silina</span>, <span class="hlFld-ContribAuthor ">Hélène  Neyret-Kahn</span>, <span class="hlFld-ContribAuthor ">Aura  Moreno-Vega</span>, <span class="hlFld-ContribAuthor ">Clémentine  Krucker</span>, <span class="hlFld-ContribAuthor ">Narjesse  Karboul</span>, <span class="hlFld-ContribAuthor ">Marion  Dorland-Galliot</span>, <span class="hlFld-ContribAuthor ">Pascale  Maillé</span>, <span class="hlFld-ContribAuthor ">Elodie  Chapeaublanc</span>, <span class="hlFld-ContribAuthor ">Yves  Allory</span>, <span class="hlFld-ContribAuthor ">Nicolas  Stransky</span>, <span class="hlFld-ContribAuthor ">Hélène  Haegel</span>, <span class="hlFld-ContribAuthor ">Thierry  Menguy</span>, <span class="hlFld-ContribAuthor ">Vanessa  Duong</span>, <span class="hlFld-ContribAuthor ">François  Radvanyi</span>, <span class="hlFld-ContribAuthor ">Isabelle  Bernard-Pierrot</span>. </span><span class="cited-content_cbyCitation_article-title">TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2019,</strong> <em>120 </em>
                                    (5)
                                     , 555-564. <a href="https://doi.org/10.1038/s41416-019-0397-6" title="DOI URL">https://doi.org/10.1038/s41416-019-0397-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-019-0397-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-019-0397-6%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DTYRO3%252Bas%252Ba%252Bmolecular%252Btarget%252Bfor%252Bgrowth%252Binhibition%252Band%252Bapoptosis%252Binduction%252Bin%252Bbladder%252Bcancer%26aulast%3DDufour%26aufirst%3DFlorent%26date%3D2019%26date%3D2019%26volume%3D120%26issue%3D5%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lenka  Sinik</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Minson</span>, <span class="hlFld-ContribAuthor ">John J.  Tentler</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Carrico</span>, <span class="hlFld-ContribAuthor ">Stacey M.  Bagby</span>, <span class="hlFld-ContribAuthor ">William A.  Robinson</span>, <span class="hlFld-ContribAuthor ">Rotem  Kami</span>, <span class="hlFld-ContribAuthor ">Tal  Burstyn-Cohen</span>, <span class="hlFld-ContribAuthor ">S. Gail  Eckhardt</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (2)
                                     , 278-288. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0456" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0456%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DInhibition%252Bof%252BMERTK%252BPromotes%252BSuppression%252Bof%252BTumor%252BGrowth%252Bin%252BBRAF%252BMutant%252Band%252BBRAF%252BWild-Type%252BMelanoma%26aulast%3DSinik%26aufirst%3DLenka%26date%3D2019%26date%3D2018%26volume%3D18%26issue%3D2%26spage%3D278%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan J.  Summers</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Minson</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Roles for AXL and MERTK in Resistance to Cytotoxic and Targeted Therapies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 61-85. <a href="https://doi.org/10.1016/B978-0-12-813753-6.00003-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-813753-6.00003-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813753-6.00003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813753-6.00003-2%26sid%3Dliteratum%253Aachs%26atitle%3DRoles%252Bfor%252BAXL%252Band%252BMERTK%252Bin%252BResistance%252Bto%252BCytotoxic%252Band%252BTargeted%252BTherapies%26aulast%3DSummers%26aufirst%3DRyan%2BJ.%26date%3D2019%26spage%3D61%26epage%3D85%26pub%3DElsevier%26atitle%3DTargeting%252BCell%252BSurvival%252BPathways%252Bto%252BEnhance%252BResponse%252Bto%252BChemotherapy%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Parker</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non–small Cell Lung Cancers Expressing Wild-type
              EGFR
              Family Members. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2018,</strong> <em>24 </em>
                                    (24)
                                     , 6523-6535. <a href="https://doi.org/10.1158/1078-0432.CCR-18-0040" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-18-0040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-18-0040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-18-0040%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DMERTK%252BPromotes%252BResistance%252Bto%252BIrreversible%252BEGFR%252BTyrosine%252BKinase%252BInhibitors%252Bin%252BNon%2525E2%252580%252593small%252BCell%252BLung%252BCancers%252BExpressing%252BWild-type%252BEGFR%252BFamily%252BMembers%26aulast%3DYan%26aufirst%3DDan%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D24%26spage%3D6523%26epage%3D6535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cunzhen  Shi</span>, <span class="hlFld-ContribAuthor ">Xiangqun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaogan  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, <span class="hlFld-ContribAuthor ">Lingyan  Ping</span>, <span class="hlFld-ContribAuthor ">Yunfei  Shi</span>, <span class="hlFld-ContribAuthor ">Lan  Mi</span>, <span class="hlFld-ContribAuthor ">Yumei  Lai</span>, <span class="hlFld-ContribAuthor ">Yuqin  Song</span>, <span class="hlFld-ContribAuthor ">Jun  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2018,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-018-0584-6" title="DOI URL">https://doi.org/10.1186/s13045-018-0584-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-018-0584-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-018-0584-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DThe%252Bproto-oncogene%252BMer%252Btyrosine%252Bkinase%252Bis%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Bmantle%252Bcell%252Blymphoma%26aulast%3DShi%26aufirst%3DCunzhen%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sherri  Smart</span>, <span class="hlFld-ContribAuthor ">Eleana  Vasileiadi</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">The Emerging Role of TYRO3 as a Therapeutic Target in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (12)
                                     , 474. <a href="https://doi.org/10.3390/cancers10120474" title="DOI URL">https://doi.org/10.3390/cancers10120474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10120474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10120474%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BEmerging%252BRole%252Bof%252BTYRO3%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BCancer%26aulast%3DSmart%26aufirst%3DSherri%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D12%26spage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alisa B.  Lee-Sherick</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Curtis J.  Henry</span>, <span class="hlFld-ContribAuthor ">Madeline G.  Huey</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Parker</span>, <span class="hlFld-ContribAuthor ">Lauren S.  Page</span>, <span class="hlFld-ContribAuthor ">Amanda A.  Hill</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Craig T.  Jordan</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2018,</strong> <em>3 </em>
                                    (21)
                                     <a href="https://doi.org/10.1172/jci.insight.97941" title="DOI URL">https://doi.org/10.1172/jci.insight.97941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.97941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.97941%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DMERTK%252Binhibition%252Balters%252Bthe%252BPD-1%252Baxis%252Band%252Bpromotes%252Banti-leukemia%252Bimmunity%26aulast%3DLee-Sherick%26aufirst%3DAlisa%2BB.%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Werfel</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Efferocytosis in the tumor microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Immunopathology</span><span> <strong>2018,</strong> <em>40 </em>
                                    (6)
                                     , 545-554. <a href="https://doi.org/10.1007/s00281-018-0698-5" title="DOI URL">https://doi.org/10.1007/s00281-018-0698-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00281-018-0698-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00281-018-0698-5%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Immunopathology%26atitle%3DEfferocytosis%252Bin%252Bthe%252Btumor%252Bmicroenvironment%26aulast%3DWerfel%26aufirst%3DThomas%2BA.%26date%3D2018%26date%3D2018%26volume%3D40%26issue%3D6%26spage%3D545%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nellie K.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Mari  Iida</span>, <span class="hlFld-ContribAuthor ">Justus  Hülse</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Pearson</span>, <span class="hlFld-ContribAuthor ">Eleana  Vasileiadi</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  Parker</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Orbuch</span>, <span class="hlFld-ContribAuthor ">Olivia J.  Ondracek</span>, <span class="hlFld-ContribAuthor ">Noah B.  Welke</span>, <span class="hlFld-ContribAuthor ">Grace H.  Kang</span>, <span class="hlFld-ContribAuthor ">Kurtis D.  Davies</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Paul M.  Harari</span>, <span class="hlFld-ContribAuthor ">Randall J.  Kimple</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">Deric L.  Wheeler</span>. </span><span class="cited-content_cbyCitation_article-title">MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (11)
                                     , 2297-2308. <a href="https://doi.org/10.1158/1535-7163.MCT-17-1239" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-1239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-1239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-1239%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DMERTK%252BMediates%252BIntrinsic%252Band%252BAdaptive%252BResistance%252Bto%252BAXL-targeting%252BAgents%26aulast%3DMcDaniel%26aufirst%3DNellie%2BK.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D11%26spage%3D2297%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bridget  Shafit-Zagardo</span>, <span class="hlFld-ContribAuthor ">Ross C.  Gruber</span>, <span class="hlFld-ContribAuthor ">Juwen C.  DuBois</span>. </span><span class="cited-content_cbyCitation_article-title">The role of TAM family receptors and ligands in the nervous system: From development to pathobiology. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>188 </em>, 97-117. <a href="https://doi.org/10.1016/j.pharmthera.2018.03.002" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252Brole%252Bof%252BTAM%252Bfamily%252Breceptors%252Band%252Bligands%252Bin%252Bthe%252Bnervous%252Bsystem%25253A%252BFrom%252Bdevelopment%252Bto%252Bpathobiology%26aulast%3DShafit-Zagardo%26aufirst%3DBridget%26date%3D2018%26volume%3D188%26spage%3D97%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Danielle  Froio</span>, <span class="hlFld-ContribAuthor ">Jennifer  Man</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Brett W.  Stringer</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Marina  Pajic</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>. </span><span class="cited-content_cbyCitation_article-title">Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2018,</strong> <em>134 </em>, 166-178. <a href="https://doi.org/10.1016/j.phrs.2018.06.023" title="DOI URL">https://doi.org/10.1016/j.phrs.2018.06.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2018.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2018.06.023%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DChanges%252Bin%252Bcell%252Bmorphology%252Bguide%252Bidentification%252Bof%252Btubulin%252Bas%252Bthe%252Boff-target%252Bfor%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DHoque%26aufirst%3DMonira%26date%3D2018%26volume%3D134%26spage%3D166%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke A.  Law</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">Jorge  Di Paola</span>, <span class="hlFld-ContribAuthor ">Brian R.  Branchford</span>. </span><span class="cited-content_cbyCitation_article-title">GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2018,</strong> <em>5 </em><a href="https://doi.org/10.3389/fmed.2018.00137" title="DOI URL">https://doi.org/10.3389/fmed.2018.00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2018.00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2018.00137%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DGAS6%25252FTAM%252BPathway%252BSignaling%252Bin%252BHemostasis%252Band%252BThrombosis%26aulast%3DLaw%26aufirst%3DLuke%2BA.%26date%3D2018%26date%3D2018%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus M.  Rinschen</span>, <span class="hlFld-ContribAuthor ">Markus  Gödel</span>, <span class="hlFld-ContribAuthor ">Florian  Grahammer</span>, <span class="hlFld-ContribAuthor ">Stefan  Zschiedrich</span>, <span class="hlFld-ContribAuthor ">Martin  Helmstädter</span>, <span class="hlFld-ContribAuthor ">Oliver  Kretz</span>, <span class="hlFld-ContribAuthor ">Mostafa  Zarei</span>, <span class="hlFld-ContribAuthor ">Daniela A.  Braun</span>, <span class="hlFld-ContribAuthor ">Sebastian  Dittrich</span>, <span class="hlFld-ContribAuthor ">Caroline  Pahmeyer</span>, <span class="hlFld-ContribAuthor ">Patricia  Schroder</span>, <span class="hlFld-ContribAuthor ">Carolin  Teetzen</span>, <span class="hlFld-ContribAuthor ">HeonYung  Gee</span>, <span class="hlFld-ContribAuthor ">Ghaleb  Daouk</span>, <span class="hlFld-ContribAuthor ">Martin  Pohl</span>, <span class="hlFld-ContribAuthor ">Elisa  Kuhn</span>, <span class="hlFld-ContribAuthor ">Bernhard  Schermer</span>, <span class="hlFld-ContribAuthor ">Victoria  Küttner</span>, <span class="hlFld-ContribAuthor ">Melanie  Boerries</span>, <span class="hlFld-ContribAuthor ">Hauke  Busch</span>, <span class="hlFld-ContribAuthor ">Mario  Schiffer</span>, <span class="hlFld-ContribAuthor ">Carsten  Bergmann</span>, <span class="hlFld-ContribAuthor ">Marcus  Krüger</span>, <span class="hlFld-ContribAuthor ">Friedhelm  Hildebrandt</span>, <span class="hlFld-ContribAuthor ">Joern  Dengjel</span>, <span class="hlFld-ContribAuthor ">Thomas  Benzing</span>, <span class="hlFld-ContribAuthor ">Tobias B.  Huber</span>. </span><span class="cited-content_cbyCitation_article-title">A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 2495-2508. <a href="https://doi.org/10.1016/j.celrep.2018.04.059" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.04.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.04.059%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DA%252BMulti-layered%252BQuantitative%252BIn%2525C2%2525A0Vivo%252BExpression%252BAtlas%252Bof%252Bthe%252BPodocyte%252BUnravels%252BKidney%252BDisease%252BCandidate%252BGenes%26aulast%3DRinschen%26aufirst%3DMarkus%2BM.%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D2495%26epage%3D2508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingying  Shen</span>, <span class="hlFld-ContribAuthor ">Xiguang  Chen</span>, <span class="hlFld-ContribAuthor ">Jun  He</span>, <span class="hlFld-ContribAuthor ">Duanfang  Liao</span>, <span class="hlFld-ContribAuthor ">Xuyu  Zu</span>. </span><span class="cited-content_cbyCitation_article-title">Axl inhibitors as novel cancer therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2018,</strong> <em>198 </em>, 99-111. <a href="https://doi.org/10.1016/j.lfs.2018.02.033" title="DOI URL">https://doi.org/10.1016/j.lfs.2018.02.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2018.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2018.02.033%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DAxl%252Binhibitors%252Bas%252Bnovel%252Bcancer%252Btherapeutic%252Bagents%26aulast%3DShen%26aufirst%3DYingying%26date%3D2018%26volume%3D198%26spage%3D99%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B. R.  Branchford</span>, <span class="hlFld-ContribAuthor ">T. J.  Stalker</span>, <span class="hlFld-ContribAuthor ">L.  Law</span>, <span class="hlFld-ContribAuthor ">G.  Acevedo</span>, <span class="hlFld-ContribAuthor ">S.  Sather</span>, <span class="hlFld-ContribAuthor ">C.  Brzezinski</span>, <span class="hlFld-ContribAuthor ">K. M.  Wilson</span>, <span class="hlFld-ContribAuthor ">K.  Minson</span>, <span class="hlFld-ContribAuthor ">A. B.  Lee-Sherick</span>, <span class="hlFld-ContribAuthor ">P.  Davizon-Castillo</span>, <span class="hlFld-ContribAuthor ">C.  Ng</span>, <span class="hlFld-ContribAuthor ">W.  Zhang</span>, <span class="hlFld-ContribAuthor ">K. B.  Neeves</span>, <span class="hlFld-ContribAuthor ">S. R.  Lentz</span>, <span class="hlFld-ContribAuthor ">X.  Wang</span>, <span class="hlFld-ContribAuthor ">S. V.  Frye</span>, <span class="hlFld-ContribAuthor ">H.  Shelton Earp</span>, <span class="hlFld-ContribAuthor ">D.  DeRyckere</span>, <span class="hlFld-ContribAuthor ">L. F.  Brass</span>, <span class="hlFld-ContribAuthor ">D. K.  Graham</span>, <span class="hlFld-ContribAuthor ">J. A.  Di Paola</span>. </span><span class="cited-content_cbyCitation_article-title">The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Thrombosis and Haemostasis</span><span> <strong>2018,</strong> <em>16 </em>
                                    (2)
                                     , 352-363. <a href="https://doi.org/10.1111/jth.13875" title="DOI URL">https://doi.org/10.1111/jth.13875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jth.13875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjth.13875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Thrombosis%2520and%2520Haemostasis%26atitle%3DThe%252Bsmall-molecule%252BMERTK%252Binhibitor%252BUNC2025%252Bdecreases%252Bplatelet%252Bactivation%252Band%252Bprevents%252Bthrombosis%26aulast%3DBranchford%26aufirst%3DB.%2BR.%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D2%26spage%3D352%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Lauren N  Frady</span>, <span class="hlFld-ContribAuthor ">Ryan E  Bash</span>, <span class="hlFld-ContribAuthor ">Stephanie M  Cohen</span>, <span class="hlFld-ContribAuthor ">Allison N  Schorzman</span>, <span class="hlFld-ContribAuthor ">Yu-Ting  Su</span>, <span class="hlFld-ContribAuthor ">David M  Irvin</span>, <span class="hlFld-ContribAuthor ">William C  Zamboni</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V  Frye</span>, <span class="hlFld-ContribAuthor ">Matthew G  Ewend</span>, <span class="hlFld-ContribAuthor ">Erik P  Sulman</span>, <span class="hlFld-ContribAuthor ">Mark R  Gilbert</span>, <span class="hlFld-ContribAuthor ">H Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">C Ryan  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">MerTK as a therapeutic target in glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (1)
                                     , 92-102. <a href="https://doi.org/10.1093/neuonc/nox111" title="DOI URL">https://doi.org/10.1093/neuonc/nox111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/neuonc/nox111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fneuonc%2Fnox111%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%26atitle%3DMerTK%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bglioblastoma%26aulast%3DWu%26aufirst%3DJing%26date%3D2018%26date%3D2017%26volume%3D20%26issue%3D1%26spage%3D92%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miles A.  Miller</span>, <span class="hlFld-ContribAuthor ">Eunha  Kim</span>, <span class="hlFld-ContribAuthor ">Michael F.  Cuccarese</span>, <span class="hlFld-ContribAuthor ">Alec L.  Plotkin</span>, <span class="hlFld-ContribAuthor ">Mark  Prytyskach</span>, <span class="hlFld-ContribAuthor ">Rainer H.  Kohler</span>, <span class="hlFld-ContribAuthor ">Mikael J.  Pittet</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>. </span><span class="cited-content_cbyCitation_article-title">Near infrared imaging of Mer tyrosine kinase (
              MERTK
              ) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (1)
                                     , 42-45. <a href="https://doi.org/10.1039/C7CC07581B" title="DOI URL">https://doi.org/10.1039/C7CC07581B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC07581B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC07581B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DNear%252Binfrared%252Bimaging%252Bof%252BMer%252Btyrosine%252Bkinase%252B%252528%252BMERTK%252B%252529%252Busing%252BMERi-SiR%252Breveals%252Btumor%252Bassociated%252Bmacrophage%252Buptake%252Bin%252Bmetastatic%252Bdisease%26aulast%3DMiller%26aufirst%3DMiles%2BA.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D1%26spage%3D42%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Garth W.  Tormoen</span>, <span class="hlFld-ContribAuthor ">Marka R.  Crittenden</span>, <span class="hlFld-ContribAuthor ">Michael J.  Gough</span>. </span><span class="cited-content_cbyCitation_article-title">The TAM family as a therapeutic target in combination with radiation therapy. </span><span class="cited-content_cbyCitation_journal-name">Emerging Topics in Life Sciences</span><span> <strong>2017,</strong> <em>1 </em>
                                    (5)
                                     , 493-500. <a href="https://doi.org/10.1042/ETLS20170066" title="DOI URL">https://doi.org/10.1042/ETLS20170066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/ETLS20170066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FETLS20170066%26sid%3Dliteratum%253Aachs%26jtitle%3DEmerging%2520Topics%2520in%2520Life%2520Sciences%26atitle%3DThe%252BTAM%252Bfamily%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bcombination%252Bwith%252Bradiation%252Btherapy%26aulast%3DMarincola%26aufirst%3DFrancesco%2BM.%26date%3D2017%26date%3D2017%26volume%3D1%26issue%3D5%26spage%3D493%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun Ho  Yi</span>, <span class="hlFld-ContribAuthor ">Jiryeon  Jang</span>, <span class="hlFld-ContribAuthor ">Jeonghee  Cho</span>, <span class="hlFld-ContribAuthor ">In-Gu  Do</span>, <span class="hlFld-ContribAuthor ">Mineui  Hong</span>, <span class="hlFld-ContribAuthor ">Seung Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Kyoung-Mee  Kim</span>, <span class="hlFld-ContribAuthor ">Sujin  Lee</span>, <span class="hlFld-ContribAuthor ">Se Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Joon Oh  Park</span>, <span class="hlFld-ContribAuthor ">Young Suk  Park</span>, <span class="hlFld-ContribAuthor ">Won Ki  Kang</span>, <span class="hlFld-ContribAuthor ">Ho Yeong  Lim</span>, <span class="hlFld-ContribAuthor ">Jeeyun  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">MerTK is a novel therapeutic target in gastric cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (57)
                                     , 96656-96667. <a href="https://doi.org/10.18632/oncotarget.3750" title="DOI URL">https://doi.org/10.18632/oncotarget.3750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.3750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.3750%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMerTK%252Bis%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Bgastric%252Bcancer%26aulast%3DYi%26aufirst%3DJun%2BHo%26date%3D2017%26date%3D2015%26volume%3D8%26issue%3D57%26spage%3D96656%26epage%3D96667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Alisa B.  Lee-Sherick</span>, <span class="hlFld-ContribAuthor ">Madeline G.  Huey</span>, <span class="hlFld-ContribAuthor ">Amanda A.  Hill</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Tyner</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Lauren S.  Page</span>, <span class="hlFld-ContribAuthor ">Gregory G.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Fatma  Eryildiz</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Montgomery</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2017,</strong> <em>23 </em>
                                    (6)
                                     , 1481-1492. <a href="https://doi.org/10.1158/1078-0432.CCR-16-1330" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-16-1330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-16-1330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-16-1330%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DUNC2025%25252C%252Ba%252BMERTK%252BSmall-Molecule%252BInhibitor%25252C%252BIs%252BTherapeutically%252BEffective%252BAlone%252Band%252Bin%252BCombination%252Bwith%252BMethotrexate%252Bin%252BLeukemia%252BModels%26aulast%3DDeRyckere%26aufirst%3DDeborah%26date%3D2017%26date%3D2016%26volume%3D23%26issue%3D6%26spage%3D1481%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yemsratch T.  Akalu</span>, <span class="hlFld-ContribAuthor ">Carla V.  Rothlin</span>, <span class="hlFld-ContribAuthor ">Sourav  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Immunological Reviews</span><span> <strong>2017,</strong> <em>276 </em>
                                    (1)
                                     , 165-177. <a href="https://doi.org/10.1111/imr.12522" title="DOI URL">https://doi.org/10.1111/imr.12522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/imr.12522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fimr.12522%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunological%2520Reviews%26atitle%3DTAM%252Breceptor%252Btyrosine%252Bkinases%252Bas%252Bemerging%252Btargets%252Bof%252Binnate%252Bimmune%252Bcheckpoint%252Bblockade%252Bfor%252Bcancer%252Btherapy%26aulast%3DAkalu%26aufirst%3DYemsratch%2BT.%26date%3D2017%26date%3D2017%26volume%3D276%26issue%3D1%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew L.  McIver</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingyang  Liu</span>, <span class="hlFld-ContribAuthor ">Xinpeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">James  Nichols</span>, <span class="hlFld-ContribAuthor ">Michael J.  Miley</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Norris-Drouin</span>, <span class="hlFld-ContribAuthor ">Mischa  Machius</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Edgar  Wood</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (3)
                                     , 207-213. <a href="https://doi.org/10.1002/cmdc.201600589" title="DOI URL">https://doi.org/10.1002/cmdc.201600589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600589%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BMacrocyclic%252BPyrimidines%252Bas%252BMerTK-Specific%252BInhibitors%26aulast%3DMcIver%26aufirst%3DAndrew%2BL.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Viralkumar  Davra</span>, <span class="hlFld-ContribAuthor ">Stanley  Kimani</span>, <span class="hlFld-ContribAuthor ">David  Calianese</span>, <span class="hlFld-ContribAuthor ">Raymond  Birge</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2016,</strong> <em>8 </em>
                                    (12)
                                     , 107. <a href="https://doi.org/10.3390/cancers8120107" title="DOI URL">https://doi.org/10.3390/cancers8120107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers8120107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers8120107%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLigand%252BActivation%252Bof%252BTAM%252BFamily%252BReceptors-Implications%252Bfor%252BTumor%252BBiology%252Band%252BTherapeutic%252BResponse%26aulast%3DDavra%26aufirst%3DViralkumar%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D12%26spage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madeline  Huey</span>, <span class="hlFld-ContribAuthor ">Katherine  Minson</span>, <span class="hlFld-ContribAuthor ">H.  Earp</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the TAM Receptors in Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 101. <a href="https://doi.org/10.3390/cancers8110101" title="DOI URL">https://doi.org/10.3390/cancers8110101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers8110101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers8110101%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTargeting%252Bthe%252BTAM%252BReceptors%252Bin%252BLeukemia%26aulast%3DHuey%26aufirst%3DMadeline%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Sufit</span>, <span class="hlFld-ContribAuthor ">Alisa B.  Lee-Sherick</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Manali  Rupji</span>, <span class="hlFld-ContribAuthor ">Bhakti  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Marileila  Varella-Garcia</span>, <span class="hlFld-ContribAuthor ">Angela M.  Pierce</span>, <span class="hlFld-ContribAuthor ">Jeanne  Kowalski</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Amy K.  Keating</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, . </span><span class="cited-content_cbyCitation_article-title">MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (10)
                                     , e0165107. <a href="https://doi.org/10.1371/journal.pone.0165107" title="DOI URL">https://doi.org/10.1371/journal.pone.0165107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0165107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0165107%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMERTK%252BInhibition%252BInduces%252BPolyploidy%252Band%252BPromotes%252BCell%252BDeath%252Band%252BCellular%252BSenescence%252Bin%252BGlioblastoma%252BMultiforme%26aulast%3DSufit%26aufirst%3DAlexandra%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D10%26spage%3De0165107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne  von Mässenhausen</span>, <span class="hlFld-ContribAuthor ">Christine  Sanders</span>, <span class="hlFld-ContribAuthor ">Britta  Thewes</span>, <span class="hlFld-ContribAuthor ">Mario  Deng</span>, <span class="hlFld-ContribAuthor ">Angela  Queisser</span>, <span class="hlFld-ContribAuthor ">Wenzel  Vogel</span>, <span class="hlFld-ContribAuthor ">Glen  Kristiansen</span>, <span class="hlFld-ContribAuthor ">Stefan  Duensing</span>, <span class="hlFld-ContribAuthor ">Andreas  Schröck</span>, <span class="hlFld-ContribAuthor ">Friedrich  Bootz</span>, <span class="hlFld-ContribAuthor ">Peter  Brossart</span>, <span class="hlFld-ContribAuthor ">Jutta  Kirfel</span>, <span class="hlFld-ContribAuthor ">Lynn  Heasley</span>, <span class="hlFld-ContribAuthor ">Johannes  Brägelmann</span>, <span class="hlFld-ContribAuthor ">Sven  Perner</span>. </span><span class="cited-content_cbyCitation_article-title">MERTK as a novel therapeutic target in head and neck cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (22)
                                     , 32678-32694. <a href="https://doi.org/10.18632/oncotarget.8724" title="DOI URL">https://doi.org/10.18632/oncotarget.8724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.8724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.8724%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMERTK%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bin%252Bhead%252Band%252Bneck%252Bcancer%26aulast%3Dvon%2BM%25C3%25A4ssenhausen%26aufirst%3DAnne%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D22%26spage%3D32678%26epage%3D32694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke M.  Healy</span>, <span class="hlFld-ContribAuthor ">Gabrielle  Perron</span>, <span class="hlFld-ContribAuthor ">So-Yoon  Won</span>, <span class="hlFld-ContribAuthor ">Mackenzie A.  Michell-Robinson</span>, <span class="hlFld-ContribAuthor ">Ayman  Rezk</span>, <span class="hlFld-ContribAuthor ">Samuel K.  Ludwin</span>, <span class="hlFld-ContribAuthor ">Craig S.  Moore</span>, <span class="hlFld-ContribAuthor ">Jeffery A.  Hall</span>, <span class="hlFld-ContribAuthor ">Amit  Bar-Or</span>, <span class="hlFld-ContribAuthor ">Jack P.  Antel</span>. </span><span class="cited-content_cbyCitation_article-title">MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2016,</strong> <em>196 </em>
                                    (8)
                                     , 3375-3384. <a href="https://doi.org/10.4049/jimmunol.1502562" title="DOI URL">https://doi.org/10.4049/jimmunol.1502562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1502562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1502562%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DMerTK%252BIs%252Ba%252BFunctional%252BRegulator%252Bof%252BMyelin%252BPhagocytosis%252Bby%252BHuman%252BMyeloid%252BCells%26aulast%3DHealy%26aufirst%3DLuke%2BM.%26date%3D2016%26date%3D2016%26volume%3D196%26issue%3D8%26spage%3D3375%26epage%3D3384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dehui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongchao  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">General and cost-effective synthesis of 1-heteroaryl/arylcycloalkylamines and their broad applications. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (16)
                                     , 1941-1953. <a href="https://doi.org/10.1016/j.tet.2016.02.060" title="DOI URL">https://doi.org/10.1016/j.tet.2016.02.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.02.060%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DGeneral%252Band%252Bcost-effective%252Bsynthesis%252Bof%252B1-heteroaryl%25252Farylcycloalkylamines%252Band%252Btheir%252Bbroad%252Bapplications%26aulast%3DZhang%26aufirst%3DDehui%26date%3D2016%26volume%3D72%26issue%3D16%26spage%3D1941%26epage%3D1953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine A.  Minson</span>, <span class="hlFld-ContribAuthor ">Catherine C.  Smith</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Clara  Libbrecht</span>, <span class="hlFld-ContribAuthor ">Alisa B.  Lee-Sherick</span>, <span class="hlFld-ContribAuthor ">Madeline G.  Huey</span>, <span class="hlFld-ContribAuthor ">Elisabeth A.  Lasater</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Craig T.  Jordan</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Neil P.  Shah</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2016,</strong> <em>1 </em>
                                    (3)
                                     <a href="https://doi.org/10.1172/jci.insight.85630" title="DOI URL">https://doi.org/10.1172/jci.insight.85630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.85630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.85630%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DThe%252BMERTK%25252FFLT3%252Binhibitor%252BMRX-2843%252Bovercomes%252Bresistance-conferring%252BFLT3%252Bmutations%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DMinson%26aufirst%3DKatherine%2BA.%26date%3D2016%26volume%3D1%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening of Commercially Available Compound Libraries. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 65-76. <a href="https://doi.org/10.1007/978-1-4939-3673-1_4" title="DOI URL">https://doi.org/10.1007/978-1-4939-3673-1_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-3673-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-3673-1_4%26sid%3Dliteratum%253Aachs%26atitle%3DStructure-Based%252BVirtual%252BScreening%252Bof%252BCommercially%252BAvailable%252BCompound%252BLibraries%26aulast%3DKireev%26aufirst%3DDmitri%26date%3D2016%26date%3D2016%26spage%3D65%26epage%3D76%26pub%3DSpringer%2520New%2520York%26atitle%3DHigh%252BThroughput%252BScreening%26aulast%3DJanzen%26aufirst%3DWilliam%2BP.%26date%3D2016%26volume%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tom  Baladi</span>, <span class="hlFld-ContribAuthor ">Valentina  Abet</span>, <span class="hlFld-ContribAuthor ">Sandrine  Piguel</span>. </span><span class="cited-content_cbyCitation_article-title">State-of-the-art of small molecule inhibitors of the TAM family: The point of view of the chemist. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>105 </em>, 220-237. <a href="https://doi.org/10.1016/j.ejmech.2015.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DState-of-the-art%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bthe%252BTAM%252Bfamily%25253A%252BThe%252Bpoint%252Bof%252Bview%252Bof%252Bthe%252Bchemist%26aulast%3DBaladi%26aufirst%3DTom%26date%3D2015%26volume%3D105%26spage%3D220%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Kurtis D.  Davies</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">Dehui  Zhang</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (9)
                                     , 2014-2022. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0116" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0116%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSmall%252BMolecule%252BInhibition%252Bof%252BMERTK%252BIs%252BEfficacious%252Bin%252BNon%2525E2%252580%252593Small%252BCell%252BLung%252BCancer%252BModels%252BIndependent%252Bof%252BDriver%252BOncogene%252BStatus%26aulast%3DCummings%26aufirst%3DChristopher%2BT.%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D9%26spage%3D2014%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengzhi  Xie</span>, <span class="hlFld-ContribAuthor ">Yongwu  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Li</span>, <span class="hlFld-ContribAuthor ">Linxiong  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Yang</span>, <span class="hlFld-ContribAuthor ">Yadi  Wang</span>, <span class="hlFld-ContribAuthor ">Huafeng  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 9206-9219. <a href="https://doi.org/10.18632/oncotarget.3280" title="DOI URL">https://doi.org/10.18632/oncotarget.3280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.3280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.3280%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMer%252Breceptor%252Btyrosine%252Bkinase%252Bis%252Bfrequently%252Boverexpressed%252Bin%252Bhuman%252Bnon-small%252Bcell%252Blung%252Bcancer%25252C%252Bconfirming%252Bresistance%252Bto%252Berlotinib%26aulast%3DXie%26aufirst%3DShengzhi%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D9206%26epage%3D9219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amanda A  Hill</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Carrico</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Douglas K  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">The MERTK Signalling Pathway in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-8. <a href="https://doi.org/10.1002/9780470015902.a0025726" title="DOI URL">https://doi.org/10.1002/9780470015902.a0025726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470015902.a0025726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470015902.a0025726%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BMERTK%252BSignalling%252BPathway%252Bin%252BCancer%26aulast%3DHill%26aufirst%3DAmanda%2BA%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D8%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DeLS%26aulast%3DJohn%2BWiley%2B%2526%2BSons%2BLtd%26date%3D2001%26date%3D2001%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Da</span>, <span class="hlFld-ContribAuthor ">M.  Stashko</span>, <span class="hlFld-ContribAuthor ">C.  Jayakody</span>, <span class="hlFld-ContribAuthor ">X.  Wang</span>, <span class="hlFld-ContribAuthor ">W.  Janzen</span>, <span class="hlFld-ContribAuthor ">S.  Frye</span>, <span class="hlFld-ContribAuthor ">D.  Kireev</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Mer kinase inhibitors by virtual screening using Structural Protein–Ligand Interaction Fingerprints. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (5)
                                     , 1096-1101. <a href="https://doi.org/10.1016/j.bmc.2015.01.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BMer%252Bkinase%252Binhibitors%252Bby%252Bvirtual%252Bscreening%252Busing%252BStructural%252BProtein%2525E2%252580%252593Ligand%252BInteraction%252BFingerprints%26aulast%3DDa%26aufirst%3DC.%26date%3D2015%26volume%3D23%26issue%3D5%26spage%3D1096%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongyun  Shen</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Anming  Wang</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel glycosyl <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c6b6bfb4afa2bfaaebb2b4afa7bca9aaa386b6a7aaaaa7a2afb3ab">[email protected]</a> nanoparticles: efficient and recoverable catalysts for C–C cross-coupling reactions. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2015,</strong> <em>5 </em>
                                    (4)
                                     , 2065-2071. <a href="https://doi.org/10.1039/C5CY00013K" title="DOI URL">https://doi.org/10.1039/C5CY00013K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CY00013K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CY00013K%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DNovel%252Bglycosyl%252Bpyridyl-triazole%252540palladium%252Bnanoparticles%25253A%252Befficient%252Band%252Brecoverable%252Bcatalysts%252Bfor%252BC%2525E2%252580%252593C%252Bcross-coupling%252Breactions%26aulast%3DShen%26aufirst%3DHongyun%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D4%26spage%3D2065%26epage%3D2071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Kurtis D.  Davies</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>. </span><span class="cited-content_cbyCitation_article-title">The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2014,</strong> <em>14 </em>
                                    (12)
                                     , 769-785. <a href="https://doi.org/10.1038/nrc3847" title="DOI URL">https://doi.org/10.1038/nrc3847</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrc3847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrc3847%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DThe%252BTAM%252Bfamily%25253A%252Bphosphatidylserine-sensing%252Breceptor%252Btyrosine%252Bkinases%252Bgone%252Bawry%252Bin%252Bcancer%26aulast%3DGraham%26aufirst%3DDouglas%2BK.%26date%3D2014%26date%3D2014%26volume%3D14%26issue%3D12%26spage%3D769%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Pyrrolopyrimidine Analogue <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures and enzymatic activity of <b>9</b>–<b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Scale-up Route for <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <b>11</b> Inhibits activation of Mer in acute leukemia cells. 697 Cells were treated with the indicated concentrations of <b>11</b> for 1 h. Pervanadate was added to cultures for 3 min to stabilize the phosphorylated form of Mer. Mer was immunoprecipitated from cell lysates, and total MER protein and Mer phosphoprotein (p-Mer) were detected by immunoblot. (A) Representative Western blots. (B) Relative levels of p-Mer and Mer proteins were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> = 2.7 nM with a 95% confidence interval from 1.8 to 4.2 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>11</b> Inhibits activation of Flt3 in acute leukemia cells. Flt3-ITD positive Molm-14 cells were treated with the indicated concentrations of <b>11</b> for 1 h. Pervanadate was added to cultures for 3 min to stabilize the phosphorylated form of Flt3. Flt3 was immunoprecipitated from cell lysates and total Flt3 protein and Flt3 phosphoprotein (p-Flt3) were detected by immunoblot. (A) Representative Western blots. (B) Relative levels of p-Flt3 and Flt3 proteins were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> = 14 nM with a 95% confidence interval from 8.4 to 24 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>11</b> Inhibits colony formation in Mer-dependent and Flt3-dependent tumor cell lines. (A) A549 NSCLC cells or (B) Molm-14 AML cells were cultured in 0.35% soft agar overlaid with medium containing <b>11</b>, a negative control (<b>20</b>) (300 nM for A549 NSCLC cells and 50 nM for Molm-14 AML cells), or vehicle. Medium and compounds were refreshed 3 times per week. Colonies were stained and counted. Mean values ± standard error derived from 3 to 4 independent experiments are shown. Statistically significant differences were determined using the student’s paired <i>t</i> test (* <i>p</i> < 0.05, ** <i>p</i> ≤ 0.005, ***<i>P</i> < 0.0005 relative to vehicle only). (C) Structure and enzymatic IC<sub>50</sub>’s of compound <b>20</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>11</b> Selectively inhibits Mer in cell-based assays. 32D Cells stably expressing chimeric receptors consisting of the extracellular ligand-binding and transmembrane domains of the EGF receptor and the intracellular kinase domain of Mer, Axl, or Tyro3 were treated with <b>11</b> or vehicle for 1 h prior to stimulation for 15 min with 100 ng/mL EGF. Chimeric proteins were immunoprecipitated from whole cell lysates and phospho-tyrosine-containing and total proteins were detected by Western blot. (A) Representative Western blots are shown. (B and C) Phosphorylated and total protein levels were determined by densitometry. Mean values ± standard error derived from 3 independent experiments are shown. IC<sub>50</sub> values and 95% confidence intervals were determined by nonlinear regression and are 2.7 nM (1.7–4.2 nM) for Mer, 122 nM (64–230 nM) for Axl, and 301 nM (110–820 nM) for Tyro3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Correlation of in vitro and phospho-protein potency for <b>11</b> versus Mer, Flt3, Axl, and Tyro3 utilizing the Morrison <i>K</i><sub>i</sub> for Mer and the IC<sub>50</sub>’s from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for all others.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>11</b> Inhibits Mer phosphorylation in bone marrow leukemia cells in vivo. NOD/SCID/gamma mice were transplanted with 697 acute leukemia cells and allowed to engraft for 14 days. Leukemic mice were then treated with a single 3 mg/kg dose of <b>11</b> or saline vehicle administered by oral gavage. Femurs were collected 30 min later. Bone marrow cells were flushed and incubated for 10 min in the presence of 20% FBS and pervanadate phosphatase inhibitor to stabilize Mer phosphoprotein. Cell lysates were prepared and Mer was immunoprecipitated. (A) Phosphorylated and total Mer proteins were detected by Western blot. (B) Phosphorylated and total Mer protein levels were determined by densitometry. Mean values ± standard error are shown. Mer phosphoprotein was significantly decreased in leukemia cells collected from mice treated with <b>11</b> relative to mice treated with vehicle (0.07 ± 0.04 versus 1.00 ± 0.29; *(* <i>p</i> = 0.01, student’s unpaired <i>t</i> test; <i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/medium/jm-2014-00749d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Predicted free concentration of <b>11</b> required in vivo for 90% inhibition of the top 10 kinases from Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The vertical line corresponds to the measured free concentration of <b>11</b> at 30 min following a 3 mg/kg oral dose (Cmax, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). (See the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for methods and comparison to clinically approved RTK profiles assessed in the same manner.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500749d/20150728/images/large/jm-2014-00749d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500749d&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the Pharmaceutical Industry Reduce Attrition Rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&issue=8&author=I.+Kolaauthor=J.+Landis&title=Can+the+Pharmaceutical+Industry+Reduce+Attrition+Rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520Pharmaceutical%2520Industry%2520Reduce%2520Attrition%2520Rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D8%26spage%3D711%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Palmer, A. M.</span><span> </span><span class="NLM_article-title">New Horizons in Drug Metabolism, Pharmacokinetics and Drug Discovery</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=12682673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtl2lsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2003&pages=57-62&issue=1&author=A.+M.+Palmer&title=New+Horizons+in+Drug+Metabolism%2C+Pharmacokinetics+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New horizons in drug metabolism, pharmacokinetics and drug discovery</span></div><div class="casAuthors">Palmer, Alan M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Along with minimal toxicity, good drug metab. and pharmacokinetic (DMPK) properties are essential for the clin. success of a drug candidate.  A major cause of failure of orally administered drugs during their development is the discovery that in humans they have low intestinal absorption and/or high clearance causing low and variable bioavailability.  In addn., drug interactions and the presence of active metabolites can prevent or complicate their successful development.  With poor pharmacokinetics it can be difficult to achieve a suitable dosage regimen for the required pharmacodynamic action.  The main role of DMPK in discovery is, therefore, the prediction of human pharmacokinetics and metab.  Reducing the rate of attrition during drug discovery and development is now considered essential, particularly as it is now possible to screen an ever-greater no. of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWHp2pRnOBHbVg90H21EOLACvtfcHk0lixZ4KlV5JC3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtl2lsrk%253D&md5=48ded4f26a1863ae96c1b2e688269009</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26atitle%3DNew%2520Horizons%2520in%2520Drug%2520Metabolism%252C%2520Pharmacokinetics%2520and%2520Drug%2520Discovery%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2003%26volume%3D16%26issue%3D1%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Norman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bo, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caenepeel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Angelo, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herberich, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, C. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullady, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aidasani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamayo, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurz, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. E.</span><span> </span><span class="NLM_article-title">Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">7796</span><span class="NLM_x">–</span> <span class="NLM_lpage">7816</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300846z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7796-7816&issue=17&author=M.+H.+Normanauthor=K.+L.+Andrewsauthor=Y.+Y.+Boauthor=S.+K.+Bookerauthor=S.+Caenepeelauthor=V.+J.+Ceeauthor=N.+D.+D%E2%80%99Angeloauthor=D.+J.+Freemanauthor=B.+J.+Herberichauthor=F.-T.+Hongauthor=C.+L.+M.+Jacksonauthor=J.+Jiangauthor=B.+A.+Lanmanauthor=L.+Liuauthor=J.+D.+McCarterauthor=E.+L.+Mulladyauthor=N.+Nishimuraauthor=L.+H.+Pettusauthor=A.+B.+Reedauthor=T.+S.+Miguelauthor=A.+L.+Smithauthor=M.+M.+Stecauthor=S.+Tadesseauthor=A.+Taskerauthor=D.+Aidasaniauthor=X.+Zhuauthor=R.+Subramanianauthor=N.+A.+Tamayoauthor=L.+Wangauthor=D.+A.+Whittingtonauthor=B.+Wuauthor=T.+Wuauthor=R.+P.+Wurzauthor=K.+Yangauthor=L.+Zalamedaauthor=N.+Zhangauthor=P.+E.+Hughes&title=Selective+Class+I+Phosphoinositide+3-Kinase+Inhibitors%3A+Optimization+of+a+Series+of+Pyridyltriazines+Leading+to+the+Identification+of+a+Clinical+Candidate%2C+AMG+511"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm300846z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300846z%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DM.%2BH.%26aulast%3DAndrews%26aufirst%3DK.%2BL.%26aulast%3DBo%26aufirst%3DY.%2BY.%26aulast%3DBooker%26aufirst%3DS.%2BK.%26aulast%3DCaenepeel%26aufirst%3DS.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DD%25E2%2580%2599Angelo%26aufirst%3DN.%2BD.%26aulast%3DFreeman%26aufirst%3DD.%2BJ.%26aulast%3DHerberich%26aufirst%3DB.%2BJ.%26aulast%3DHong%26aufirst%3DF.-T.%26aulast%3DJackson%26aufirst%3DC.%2BL.%2BM.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLanman%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReed%26aufirst%3DA.%2BB.%26aulast%3DMiguel%26aufirst%3DT.%2BS.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DStec%26aufirst%3DM.%2BM.%26aulast%3DTadesse%26aufirst%3DS.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DAidasani%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DTamayo%26aufirst%3DN.%2BA.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DWurz%26aufirst%3DR.%2BP.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DHughes%26aufirst%3DP.%2BE.%26atitle%3DSelective%2520Class%2520I%2520Phosphoinositide%25203-Kinase%2520Inhibitors%253A%2520Optimization%2520of%2520a%2520Series%2520of%2520Pyridyltriazines%2520Leading%2520to%2520the%2520Identification%2520of%2520a%2520Clinical%2520Candidate%252C%2520AMG%2520511%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D17%26spage%3D7796%26epage%3D7816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barlind, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birtles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckett, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butlin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, R. D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannesson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmitt, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindmark, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noeske, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redzic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinblad, J.</span><span> </span><span class="NLM_article-title">Design and Optimization of Pyrazinecarboxamide-Based Inhibitors of Diacylglycerol Acyltransferase 1 (DGAT1) Leading to a Clinical Candidate Dimethylpyrazinecarboxamide Phenylcyclohexylacetic Acid (AZD7687)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">10610</span><span class="NLM_x">–</span> <span class="NLM_lpage">10629</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301296t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10610-10629&issue=23&author=J.+G.+Barlindauthor=U.+A.+Bauerauthor=A.+M.+Birchauthor=S.+Birtlesauthor=L.+K.+Buckettauthor=R.+J.+Butlinauthor=R.+D.+M.+Daviesauthor=J.+W.+Erikssonauthor=C.+D.+Hammondauthor=R.+Hovlandauthor=P.+Johannessonauthor=M.+J.+Johanssonauthor=P.+D.+Kemmittauthor=B.+T.+Lindmarkauthor=P.+M.+Gutierrezauthor=T.+A.+Noeskeauthor=A.+Nordinauthor=C.+J.+O%E2%80%99Donnellauthor=A.+U.+Peterssonauthor=A.+Redzicauthor=A.+V.+Turnbullauthor=J.+Vinblad&title=Design+and+Optimization+of+Pyrazinecarboxamide-Based+Inhibitors+of+Diacylglycerol+Acyltransferase+1+%28DGAT1%29+Leading+to+a+Clinical+Candidate+Dimethylpyrazinecarboxamide+Phenylcyclohexylacetic+Acid+%28AZD7687%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm301296t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301296t%26sid%3Dliteratum%253Aachs%26aulast%3DBarlind%26aufirst%3DJ.%2BG.%26aulast%3DBauer%26aufirst%3DU.%2BA.%26aulast%3DBirch%26aufirst%3DA.%2BM.%26aulast%3DBirtles%26aufirst%3DS.%26aulast%3DBuckett%26aufirst%3DL.%2BK.%26aulast%3DButlin%26aufirst%3DR.%2BJ.%26aulast%3DDavies%26aufirst%3DR.%2BD.%2BM.%26aulast%3DEriksson%26aufirst%3DJ.%2BW.%26aulast%3DHammond%26aufirst%3DC.%2BD.%26aulast%3DHovland%26aufirst%3DR.%26aulast%3DJohannesson%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%2BJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DLindmark%26aufirst%3DB.%2BT.%26aulast%3DGutierrez%26aufirst%3DP.%2BM.%26aulast%3DNoeske%26aufirst%3DT.%2BA.%26aulast%3DNordin%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPetersson%26aufirst%3DA.%2BU.%26aulast%3DRedzic%26aufirst%3DA.%26aulast%3DTurnbull%26aufirst%3DA.%2BV.%26aulast%3DVinblad%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520Optimization%2520of%2520Pyrazinecarboxamide-Based%2520Inhibitors%2520of%2520Diacylglycerol%2520Acyltransferase%25201%2520%2528DGAT1%2529%2520Leading%2520to%2520a%2520Clinical%2520Candidate%2520Dimethylpyrazinecarboxamide%2520Phenylcyclohexylacetic%2520Acid%2520%2528AZD7687%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10610%26epage%3D10629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Coteron, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mazouni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belen Jimenez-Diaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span> </span><span class="NLM_article-title">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5540</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200592f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5540-5561&issue=15&author=J.+M.+Coteronauthor=M.+Marcoauthor=J.+Esquiviasauthor=X.+Dengauthor=K.+L.+Whiteauthor=J.+Whiteauthor=M.+Koltunauthor=F.+El+Mazouniauthor=S.+Kokkondaauthor=K.+Katneniauthor=R.+Bhamidipatiauthor=D.+M.+Shacklefordauthor=I.+Angulo-Barturenauthor=S.+B.+Ferrerauthor=M.+Belen+Jimenez-Diazauthor=F.-J.+Gamoauthor=E.+J.+Goldsmithauthor=W.+N.+Charmanauthor=I.+Bathurstauthor=D.+Floydauthor=D.+Matthewsauthor=J.+N.+Burrowsauthor=P.+K.+Rathodauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Structure-Guided+Lead+Optimization+of+Triazolopyrimidine-Ring+Substituents+Identifies+Potent+Plasmodium+falciparum+Dihydroorotate+Dehydrogenase+Inhibitors+with+Clinical+Candidate+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span></div><div class="casAuthors">Coteron, Jose M.; Marco, Maria; Esquivias, Jorge; Deng, Xiaoyi; White, Karen L.; White, John; Koltun, Maria; El Mazouni, Farah; Kokkonda, Sreekanth; Katneni, Kasiram; Bhamidipati, Ravi; Shackleford, David M.; Angulo-Barturen, Inigo; Ferrer, Santiago B.; Jimenez-Diaz, Maria Belen; Gamo, Francisco-Javier; Goldsmith, Elizabeth J.; Charman, William N.; Bathurst, Ian; Floyd, David; Matthews, David; Burrows, Jeremy N.; Rathod, Pradipsinh K.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5540-5561</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance.  In an effort to identify new potential antimalarials, we have undertaken a lead optimization program around our previously identified triazolopyrimidine-based series of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.  The X-ray structure of PfDHODH was used to inform the medicinal chem. program allowing the identification of a potent and selective inhibitor (DSM265) that acts through DHODH inhibition to kill both sensitive and drug resistant strains of the parasite.  This compd. has similar potency to chloroquine in the humanized SCID mouse P. falciparum model, can be synthesized by a simple route, and rodent pharmacokinetic studies demonstrated it has excellent oral bioavailability, a long half-life and low clearance.  These studies have identified the first candidate in the triazolopyrimidine series to meet previously established progression criteria for efficacy and ADME properties, justifying further development of this compd. toward clin. candidate status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpPPR2Tcs9rVg90H21EOLACvtfcHk0lhxA4yrv_fJ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D&md5=d92f71aeda04fbbbbcd8905a657df011</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1021%2Fjm200592f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200592f%26sid%3Dliteratum%253Aachs%26aulast%3DCoteron%26aufirst%3DJ.%2BM.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DBhamidipati%26aufirst%3DR.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%2BB.%26aulast%3DBelen%2BJimenez-Diaz%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DStructure-Guided%2520Lead%2520Optimization%2520of%2520Triazolopyrimidine-Ring%2520Substituents%2520Identifies%2520Potent%2520Plasmodium%2520falciparum%2520Dihydroorotate%2520Dehydrogenase%2520Inhibitors%2520with%2520Clinical%2520Candidate%2520Potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D15%26spage%3D5540%26epage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span> </span><span class="NLM_article-title">Metabolism-Guided Drug Design</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">652</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=631-652&issue=4&author=A.+F.+Stepanauthor=V.+Mascittiauthor=K.+Beaumontauthor=A.+S.+Kalgutkar&title=Metabolism-Guided+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMetabolism-Guided%2520Drug%2520Design%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D631%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">St Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">Mitigating Heterocycle Metabolism in Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">6002</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300343m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6002-6020&issue=13&author=D.+J.+St+Jeanauthor=C.+Fotsch&title=Mitigating+Heterocycle+Metabolism+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Mitigating Heterocycle Metabolism in Drug Discovery</span></div><div class="casAuthors">St. Jean, David J.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6002-6020</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Extensive data from metab. studies have allowed medicinal chemists to develop general principles for reducing compd. metab.  These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochem. of their compds.  While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compds.  If the specific site of metab. is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.  While several authors have reviewed these techniques for reducing metab., there is no review that summarizes different approaches to improving them metabolic stability of heterocycles.  In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability.  By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovQjdBBgXtPbVg90H21EOLACvtfcHk0lhxA4yrv_fJ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWhsL0%253D&md5=48c262556b8a2cc7dc5539ff91a53a71</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1021%2Fjm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26aulast%3DSt%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DMitigating%2520Heterocycle%2520Metabolism%2520in%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godowski, P. J.</span><span> </span><span class="NLM_article-title">Identification of Gas6 as a Ligand for Mer, a Neural Cell Adhesion Molecule Related Receptor Tyrosine Kinase Implicated in Cellular Transformation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2033-2039&issue=17&author=J.+Chenauthor=K.+Careyauthor=P.+J.+Godowski&title=Identification+of+Gas6+as+a+Ligand+for+Mer%2C+a+Neural+Cell+Adhesion+Molecule+Related+Receptor+Tyrosine+Kinase+Implicated+in+Cellular+Transformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCarey%26aufirst%3DK.%26aulast%3DGodowski%26aufirst%3DP.%2BJ.%26atitle%3DIdentification%2520of%2520Gas6%2520as%2520a%2520Ligand%2520for%2520Mer%252C%2520a%2520Neural%2520Cell%2520Adhesion%2520Molecule%2520Related%2520Receptor%2520Tyrosine%2520Kinase%2520Implicated%2520in%2520Cellular%2520Transformation%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26issue%3D17%26spage%3D2033%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Linger, R. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer</span> <span class="citation_source-journal">Adv. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2008&pages=35-83&author=R.+M.+A.+Lingerauthor=A.+K.+Keatingauthor=H.+S.+Earpauthor=D.+K.+Graham&title=TAM+Receptor+Tyrosine+Kinases%3A+Biologic+Functions%2C+Signaling%2C+and+Potential+Therapeutic+Targeting+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%2BA.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DTAM%2520Receptor%2520Tyrosine%2520Kinases%253A%2520Biologic%2520Functions%252C%2520Signaling%252C%2520and%2520Potential%2520Therapeutic%2520Targeting%2520in%2520Human%2520Cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2008%26volume%3D100%26spage%3D35%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vankayalapati, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearss, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span> </span><span class="NLM_article-title">Targeting Axl and Mer Kinases in Cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1763</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1535-7163.MCT-11-0116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=21933973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ylsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=1763-1773&author=A.+Vermaauthor=S.+L.+Warnerauthor=H.+Vankayalapatiauthor=D.+J.+Bearssauthor=S.+Sharma&title=Targeting+Axl+and+Mer+Kinases+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Axl and Mer Kinases in Cancer</span></div><div class="casAuthors">Verma, Anupam; Warner, Steven L.; Vankayalapati, Hariprasad; Bearss, David J.; Sharma, Sunil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1763-1773</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases (RTK) are cell-surface transmembrane receptors that contain regulated kinase activity within their cytoplasmic domain and play an important role in signal transduction in both normal and malignant cells.  The mammalian TAM RTK family includes 3 closely related members: Tyro-3, Axl, and Mer.  Overexpression or ectopic expression of the TAM receptors has been detected in a wide array of human cancers.  Growth arrest-specific gene 6 has been identified as the major ligand for these TAM RTKs, and its binding to the receptors has been shown to promote proliferation and survival of cancer cells in vitro.  Abnormal expression and activation of Axl or Mer can provide a survival advantage for certain cancer cells.  Inhibition of Axl and Mer may enhance the sensitivity of cancer cells to cytotoxic agents and would potentially be a therapeutic strategy to target cancer cells.  This review elucidates the role of Axl and Mer in normal cellular function and their role in oncogenesis.  In addn., we review the potential to inhibit these RTKs for the development of therapeutic targets in treatment of cancer.  Mol Cancer Ther; 10(10); 1763-73.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogR8epfrv2ArVg90H21EOLACvtfcHk0liU5nOqBmflLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ylsrfJ&md5=5048fdf6f6874a61bfbc6576db18d61c</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0116%26sid%3Dliteratum%253Aachs%26aulast%3DVerma%26aufirst%3DA.%26aulast%3DWarner%26aufirst%3DS.%2BL.%26aulast%3DVankayalapati%26aufirst%3DH.%26aulast%3DBearss%26aufirst%3DD.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%26atitle%3DTargeting%2520Axl%2520and%2520Mer%2520Kinases%2520in%2520Cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D1763%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtzberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span> </span><span class="NLM_article-title">Ectopic Expression of the Proto-Oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2662</span><span class="NLM_x">–</span> <span class="NLM_lpage">2669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1078-0432.CCR-05-2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=16675557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltlamsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2662-2669&issue=9&author=D.+K.+Grahamauthor=D.+B.+Salzbergauthor=J.+Kurtzbergauthor=S.+Satherauthor=G.+K.+Matsushimaauthor=A.+K.+Keatingauthor=X.+Y.+Liangauthor=M.+A.+Lovellauthor=S.+A.+Williamsauthor=T.+L.+Dawsonauthor=M.+J.+Schellauthor=A.+A.+Anwarauthor=H.+R.+Snodgrassauthor=H.+S.+Earp&title=Ectopic+Expression+of+the+Proto-Oncogene+Mer+in+Pediatric+T-Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia</span></div><div class="casAuthors">Graham, Douglas K.; Salzberg, Dana B.; Kurtzberg, Joanne; Sather, Susan; Matsushima, Glenn K.; Keating, Amy K.; Liang, Xiayuan; Lovell, Mark A.; Williams, Sara A.; Dawson, Thomas L.; Schell, Michael J.; Anwar, Adil A.; Snodgrass, H. Ralph; Earp, H. Shelton</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2662-2669</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The Mer receptor tyrosine kinase, cloned from a B-lymphoblastoid library, is the mammalian orthologue of the chicken retroviral oncogene v-eyk and sends antiapoptotic and transforming signals when activated.  To det. if Mer expression is ectopic in T-cell acute lymphoblastic leukemia (ALL) and potentially important in leukemogenesis, we analyzed Mer expression in normal human thymocytes and lymphocytes and in pediatric ALL patient samples.  Exptl. Design: Reverse transcription-PCR, flow cytometry, and immunohistochem. were used to det. expression of Mer in sorted human thymocyte populations, lymphocytes, and lymphocytes activated by phytohemagglutinin or phorbol 12-myristate 13-acetate/ionophore.  Mer expression in 34 T-cell ALL (T-ALL) patient samples was evaluated by reverse transcription-PCR, and Mer protein expression in a sep. cohort of 16 patient samples was assayed by flow cytometry and Western blot.  Results: Mer expression was absent in normal thymocytes or lymphocytes, and in T cells activated with phytohemagglutinin or phorbol 12-myristate 13-acetate/ionophore.  In contrast, Jurkat cells and T-ALL patient samples expressed unique 180 to 185 kDa Mer protein glycoforms.  Substantial Mer RNA levels were principally obsd. in a subset of T-ALL patient samples that expressed B220 (P = 0.004) but lacked surface expression of CD3 (P = 0.02) and CD4 (P = 0.006), a phenotypic profile consistent with immature lymphoblasts.  In addn., 8 of 16 T-ALL patient samples had Mer protein detected by flow cytometry and Western blot.  Conclusions: Transforming Mer signals may contribute to T-cell leukemogenesis, and abnormal Mer expression may be a novel therapeutic target in pediatric ALL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5MShoRa9blLVg90H21EOLACvtfcHk0lgy8PiylGKTyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltlamsrw%253D&md5=68f8310415b1984596118b40976cdd36</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-2208%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DKurtzberg%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMatsushima%26aufirst%3DG.%2BK.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DLiang%26aufirst%3DX.%2BY.%26aulast%3DLovell%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BL.%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DAnwar%26aufirst%3DA.%2BA.%26aulast%3DSnodgrass%26aufirst%3DH.%2BR.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26atitle%3DEctopic%2520Expression%2520of%2520the%2520Proto-Oncogene%2520Mer%2520in%2520Pediatric%2520T-Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26issue%3D9%26spage%3D2662%26epage%3D2669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lee-Sherick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGary, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsucker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Aberrant Mer Receptor Tyrosine Kinase Expression Contributes to Leukemogenesis in Acute Myeloid Leukemia</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">5359</span><span class="NLM_x">–</span> <span class="NLM_lpage">5368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=5359-5368&author=A.+Lee-Sherickauthor=K.+Eisenmanauthor=S.+Satherauthor=A.+McGranahanauthor=P.+Armisteadauthor=C.+McGaryauthor=S.+Hunsuckerauthor=J.+Schlegelauthor=H.+Martinsonauthor=C.+Cannonauthor=A.+K.+Keatingauthor=H.+S.+Earpauthor=X.+Liangauthor=D.+DeRyckereauthor=D.+K.+Graham&title=Aberrant+Mer+Receptor+Tyrosine+Kinase+Expression+Contributes+to+Leukemogenesis+in+Acute+Myeloid+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee-Sherick%26aufirst%3DA.%26aulast%3DEisenman%26aufirst%3DK.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DArmistead%26aufirst%3DP.%26aulast%3DMcGary%26aufirst%3DC.%26aulast%3DHunsucker%26aufirst%3DS.%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DMartinson%26aufirst%3DH.%26aulast%3DCannon%26aufirst%3DC.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DAberrant%2520Mer%2520Receptor%2520Tyrosine%2520Kinase%2520Expression%2520Contributes%2520to%2520Leukemogenesis%2520in%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D5359%26epage%3D5368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Linger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migdall-Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jedlicka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heasley, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=3420-3431&author=R.+M.+Lingerauthor=R.+A.+Cohenauthor=C.+T.+Cummingsauthor=S.+Satherauthor=J.+Migdall-Wilsonauthor=D.+H.+Middletonauthor=X.+Luauthor=A.+E.+Baronauthor=W.+A.+Franklinauthor=D.+T.+Merrickauthor=P.+Jedlickaauthor=D.+Deryckereauthor=L.+E.+Heasleyauthor=D.+K.+Graham&title=Mer+or+Axl+Receptor+Tyrosine+Kinase+Inhibition+Promotes+Apoptosis%2C+Blocks+Growth+and+Enhances+Chemosensitivity+of+Human+Non-Small+Cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DR.%2BA.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMigdall-Wilson%26aufirst%3DJ.%26aulast%3DMiddleton%26aufirst%3DD.%2BH.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DBaron%26aufirst%3DA.%2BE.%26aulast%3DFranklin%26aufirst%3DW.%2BA.%26aulast%3DMerrick%26aufirst%3DD.%2BT.%26aulast%3DJedlicka%26aufirst%3DP.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DHeasley%26aufirst%3DL.%2BE.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMer%2520or%2520Axl%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibition%2520Promotes%2520Apoptosis%252C%2520Blocks%2520Growth%2520and%2520Enhances%2520Chemosensitivity%2520of%2520Human%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D3420%26epage%3D3431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambade, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschos, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembath, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tentler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaishvili-Feinberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midkiff, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">MERTK Receptor Tyrosine Kinase Is a Therapeutic Target in Melanoma</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2257</span><span class="NLM_x">–</span> <span class="NLM_lpage">2267</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=2257-2267&issue=5&author=J.+Schlegelauthor=M.+J.+Sambadeauthor=S.+Satherauthor=S.+J.+Moschosauthor=A.+C.+Tanauthor=A.+Wingesauthor=D.+Deryckereauthor=C.+C.+Carsonauthor=D.+G.+Trembathauthor=J.+J.+Tentlerauthor=S.+G.+Eckhardtauthor=P.+F.+Kuanauthor=R.+L.+Hamiltonauthor=L.+M.+Duncanauthor=C.+R.+Millerauthor=N.+Nikolaishvili-Feinbergauthor=B.+R.+Midkiffauthor=J.+Liuauthor=W.+Zhangauthor=C.+Yangauthor=X.+Wangauthor=S.+V.+Fryeauthor=H.+S.+Earpauthor=J.+M.+Shieldsauthor=D.+K.+Graham&title=MERTK+Receptor+Tyrosine+Kinase+Is+a+Therapeutic+Target+in+Melanoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DSambade%26aufirst%3DM.%2BJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMoschos%26aufirst%3DS.%2BJ.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DCarson%26aufirst%3DC.%2BC.%26aulast%3DTrembath%26aufirst%3DD.%2BG.%26aulast%3DTentler%26aufirst%3DJ.%2BJ.%26aulast%3DEckhardt%26aufirst%3DS.%2BG.%26aulast%3DKuan%26aufirst%3DP.%2BF.%26aulast%3DHamilton%26aufirst%3DR.%2BL.%26aulast%3DDuncan%26aufirst%3DL.%2BM.%26aulast%3DMiller%26aufirst%3DC.%2BR.%26aulast%3DNikolaishvili-Feinberg%26aufirst%3DN.%26aulast%3DMidkiff%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DShields%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMERTK%2520Receptor%2520Tyrosine%2520Kinase%2520Is%2520a%2520Therapeutic%2520Target%2520in%2520Melanoma%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26issue%3D5%26spage%3D2257%26epage%3D2267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tworkoski, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchiocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D. F.</span><span> </span><span class="NLM_article-title">MERTK Controls Melanoma Cell Migration and Survival and Differentially Regulates Cell Behavior Relative to AXL</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1111%2Fpcmr.12110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=23617806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlalsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=527-541&issue=4&author=K.+A.+Tworkoskiauthor=J.+T.+Plattauthor=A.+Bacchiocchiauthor=M.+Bosenbergauthor=T.+J.+Boggonauthor=D.+F.+Stern&title=MERTK+Controls+Melanoma+Cell+Migration+and+Survival+and+Differentially+Regulates+Cell+Behavior+Relative+to+AXL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL</span></div><div class="casAuthors">Tworkoski, Kathryn A.; Platt, James T.; Bacchiocchi, Antonella; Bosenberg, Marcus; Boggon, Titus J.; Stern, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-541</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The receptor tyrosine kinase AXL regulates melanoma cell proliferation and migration.  We now demonstrate that AXL and the related kinase MERTK are alternately expressed in melanoma and are assocd. with different transcriptional signatures.  MERTK-pos. melanoma cells are more proliferative and less migratory than AXL-pos. melanoma cells and overexpression of AXL increases cell motility relative to MERTK.  MERTK is expressed in up to 50% of melanoma cells and shRNA-mediated knockdown of MERTK reduces colony formation and cell migration in a CDC42-dependent fashion.  Targeting MERTK also decreases cell survival and proliferation in an AKT-dependent manner.  Finally, we identify a novel mutation in the kinase domain of MERTK, MERTKP802S, that increases the motility of melanoma cells relative to wild-type MERTK.  Together, these data demonstrate that MERTK is a possible therapeutic target in melanoma, that AXL and MERTK are assocd. with differential cell behaviors, and that mutations in MERTK may contribute to melanoma pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNyjI7PbukObVg90H21EOLACvtfcHk0li33TwI4buQaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlalsLjE&md5=1207422adb7d06e7380fe02700e5634f</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1111%2Fpcmr.12110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcmr.12110%26sid%3Dliteratum%253Aachs%26aulast%3DTworkoski%26aufirst%3DK.%2BA.%26aulast%3DPlatt%26aufirst%3DJ.%2BT.%26aulast%3DBacchiocchi%26aufirst%3DA.%26aulast%3DBosenberg%26aufirst%3DM.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DStern%26aufirst%3DD.%2BF.%26atitle%3DMERTK%2520Controls%2520Melanoma%2520Cell%2520Migration%2520and%2520Survival%2520and%2520Differentially%2520Regulates%2520Cell%2520Behavior%2520Relative%2520to%2520AXL%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2013%26volume%3D26%26issue%3D4%26spage%3D527%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzmil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lino, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clement-Schatlo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Promotes Invasion and Survival in Glioblastoma Multiforme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">872</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=872-882&issue=7&author=Y.+Wangauthor=G.+Moncayoauthor=P.+Morinauthor=G.+Xueauthor=M.+Grzmilauthor=M.+M.+Linoauthor=V.+Clement-Schatloauthor=S.+Frankauthor=A.+Merloauthor=B.+A.+Hemmings&title=Mer+Receptor+Tyrosine+Kinase+Promotes+Invasion+and+Survival+in+Glioblastoma+Multiforme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMoncayo%26aufirst%3DG.%26aulast%3DMorin%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DGrzmil%26aufirst%3DM.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DClement-Schatlo%26aufirst%3DV.%26aulast%3DFrank%26aufirst%3DS.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Promotes%2520Invasion%2520and%2520Survival%2520in%2520Glioblastoma%2520Multiforme%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26issue%3D7%26spage%3D872%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rogers, A. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Inhibition Impedes Glioblastoma Multiforme Migration and Alters Cellular Morphology</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">38</span><span class="NLM_x">) </span> <span class="NLM_fpage">4171</span><span class="NLM_x">–</span> <span class="NLM_lpage">4181</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=4171-4181&issue=38&author=A.+E.+J.+Rogersauthor=J.+P.+Leauthor=S.+Satherauthor=B.+M.+Pernuauthor=D.+K.+Grahamauthor=A.+M.+Pierceauthor=A.+K.+Keating&title=Mer+Receptor+Tyrosine+Kinase+Inhibition+Impedes+Glioblastoma+Multiforme+Migration+and+Alters+Cellular+Morphology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DA.%2BE.%2BJ.%26aulast%3DLe%26aufirst%3DJ.%2BP.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DPernu%26aufirst%3DB.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DPierce%26aufirst%3DA.%2BM.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibition%2520Impedes%2520Glioblastoma%2520Multiforme%2520Migration%2520and%2520Alters%2520Cellular%2520Morphology%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26issue%3D38%26spage%3D4171%26epage%3D4181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickoloff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczyn, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran-Everett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGavran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltesen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Lymphoblastic Leukemia/Lymphoma in Mice Overexpressing the Mer (MerTK) Receptor Tyrosine Kinase</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">6092</span><span class="NLM_x">–</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=6092-6100&issue=45&author=A.+K.+Keatingauthor=D.+B.+Salzbergauthor=S.+Satherauthor=X.+Liangauthor=S.+Nickoloffauthor=A.+Anwarauthor=D.+Deryckereauthor=K.+Hillauthor=D.+Joungauthor=K.+K.+Sawczynauthor=J.+Parkauthor=D.+Curran-Everettauthor=L.+McGavranauthor=L.+Meltesenauthor=L.+Goreauthor=G.+L.+Johnsonauthor=D.+K.+Graham&title=Lymphoblastic+Leukemia%2FLymphoma+in+Mice+Overexpressing+the+Mer+%28MerTK%29+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DNickoloff%26aufirst%3DS.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DHill%26aufirst%3DK.%26aulast%3DJoung%26aufirst%3DD.%26aulast%3DSawczyn%26aufirst%3DK.%2BK.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DCurran-Everett%26aufirst%3DD.%26aulast%3DMcGavran%26aufirst%3DL.%26aulast%3DMeltesen%26aufirst%3DL.%26aulast%3DGore%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DLymphoblastic%2520Leukemia%252FLymphoma%2520in%2520Mice%2520Overexpressing%2520the%2520Mer%2520%2528MerTK%2529%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26issue%3D45%26spage%3D6092%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ware, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulcahy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorburn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1298</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1158%2F1535-7163.MCT-09-0707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=20423999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslektrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1298-1307&issue=5&author=A.+K.+Keatingauthor=G.+K.+Kimauthor=A.+E.+Jonesauthor=A.+M.+Donsonauthor=K.+Wareauthor=J.+M.+Mulcahyauthor=D.+B.+Salzbergauthor=N.+K.+Foremanauthor=X.+Liangauthor=A.+Thorburnauthor=D.+K.+Graham&title=Inhibition+of+Mer+and+Axl+Receptor+Tyrosine+Kinases+in+Astrocytoma+Cells+Leads+to+Increased+Apoptosis+and+Improved+Chemosensitivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity</span></div><div class="casAuthors">Keating, Amy K.; Kim, Grace K.; Jones, Ashley E.; Donson, Andrew M.; Ware, Kathryn; Mulcahy, Jean M.; Salzberg, Dana B.; Foreman, Nicholas K.; Liang, Xiayuan; Thorburn, Andrew; Graham, Douglas K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1298-1307</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Astrocytomas account for the majority of malignant brain tumors diagnosed in both adult and pediatric patients.  The therapies available to treat these neoplasms are limited, and the prognosis assocd. with high-grade lesions is extremely poor.  Mer (MerTK) and Axl receptor tyrosine kinases (RTK) are expressed at abnormally high levels in a variety of malignancies, and these receptors are known to activate strong antiapoptotic signaling pathways that promote oncogenesis.  In this study, the authors found that Mer and Axl mRNA transcript and protein expression were elevated in astrocytic patient samples and cell lines.  ShRNA-mediated knockdown of Mer and Axl RTK expression led to an increase in apoptosis in astrocytoma cells.  Apoptotic signaling pathways including Akt and extracellular signal-regulated kinase 1/2, which have been shown to be activated in resistant astrocytomas, were downregulated with Mer and Axl inhibition, whereas poly(ADP-ribose) polymerase cleavage was increased.  Furthermore, Mer and Axl shRNA knockdown led to a profound decrease of astrocytoma cell proliferation in soft agar and a significant increase in chemosensitivity in response to temozolomide, carboplatin, and vincristine treatment.  The authors' results suggest Mer and Axl RTK inhibition as a novel method to improve apoptotic response and chemosensitivity in astrocytoma and provide support for these oncogenes as attractive biol. targets for astrocytoma drug development.  Mol Cancer Ther; 9(5); 1298-307.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPZlqtANWfZbVg90H21EOLACvtfcHk0lg6wYbDkbsHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslektrY%253D&md5=04e8a0c70eba12c28f58a989131ab885</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0707%26sid%3Dliteratum%253Aachs%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DKim%26aufirst%3DG.%2BK.%26aulast%3DJones%26aufirst%3DA.%2BE.%26aulast%3DDonson%26aufirst%3DA.%2BM.%26aulast%3DWare%26aufirst%3DK.%26aulast%3DMulcahy%26aufirst%3DJ.%2BM.%26aulast%3DSalzberg%26aufirst%3DD.%2BB.%26aulast%3DForeman%26aufirst%3DN.%2BK.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DThorburn%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DInhibition%2520of%2520Mer%2520and%2520Axl%2520Receptor%2520Tyrosine%2520Kinases%2520in%2520Astrocytoma%2520Cells%2520Leads%2520to%2520Increased%2520Apoptosis%2520and%2520Improved%2520Chemosensitivity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D5%26spage%3D1298%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brandao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoph, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migdall-Wilson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span> </span><span class="NLM_article-title">Inhibition of MerTK Increases Chemosensitivity and Decreases Oncogenic Potential in T-Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Blood Cancer Journal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">e101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e101&issue=1&author=L.+Brandaoauthor=A.+Wingesauthor=S.+Christophauthor=S.+Satherauthor=J.+Migdall-Wilsonauthor=J.+Schlegelauthor=A.+McGranahanauthor=D.+Gaoauthor=X.+Liangauthor=D.+DeRyckere&title=Inhibition+of+MerTK+Increases+Chemosensitivity+and+Decreases+Oncogenic+Potential+in+T-Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrandao%26aufirst%3DL.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DChristoph%26aufirst%3DS.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DMigdall-Wilson%26aufirst%3DJ.%26aulast%3DSchlegel%26aufirst%3DJ.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DDeRyckere%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520MerTK%2520Increases%2520Chemosensitivity%2520and%2520Decreases%2520Oncogenic%2520Potential%2520in%2520T-Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DBlood%2520Cancer%2520Journal%26date%3D2013%26volume%3D3%26issue%3D1%26spage%3De101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Linger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee-Sherick, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGranahan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandão, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczyn, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span> </span><span class="NLM_article-title">Mer Receptor Tyrosine Kinase Is a Therapeutic Target in Pre-B Cell Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1599-1609&author=R.+M.+Lingerauthor=A.+B.+Lee-Sherickauthor=D.+Deryckereauthor=R.+A.+Cohenauthor=K.+M.+Jacobsenauthor=A.+McGranahanauthor=L.+Brand%C3%A3oauthor=A.+Wingesauthor=K.+K.+Sawczynauthor=X.+Liangauthor=A.+K.+Keatingauthor=A.+C.+Tanauthor=H.+S.+Earpauthor=D.+K.+Graham&title=Mer+Receptor+Tyrosine+Kinase+Is+a+Therapeutic+Target+in+Pre-B+Cell+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinger%26aufirst%3DR.%2BM.%26aulast%3DLee-Sherick%26aufirst%3DA.%2BB.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DCohen%26aufirst%3DR.%2BA.%26aulast%3DJacobsen%26aufirst%3DK.%2BM.%26aulast%3DMcGranahan%26aufirst%3DA.%26aulast%3DBrand%25C3%25A3o%26aufirst%3DL.%26aulast%3DWinges%26aufirst%3DA.%26aulast%3DSawczyn%26aufirst%3DK.%2BK.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26aulast%3DTan%26aufirst%3DA.%2BC.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26atitle%3DMer%2520Receptor%2520Tyrosine%2520Kinase%2520Is%2520a%2520Therapeutic%2520Target%2520in%2520Pre-B%2520Cell%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1599%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Knubel, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, A. K.</span><span> </span><span class="NLM_article-title">MerTK Inhibition is a Novel Therapeutic Approach for Glioblastoma Multiforme</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1338-1351&issue=5&author=K.+H.+Knubelauthor=B.+M.+Pernuauthor=A.+Sufitauthor=S.+Nelsonauthor=A.+M.+Pierceauthor=A.+K.+Keating&title=MerTK+Inhibition+is+a+Novel+Therapeutic+Approach+for+Glioblastoma+Multiforme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnubel%26aufirst%3DK.%2BH.%26aulast%3DPernu%26aufirst%3DB.%2BM.%26aulast%3DSufit%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DA.%2BM.%26aulast%3DKeating%26aufirst%3DA.%2BK.%26atitle%3DMerTK%2520Inhibition%2520is%2520a%2520Novel%2520Therapeutic%2520Approach%2520for%2520Glioblastoma%2520Multiforme%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D1338%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abu-Duhier, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodeve, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gari, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peake, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winship, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. T.</span><span> </span><span class="NLM_article-title">FLT3 Internal Tandem Duplication Mutations in Adult Acute Myeloid Leukaemia Define a High-Risk Group</span> <span class="citation_source-journal">Br. J. Hamaetol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1046%2Fj.1365-2141.2000.02317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=11091200" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2000&pages=190-195&issue=1&author=F.+M.+Abu-Duhierauthor=A.+C.+Goodeveauthor=G.+A.+Wilsonauthor=M.+A.+Gariauthor=I.+R.+Peakeauthor=D.+C.+Reesauthor=E.+A.+Vandenbergheauthor=P.+R.+Winshipauthor=J.+T.+Reilly&title=FLT3+Internal+Tandem+Duplication+Mutations+in+Adult+Acute+Myeloid+Leukaemia+Define+a+High-Risk+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2141.2000.02317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2141.2000.02317.x%26sid%3Dliteratum%253Aachs%26aulast%3DAbu-Duhier%26aufirst%3DF.%2BM.%26aulast%3DGoodeve%26aufirst%3DA.%2BC.%26aulast%3DWilson%26aufirst%3DG.%2BA.%26aulast%3DGari%26aufirst%3DM.%2BA.%26aulast%3DPeake%26aufirst%3DI.%2BR.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DVandenberghe%26aufirst%3DE.%2BA.%26aulast%3DWinship%26aufirst%3DP.%2BR.%26aulast%3DReilly%26aufirst%3DJ.%2BT.%26atitle%3DFLT3%2520Internal%2520Tandem%2520Duplication%2520Mutations%2520in%2520Adult%2520Acute%2520Myeloid%2520Leukaemia%2520Define%2520a%2520High-Risk%2520Group%26jtitle%3DBr.%2520J.%2520Hamaetol.%26date%3D2000%26volume%3D111%26issue%3D1%26spage%3D190%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kottaridis, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frew, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langabeer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstone, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linch, D. C.</span><span> </span><span class="NLM_article-title">The Presence of a FLT3 Internal Tandem Duplication in Patients with Acute Myeloid Leukemia (AML) Adds Important Prognostic Information to Cytogenetic Risk Group and Response to the First Cycle of Chemotherapy: Analysis of 854 Patients from the United Kingdom Medical Research Council AML 10 and 12 Trials</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=1752-1759&issue=6&author=P.+D.+Kottaridisauthor=R.+E.+Galeauthor=M.+E.+Frewauthor=G.+Harrisonauthor=S.+E.+Langabeerauthor=A.+A.+Beltonauthor=H.+Walkerauthor=K.+Wheatleyauthor=D.+T.+Bowenauthor=A.+K.+Burnettauthor=A.+H.+Goldstoneauthor=D.+C.+Linch&title=The+Presence+of+a+FLT3+Internal+Tandem+Duplication+in+Patients+with+Acute+Myeloid+Leukemia+%28AML%29+Adds+Important+Prognostic+Information+to+Cytogenetic+Risk+Group+and+Response+to+the+First+Cycle+of+Chemotherapy%3A+Analysis+of+854+Patients+from+the+United+Kingdom+Medical+Research+Council+AML+10+and+12+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKottaridis%26aufirst%3DP.%2BD.%26aulast%3DGale%26aufirst%3DR.%2BE.%26aulast%3DFrew%26aufirst%3DM.%2BE.%26aulast%3DHarrison%26aufirst%3DG.%26aulast%3DLangabeer%26aufirst%3DS.%2BE.%26aulast%3DBelton%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DH.%26aulast%3DWheatley%26aufirst%3DK.%26aulast%3DBowen%26aufirst%3DD.%2BT.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DGoldstone%26aufirst%3DA.%2BH.%26aulast%3DLinch%26aufirst%3DD.%2BC.%26atitle%3DThe%2520Presence%2520of%2520a%2520FLT3%2520Internal%2520Tandem%2520Duplication%2520in%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520%2528AML%2529%2520Adds%2520Important%2520Prognostic%2520Information%2520to%2520Cytogenetic%2520Risk%2520Group%2520and%2520Response%2520to%2520the%2520First%2520Cycle%2520of%2520Chemotherapy%253A%2520Analysis%2520of%2520854%2520Patients%2520from%2520the%2520United%2520Kingdom%2520Medical%2520Research%2520Council%2520AML%252010%2520and%252012%2520Trials%26jtitle%3DBlood%26date%3D2001%26volume%3D98%26issue%3D6%26spage%3D1752%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klimek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galinsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span> </span><span class="NLM_article-title">Patients with Acute Myeloid Leukemia and an Activating Mutation in FLT3 Respond to a Small-Molecule FLT3 Tyrosine Kinase Inhibitor, PKC412</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=54-60&issue=1&author=R.+M.+Stoneauthor=D.+J.+DeAngeloauthor=V.+Klimekauthor=I.+Galinskyauthor=E.+Esteyauthor=S.+D.+Nimerauthor=W.+Grandinauthor=D.+Lebwohlauthor=Y.+Wangauthor=P.+Cohenauthor=E.+A.+Foxauthor=D.+Neubergauthor=J.+Clarkauthor=D.+G.+Gillilandauthor=J.+D.+Griffin&title=Patients+with+Acute+Myeloid+Leukemia+and+an+Activating+Mutation+in+FLT3+Respond+to+a+Small-Molecule+FLT3+Tyrosine+Kinase+Inhibitor%2C+PKC412"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DKlimek%26aufirst%3DV.%26aulast%3DGalinsky%26aufirst%3DI.%26aulast%3DEstey%26aufirst%3DE.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DGrandin%26aufirst%3DW.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DFox%26aufirst%3DE.%2BA.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26atitle%3DPatients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520and%2520an%2520Activating%2520Mutation%2520in%2520FLT3%2520Respond%2520to%2520a%2520Small-Molecule%2520FLT3%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520PKC412%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D1%26spage%3D54%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DeAngelo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klisovic, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecerf, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karol, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span> </span><span class="NLM_article-title">Phase 1 Clinical Results with Tandutinib (MLN518), a Novel FLT3 Antagonist, In Patients with Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome: Safety, Pharmacokinetics, And Pharmacodynamics</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3674-3681&issue=12&author=D.+J.+DeAngeloauthor=R.+M.+Stoneauthor=M.+L.+Heaneyauthor=S.+D.+Nimerauthor=R.+L.+Paquetteauthor=R.+B.+Klisovicauthor=M.+A.+Caligiuriauthor=M.+R.+Cooperauthor=J.+M.+Lecerfauthor=M.+D.+Karolauthor=S.+Shengauthor=N.+Holfordauthor=P.+T.+Curtinauthor=B.+J.+Drukerauthor=M.+C.+Heinrich&title=Phase+1+Clinical+Results+with+Tandutinib+%28MLN518%29%2C+a+Novel+FLT3+Antagonist%2C+In+Patients+with+Acute+Myelogenous+Leukemia+or+High-Risk+Myelodysplastic+Syndrome%3A+Safety%2C+Pharmacokinetics%2C+And+Pharmacodynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeAngelo%26aufirst%3DD.%2BJ.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DHeaney%26aufirst%3DM.%2BL.%26aulast%3DNimer%26aufirst%3DS.%2BD.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKlisovic%26aufirst%3DR.%2BB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DLecerf%26aufirst%3DJ.%2BM.%26aulast%3DKarol%26aufirst%3DM.%2BD.%26aulast%3DSheng%26aufirst%3DS.%26aulast%3DHolford%26aufirst%3DN.%26aulast%3DCurtin%26aufirst%3DP.%2BT.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26atitle%3DPhase%25201%2520Clinical%2520Results%2520with%2520Tandutinib%2520%2528MLN518%2529%252C%2520a%2520Novel%2520FLT3%2520Antagonist%252C%2520In%2520Patients%2520with%2520Acute%2520Myelogenous%2520Leukemia%2520or%2520High-Risk%2520Myelodysplastic%2520Syndrome%253A%2520Safety%252C%2520Pharmacokinetics%252C%2520And%2520Pharmacodynamics%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26issue%3D12%26spage%3D3674%26epage%3D3681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knapper, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littlewood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kell, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">A Phase 2 Trial of the FLT3 Inhibitor Lestaurtinib (CEP701) as First-Line Treatment for Older Patients with Acute Myeloid Leukemia Not Considered Fit for Intensive Chemotherapy</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3262</span><span class="NLM_x">–</span> <span class="NLM_lpage">3270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2006&pages=3262-3270&issue=10&author=S.+Knapperauthor=A.+K.+Burnettauthor=T.+Littlewoodauthor=W.+J.+Kellauthor=S.+Agrawalauthor=R.+Chopraauthor=R.+Clarkauthor=M.+J.+Levisauthor=D.+Small&title=A+Phase+2+Trial+of+the+FLT3+Inhibitor+Lestaurtinib+%28CEP701%29+as+First-Line+Treatment+for+Older+Patients+with+Acute+Myeloid+Leukemia+Not+Considered+Fit+for+Intensive+Chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnapper%26aufirst%3DS.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DLittlewood%26aufirst%3DT.%26aulast%3DKell%26aufirst%3DW.%2BJ.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DA%2520Phase%25202%2520Trial%2520of%2520the%2520FLT3%2520Inhibitor%2520Lestaurtinib%2520%2528CEP701%2529%2520as%2520First-Line%2520Treatment%2520for%2520Older%2520Patients%2520with%2520Acute%2520Myeloid%2520Leukemia%2520Not%2520Considered%2520Fit%2520for%2520Intensive%2520Chemotherapy%26jtitle%3DBlood%26date%3D2006%26volume%3D108%26issue%3D10%26spage%3D3262%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pratz, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, S. M.</span><span> </span><span class="NLM_article-title">Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?</span> <span class="citation_source-journal">Curr. Opin. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1097%2FMOH.0000000000000022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=24468836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC2cXit12qt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=72-78&issue=2&author=K.+W.+Pratzauthor=S.+M.+Luger&title=Will+FLT3+inhibitors+fulfill+their+promise+in+acute+meyloid+leukemia%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?</span></div><div class="casAuthors">Pratz, Keith W.; Luger, Selina M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Hematology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-78</span>CODEN:
                <span class="NLM_cas:coden">COHEF4</span>;
        ISSN:<span class="NLM_cas:issn">1065-6251</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: 'FMS'-like tyrosine kinase 3 (FLT3) mutations in acute myeloid leukemia (AML) have been brought from discovery in the early 1990s to clin. targeting in the past 10 years.  Despite several promising leads in preclin. models, no agent has yet been approved for clin. use.  Here we will review the development of novel therapies for AML with FLT3 mutations.  Recent findings: Initial clin. development focused on broad kinase inhibitors which were found to have limited clin. activity due to insufficient kinase inhibitory activity and high toxicity.  Subsequent development has brought forth narrow-spectrum inhibitors with potent in-vivo activity and reasonable clin. tolerance, but many patients still progress with prolonged use.  Summary: The optimal role for targeting FLT3 may depend on multimodality therapy and will likely require hematopoietic transplant.  The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clin. care.  Strategies incorporating FLT3-targeted agents into AML therapy are ongoing, but challenges in trial design, clin. heterogeneity and need for long-term follow-up make these investigations complicated in design and implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhd0WIK8avjbVg90H21EOLACvtfcHk0lji_LGDk5aeNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXit12qt74%253D&md5=ab564d98a69f62226f0775c88e2eb106</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2FMOH.0000000000000022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOH.0000000000000022%26sid%3Dliteratum%253Aachs%26aulast%3DPratz%26aufirst%3DK.%2BW.%26aulast%3DLuger%26aufirst%3DS.%2BM.%26atitle%3DWill%2520FLT3%2520inhibitors%2520fulfill%2520their%2520promise%2520in%2520acute%2520meyloid%2520leukemia%253F%26jtitle%3DCurr.%2520Opin.%2520Hematol.%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D72%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korboukh, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200239k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=129-134&author=J.+Liuauthor=C.+Yangauthor=C.+Simpsonauthor=D.+DeRyckereauthor=D.+A.+Vanauthor=M.+J.+Mileyauthor=D.+Kireevauthor=J.+Norris-Drouinauthor=S.+Satherauthor=D.+Hunterauthor=V.+K.+Korboukhauthor=H.+S.+Patelauthor=W.+P.+Janzenauthor=M.+Machiusauthor=G.+L.+Johnsonauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Discovery+of+Small+Molecule+Mer+Kinase+Inhibitors+for+the+Treatment+of+Pediatric+Acute+Lymphoblastic+Leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fml200239k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200239k%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DSimpson%26aufirst%3DC.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DVan%26aufirst%3DD.%2BA.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKorboukh%26aufirst%3DV.%2BK.%26aulast%3DPatel%26aufirst%3DH.%2BS.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520Small%2520Molecule%2520Mer%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Pediatric%2520Acute%2520Lymphoblastic%2520Leukemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D129%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakody, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">UNC1062, a New and Potent Mer Inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=83-93&author=J.+Liuauthor=W.+Zhangauthor=M.+A.+Stashkoauthor=D.+DeRyckereauthor=C.+T.+Cummingsauthor=D.+Hunterauthor=C.+Yangauthor=C.+N.+Jayakodyauthor=N.+Chengauthor=C.+Simpsonauthor=J.+Norris-Drouinauthor=S.+Satherauthor=D.+Kireevauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=UNC1062%2C+a+New+and+Potent+Mer+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DCummings%26aufirst%3DC.%2BT.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DJayakody%26aufirst%3DC.%2BN.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DSimpson%26aufirst%3DC.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DUNC1062%252C%2520a%2520New%2520and%2520Potent%2520Mer%2520Inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D65%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRyckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">9683</span><span class="NLM_x">–</span> <span class="NLM_lpage">9692</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401387j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9683-9692&issue=23&author=W.+Zhangauthor=D.+Zhangauthor=M.+A.+Stashkoauthor=D.+DeRyckereauthor=D.+Hunterauthor=D.+Kireevauthor=M.+J.+Mileyauthor=C.+Cummingsauthor=M.+Leeauthor=J.+Norris-Drouinauthor=W.+M.+Stewartauthor=S.+Satherauthor=Y.+Zhouauthor=G.+Kirkpatrickauthor=M.+Machiusauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Pseudo-Cyclization+through+Intramolecular+Hydrogen+Bond+Enables+Discovery+of+Pyridine+Substituted+Pyrimidines+as+New+Mer+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fjm401387j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401387j%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeRyckere%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DCummings%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DW.%2BM.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKirkpatrick%26aufirst%3DG.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DPseudo-Cyclization%2520through%2520Intramolecular%2520Hydrogen%2520Bond%2520Enables%2520Discovery%2520of%2520Pyridine%2520Substituted%2520Pyrimidines%2520as%2520New%2520Mer%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9683%26epage%3D9692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIver, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stashko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deryckere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchford, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kireev, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris-Drouin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sather, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Paola, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machius, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earp, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Discovery of mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">9693</span><span class="NLM_x">–</span> <span class="NLM_lpage">9700</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4013888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9693-9700&issue=23&author=W.+Zhangauthor=A.+L.+McIverauthor=M.+A.+Stashkoauthor=D.+Deryckereauthor=B.+R.+Branchfordauthor=D.+Hunterauthor=D.+Kireevauthor=M.+J.+Mileyauthor=J.+Norris-Drouinauthor=W.+M.+Stewartauthor=M.+Leeauthor=S.+Satherauthor=Y.+Zhouauthor=J.+A.+Di+Paolaauthor=M.+Machiusauthor=W.+P.+Janzenauthor=H.+S.+Earpauthor=D.+K.+Grahamauthor=S.+V.+Fryeauthor=X.+Wang&title=Discovery+of+mer+Specific+Tyrosine+Kinase+Inhibitors+for+the+Treatment+and+Prevention+of+Thrombosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1021%2Fjm4013888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4013888%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMcIver%26aufirst%3DA.%2BL.%26aulast%3DStashko%26aufirst%3DM.%2BA.%26aulast%3DDeryckere%26aufirst%3DD.%26aulast%3DBranchford%26aufirst%3DB.%2BR.%26aulast%3DHunter%26aufirst%3DD.%26aulast%3DKireev%26aufirst%3DD.%26aulast%3DMiley%26aufirst%3DM.%2BJ.%26aulast%3DNorris-Drouin%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DW.%2BM.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSather%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDi%2BPaola%26aufirst%3DJ.%2BA.%26aulast%3DMachius%26aufirst%3DM.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DGraham%26aufirst%3DD.%2BK.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520mer%2520Specific%2520Tyrosine%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520and%2520Prevention%2520of%2520Thrombosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D23%26spage%3D9693%26epage%3D9700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler-Cole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span> </span><span class="NLM_article-title">Structural Insights into the Inhibited States of the Mer Receptor Tyrosine Kinase</span> <span class="citation_source-journal">J. Struct Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2009&pages=88-96&issue=2&author=X.+Huangauthor=P.+Finertyauthor=J.+R.+Walkerauthor=C.+Butler-Coleauthor=M.+Vedadiauthor=M.+Schapiraauthor=S.+A.+Parkerauthor=B.+E.+Turkauthor=D.+A.+Thompsonauthor=S.+Dhe-Paganon&title=Structural+Insights+into+the+Inhibited+States+of+the+Mer+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DFinerty%26aufirst%3DP.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DButler-Cole%26aufirst%3DC.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DS.%2BA.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DThompson%26aufirst%3DD.%2BA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26atitle%3DStructural%2520Insights%2520into%2520the%2520Inhibited%2520States%2520of%2520the%2520Mer%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Struct%2520Biol.%26date%3D2009%26volume%3D165%26issue%3D2%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Greshock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardwicke, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wooster, R.</span><span> </span><span class="NLM_article-title">Molecular Target Class Is Predictive of In vitro Response Profile</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3677</span><span class="NLM_x">–</span> <span class="NLM_lpage">3686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3677-3686&issue=9&author=J.+Greshockauthor=K.+E.+Bachmanauthor=Y.+Y.+Degenhardtauthor=J.+Jingauthor=Y.+H.+Wenauthor=S.+Eastmanauthor=E.+McNeilauthor=C.+Moyauthor=R.+Wegrzynauthor=K.+Augerauthor=M.+A.+Hardwickeauthor=R.+Wooster&title=Molecular+Target+Class+Is+Predictive+of+In+vitro+Response+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreshock%26aufirst%3DJ.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DDegenhardt%26aufirst%3DY.%2BY.%26aulast%3DJing%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DY.%2BH.%26aulast%3DEastman%26aufirst%3DS.%26aulast%3DMcNeil%26aufirst%3DE.%26aulast%3DMoy%26aufirst%3DC.%26aulast%3DWegrzyn%26aufirst%3DR.%26aulast%3DAuger%26aufirst%3DK.%26aulast%3DHardwicke%26aufirst%3DM.%2BA.%26aulast%3DWooster%26aufirst%3DR.%26atitle%3DMolecular%2520Target%2520Class%2520Is%2520Predictive%2520of%2520In%2520vitro%2520Response%2520Profile%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D9%26spage%3D3677%26epage%3D3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Howard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinkovic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800984v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=379-388&issue=2&author=S.+Howardauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=J.+Curryauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=L.+Fazalauthor=A.+L.+Gillauthor=M.+Heathcoteauthor=S.+Mamanauthor=J.+E.+Matthewsauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=D.+C.+Reesauthor=M.+Reuleauthor=D.+Tisiauthor=G.+Williamsauthor=M.+Vinkovicauthor=P.+G.+Wyatt&title=Fragment-Based+Discovery+of+the+Pyrazol-4-yl+urea+%28AT9283%29%2C+a+Multitargeted+Kinase+Inhibitor+with+Potent+Aurora+Kinase+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm800984v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800984v%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DS.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DCurry%26aufirst%3DJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DGill%26aufirst%3DA.%2BL.%26aulast%3DHeathcote%26aufirst%3DM.%26aulast%3DMaman%26aufirst%3DS.%26aulast%3DMatthews%26aufirst%3DJ.%2BE.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DTisi%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DFragment-Based%2520Discovery%2520of%2520the%2520Pyrazol-4-yl%2520urea%2520%2528AT9283%2529%252C%2520a%2520Multitargeted%2520Kinase%2520Inhibitor%2520with%2520Potent%2520Aurora%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D2%26spage%3D379%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Schroeder, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullo-Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manne, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801586s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1251-1254&issue=5&author=G.+M.+Schroederauthor=Y.+Anauthor=Z.+W.+Caiauthor=X.+T.+Chenauthor=C.+Clarkauthor=L.+A.+Corneliusauthor=J.+Daiauthor=J.+Gullo-Brownauthor=A.+Guptaauthor=B.+Henleyauthor=J.+T.+Huntauthor=R.+Jeyaseelanauthor=A.+Kamathauthor=K.+Kimauthor=J.+Lippyauthor=L.+J.+Lombardoauthor=V.+Manneauthor=S.+Oppenheimerauthor=J.+S.+Sackauthor=R.+J.+Schmidtauthor=G.+Shenauthor=K.+Stefanskiauthor=J.+S.+Tokarskiauthor=G.+L.+Trainorauthor=B.+S.+Wautletauthor=D.+Weiauthor=D.+K.+Williamsauthor=Y.+Zhangauthor=J.+Fargnoliauthor=R.+M.+Borzilleri&title=Discovery+of+N-%284-%282-amino-3-chloropyridin-4-yloxy%29-3-fluorophenyl%29-4-ethoxy-1-%284-fluorophenyl%29-2-oxo-1%2C2-dihydropyridine-3-carboxamide+%28BMS-777607%29%2C+a+Selective+and+Orally+Efficacious+Inhibitor+of+the+Met+Kinase+Superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm801586s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801586s%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DG.%2BM.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DX.%2BT.%26aulast%3DClark%26aufirst%3DC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DGullo-Brown%26aufirst%3DJ.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DLippy%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DManne%26aufirst%3DV.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DSchmidt%26aufirst%3DR.%2BJ.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DStefanski%26aufirst%3DK.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282-amino-3-chloropyridin-4-yloxy%2529-3-fluorophenyl%2529-4-ethoxy-1-%25284-fluorophenyl%2529-2-oxo-1%252C2-dihydropyridine-3-carboxamide%2520%2528BMS-777607%2529%252C%2520a%2520Selective%2520and%2520Orally%2520Efficacious%2520Inhibitor%2520of%2520the%2520Met%2520Kinase%2520Superfamily%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D5%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomioka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funakoshi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyota, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span> </span><span class="NLM_article-title">Foretinib (GSK1363089), a Multi-Kinase Inhibitor of MET and VEGFRs, Inhibits Growth of Gastric Cancer Cell Lines by Blocking Inter-Receptor Tyrosine Kinase Networks</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1352-1360&issue=4&author=Y.+Kataokaauthor=T.+Mukoharaauthor=H.+Tomiokaauthor=Y.+Funakoshiauthor=N.+Kiyotaauthor=Y.+Fujiwaraauthor=M.+Yashiroauthor=K.+Hirakawaauthor=M.+Hiraiauthor=H.+Minami&title=Foretinib+%28GSK1363089%29%2C+a+Multi-Kinase+Inhibitor+of+MET+and+VEGFRs%2C+Inhibits+Growth+of+Gastric+Cancer+Cell+Lines+by+Blocking+Inter-Receptor+Tyrosine+Kinase+Networks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DMukohara%26aufirst%3DT.%26aulast%3DTomioka%26aufirst%3DH.%26aulast%3DFunakoshi%26aufirst%3DY.%26aulast%3DKiyota%26aufirst%3DN.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DYashiro%26aufirst%3DM.%26aulast%3DHirakawa%26aufirst%3DK.%26aulast%3DHirai%26aufirst%3DM.%26aulast%3DMinami%26aufirst%3DH.%26atitle%3DForetinib%2520%2528GSK1363089%2529%252C%2520a%2520Multi-Kinase%2520Inhibitor%2520of%2520MET%2520and%2520VEGFRs%252C%2520Inhibits%2520Growth%2520of%2520Gastric%2520Cancer%2520Cell%2520Lines%2520by%2520Blocking%2520Inter-Receptor%2520Tyrosine%2520Kinase%2520Networks%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2012%26volume%3D30%26issue%3D4%26spage%3D1352%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Yan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peek, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajamie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidler, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huss, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konicek, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uhlik, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Um, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walgren, R. A.</span><span> </span><span class="NLM_article-title">LY2801653 is an Orally Bioavailable Multi-Kinase Inhibitor with Potent Activity against MET, MST1R, and Other Oncoproteins, And Displays Anti-Tumor Activities in Mouse Xenograft Models</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=833-844&issue=4&author=S.+B.+Yanauthor=V.+L.+Peekauthor=R.+Ajamieauthor=S.+G.+Buchananauthor=J.+R.+Graffauthor=S.+A.+Heidlerauthor=Y.+H.+Huiauthor=K.+L.+Hussauthor=B.+W.+Konicekauthor=J.+R.+Manroauthor=C.+Shihauthor=J.+A.+Stewartauthor=T.+R.+Stewartauthor=S.+L.+Stoutauthor=M.+T.+Uhlikauthor=S.+L.+Umauthor=Y.+Wangauthor=W.+Wuauthor=L.+Yanauthor=W.+J.+Yangauthor=B.+Zhongauthor=R.+A.+Walgren&title=LY2801653+is+an+Orally+Bioavailable+Multi-Kinase+Inhibitor+with+Potent+Activity+against+MET%2C+MST1R%2C+and+Other+Oncoproteins%2C+And+Displays+Anti-Tumor+Activities+in+Mouse+Xenograft+Models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DS.%2BB.%26aulast%3DPeek%26aufirst%3DV.%2BL.%26aulast%3DAjamie%26aufirst%3DR.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26aulast%3DGraff%26aufirst%3DJ.%2BR.%26aulast%3DHeidler%26aufirst%3DS.%2BA.%26aulast%3DHui%26aufirst%3DY.%2BH.%26aulast%3DHuss%26aufirst%3DK.%2BL.%26aulast%3DKonicek%26aufirst%3DB.%2BW.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DStewart%26aufirst%3DJ.%2BA.%26aulast%3DStewart%26aufirst%3DT.%2BR.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DUhlik%26aufirst%3DM.%2BT.%26aulast%3DUm%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DW.%2BJ.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DWalgren%26aufirst%3DR.%2BA.%26atitle%3DLY2801653%2520is%2520an%2520Orally%2520Bioavailable%2520Multi-Kinase%2520Inhibitor%2520with%2520Potent%2520Activity%2520against%2520MET%252C%2520MST1R%252C%2520and%2520Other%2520Oncoproteins%252C%2520And%2520Displays%2520Anti-Tumor%2520Activities%2520in%2520Mouse%2520Xenograft%2520Models%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2013%26volume%3D31%26issue%3D4%26spage%3D833%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Katz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarda, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lumb, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutterbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soisson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span> </span><span class="NLM_article-title">Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4108</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200112k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4092-4108&issue=12&author=J.+D.+Katzauthor=J.+P.+Jewellauthor=D.+J.+Guerinauthor=J.+Limauthor=C.+J.+Dinsmoreauthor=S.+V.+Deshmukhauthor=B.+S.+Panauthor=C.+G.+Marshallauthor=W.+Luauthor=M.+D.+Altmanauthor=W.+K.+Dahlbergauthor=L.+Davisauthor=D.+Falconeauthor=A.+E.+Gabardaauthor=G.+Hangauthor=H.+Hatchauthor=R.+Holmesauthor=K.+Kuniiauthor=K.+J.+Lumbauthor=B.+Lutterbachauthor=R.+Mathvinkauthor=N.+Nazefauthor=S.+B.+Patelauthor=X.+Quauthor=J.+F.+Reillyauthor=K.+W.+Rickertauthor=C.+Rosensteinauthor=S.+M.+Soissonauthor=K.+B.+Spencerauthor=A.+A.+Szewczakauthor=D.+Walkerauthor=W.+Wangauthor=J.+Youngauthor=Q.+Zeng&title=Discovery+of+a+5H-Benzo%5B4%2C5%5Dcyclohepta%5B1%2C2-b%5Dpyridin-5-one+%28MK-2461%29+Inhibitor+of+c-Met+Kinase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1021%2Fjm200112k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200112k%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BD.%26aulast%3DJewell%26aufirst%3DJ.%2BP.%26aulast%3DGuerin%26aufirst%3DD.%2BJ.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DPan%26aufirst%3DB.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DDavis%26aufirst%3DL.%26aulast%3DFalcone%26aufirst%3DD.%26aulast%3DGabarda%26aufirst%3DA.%2BE.%26aulast%3DHang%26aufirst%3DG.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DHolmes%26aufirst%3DR.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DLumb%26aufirst%3DK.%2BJ.%26aulast%3DLutterbach%26aufirst%3DB.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DQu%26aufirst%3DX.%26aulast%3DReilly%26aufirst%3DJ.%2BF.%26aulast%3DRickert%26aufirst%3DK.%2BW.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DSpencer%26aufirst%3DK.%2BB.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26atitle%3DDiscovery%2520of%2520a%25205H-Benzo%255B4%252C5%255Dcyclohepta%255B1%252C2-b%255Dpyridin-5-one%2520%2528MK-2461%2529%2520Inhibitor%2520of%2520c-Met%2520Kinase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D12%26spage%3D4092%26epage%3D4108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Frye, S. V.</span><span> </span><span class="NLM_article-title">The Art of the Chemical Probe</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1038%2Fnchembio.296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=20154659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=159-161&issue=3&author=S.+V.+Frye&title=The+Art+of+the+Chemical+Probe"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The art of the chemical probe</span></div><div class="casAuthors">Frye, Stephen V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-161</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. biologists frequently aim to create small-mol. probes that interact with a specific protein in vitro in order to explore the role of the protein in a broader biol. context (cells or organisms), but a common understanding of what makes a high-quality probe is lacking.  Here I propose a set of principles to guide probe qualification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7vDfsTLhqWrVg90H21EOLACvtfcHk0lgK18TCit74Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbg%253D&md5=b7b48c591a611b8686e11b3fc4f1b85c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.296%26sid%3Dliteratum%253Aachs%26aulast%3DFrye%26aufirst%3DS.%2BV.%26atitle%3DThe%2520Art%2520of%2520the%2520Chemical%2520Probe%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D159%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Microwave-Assisted, Divergent Solution-Phase Synthesis of 1,3,6-Trisubstituted Pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/doi/10.1021/co200039k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=414-420&issue=4&author=J.+Liuauthor=X.+Wang&title=Microwave-Assisted%2C+Divergent+Solution-Phase+Synthesis+of+1%2C3%2C6-Trisubstituted+Pyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Microwave-Assisted, Divergent Solution-Phase Synthesis of 1,3,6-Trisubstituted Pyrazolo[3,4-d]pyrimidines</span></div><div class="casAuthors">Liu, Jing; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">414-420</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A concise and highly divergent synthetic route has been developed to rapidly access 1,3,6-trisubstituted pyrazolopyrimidines.  The synthesis features a microwave assisted one-pot N1-alkylation/Suzuki-Miyaura reaction as the key step.  The sequence of the synthetic scheme can be varied to selectively modify the N1, C3, or C6 position at a late synthetic stage, thereby providing a highly efficient approach to explore the structure-activity relationships of pyrazolopyrimidine derivs.  The scope of these reactions has also been explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Nc3Hpg5qpLVg90H21EOLACvtfcHk0lgK18TCit74Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVSks7g%253D&md5=3d18c62b7d30fa69acfba01324fdbc44</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fco200039k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco200039k%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMicrowave-Assisted%252C%2520Divergent%2520Solution-Phase%2520Synthesis%2520of%25201%252C3%252C6-Trisubstituted%2520Pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2011%26volume%3D13%26issue%3D4%26spage%3D414%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Palmer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonagh, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Mourik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, M. V.</span><span> </span><span class="NLM_article-title">First-Principles Calculation of the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3322</span><span class="NLM_x">–</span> <span class="NLM_lpage">3337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ct300345m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2gsrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=3322-3337&issue=9&author=D.+S.+Palmerauthor=J.+L.+McDonaghauthor=J.+B.+Mitchellauthor=T.+van+Mourikauthor=M.+V.+Fedorov&title=First-Principles+Calculation+of+the+Intrinsic+Aqueous+Solubility+of+Crystalline+Druglike+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">First-Principles Calculation of the Intrinsic Aqueous Solubility of Crystalline Druglike Molecules</span></div><div class="casAuthors">Palmer, David S.; McDonagh, James L.; Mitchell, John B. O.; van Mourik, Tanja; Fedorov, Maxim V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3322-3337</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate that the intrinsic aq. soly. of cryst. druglike mols. can be estd. with reasonable accuracy from sublimation free energies calcd. using crystal lattice simulations and hydration free energies calcd. using the 3D Ref. Interaction Site Model (3D-RISM) of the Integral Equation Theory of Mol. Liqs. (IET).  The solubilities of 25 cryst. druglike mols. taken from different chem. classes are predicted by the model with a correlation coeff. of R = 0.85 and a root mean square error (RMSE) equal to 1.45 log10S units, which is significantly more accurate than results obtained using implicit continuum solvent models.  The method is not directly parametrized against exptl. soly. data, and it offers a full computational characterization of the thermodn. of transfer of the drug mol. from crystal phase to gas phase to dil. aq. soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo2R_l3phcErVg90H21EOLACvtfcHk0liZdVbad12gYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2gsrnE&md5=fbcfafe07e5f8ccb8acc2414bdb3a021</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fct300345m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300345m%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DD.%2BS.%26aulast%3DMcDonagh%26aufirst%3DJ.%2BL.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26aulast%3Dvan%2BMourik%26aufirst%3DT.%26aulast%3DFedorov%26aufirst%3DM.%2BV.%26atitle%3DFirst-Principles%2520Calculation%2520of%2520the%2520Intrinsic%2520Aqueous%2520Solubility%2520of%2520Crystalline%2520Druglike%2520Molecules%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26issue%3D9%26spage%3D3322%26epage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Veith, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fayne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artemenko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span> </span><span class="NLM_article-title">Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity Across Chemical Libraries</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1050</span><span class="NLM_x">–</span> <span class="NLM_lpage">1055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1050-1055&issue=11&author=H.+Veithauthor=N.+Southallauthor=R.+Huangauthor=T.+Jamesauthor=D.+Fayneauthor=N.+Artemenkoauthor=M.+Shenauthor=J.+Ingleseauthor=C.+P.+Austinauthor=D.+G.+Lloydauthor=D.+S.+Auld&title=Comprehensive+Characterization+of+Cytochrome+P450+Isozyme+Selectivity+Across+Chemical+Libraries"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeith%26aufirst%3DH.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DJames%26aufirst%3DT.%26aulast%3DFayne%26aufirst%3DD.%26aulast%3DArtemenko%26aufirst%3DN.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DComprehensive%2520Characterization%2520of%2520Cytochrome%2520P450%2520Isozyme%2520Selectivity%2520Across%2520Chemical%2520Libraries%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26issue%3D11%26spage%3D1050%26epage%3D1055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Diana, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudewicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draper, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutko, F. J.</span><span> </span><span class="NLM_article-title">Picornavirus Inhibitors: Trifluoromethyl Substitution Provides a Global Protective Effect against Hepatic Metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00008a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1355-1371&issue=8&author=G.+D.+Dianaauthor=P.+Rudewiczauthor=D.+C.+Pevearauthor=T.+J.+Nitzauthor=S.+C.+Aldousauthor=D.+J.+Aldousauthor=D.+T.+Robinsonauthor=T.+Draperauthor=F.+J.+Dutko&title=Picornavirus+Inhibitors%3A+Trifluoromethyl+Substitution+Provides+a+Global+Protective+Effect+against+Hepatic+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fjm00008a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00008a014%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DG.%2BD.%26aulast%3DRudewicz%26aufirst%3DP.%26aulast%3DPevear%26aufirst%3DD.%2BC.%26aulast%3DNitz%26aufirst%3DT.%2BJ.%26aulast%3DAldous%26aufirst%3DS.%2BC.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DRobinson%26aufirst%3DD.%2BT.%26aulast%3DDraper%26aufirst%3DT.%26aulast%3DDutko%26aufirst%3DF.%2BJ.%26atitle%3DPicornavirus%2520Inhibitors%253A%2520Trifluoromethyl%2520Substitution%2520Provides%2520a%2520Global%2520Protective%2520Effect%2520against%2520Hepatic%2520Metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26issue%3D8%26spage%3D1355%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+Some+Recent+Tactical+Application+of+Bioisosteres+in+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0liZdVbad12gYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520Some%2520Recent%2520Tactical%2520Application%2520of%2520Bioisosteres%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bach, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dmitrenko, O.</span><span> </span><span class="NLM_article-title">Strain Energy of Small Ring Hydrocarbons. Influence of C-H Bond Dissociation Energies</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4444</span><span class="NLM_x">–</span> <span class="NLM_lpage">4452</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja036309a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=4444-4452&issue=13&author=R.+D.+Bachauthor=O.+Dmitrenko&title=Strain+Energy+of+Small+Ring+Hydrocarbons.+Influence+of+C-H+Bond+Dissociation+Energies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja036309a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja036309a%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DR.%2BD.%26aulast%3DDmitrenko%26aufirst%3DO.%26atitle%3DStrain%2520Energy%2520of%2520Small%2520Ring%2520Hydrocarbons.%2520Influence%2520of%2520C-H%2520Bond%2520Dissociation%2520Energies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D13%26spage%3D4444%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wenglowsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahrendt, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloor, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, G.</span><span> </span><span class="NLM_article-title">Pyrazolopyridine Inhibitors of B-Raf <sup>V600E</sup>. Part 3: An Increase in Aqueous Solubility via the Disruption of Crystal Packing</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=912-915&issue=2&author=S.+Wenglowskyauthor=D.+Morenoauthor=J.+Rudolphauthor=Y.+Ranauthor=K.+A.+Ahrendtauthor=A.+Arrigoauthor=B.+Colsonauthor=S.+L.+Gloorauthor=G.+Hastings&title=Pyrazolopyridine+Inhibitors+of+B-Raf+V600E.+Part+3%3A+An+Increase+in+Aqueous+Solubility+via+the+Disruption+of+Crystal+Packing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DAhrendt%26aufirst%3DK.%2BA.%26aulast%3DArrigo%26aufirst%3DA.%26aulast%3DColson%26aufirst%3DB.%26aulast%3DGloor%26aufirst%3DS.%2BL.%26aulast%3DHastings%26aufirst%3DG.%26atitle%3DPyrazolopyridine%2520Inhibitors%2520of%2520B-Raf%2520V600E.%2520Part%25203%253A%2520An%2520Increase%2520in%2520Aqueous%2520Solubility%2520via%2520the%2520Disruption%2520of%2520Crystal%2520Packing%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D912%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Schuürer, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muskal, S. M.</span><span> </span><span class="NLM_article-title">Kinome-Wide Activity Modeling from Diverse Public High-Quality Data Sets</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci300403k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=27-38&issue=1&author=S.+C.+Schu%C3%BCrerauthor=S.+M.+Muskal&title=Kinome-Wide+Activity+Modeling+from+Diverse+Public+High-Quality+Data+Sets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fci300403k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci300403k%26sid%3Dliteratum%253Aachs%26aulast%3DSchu%25C3%25BCrer%26aufirst%3DS.%2BC.%26aulast%3DMuskal%26aufirst%3DS.%2BM.%26atitle%3DKinome-Wide%2520Activity%2520Modeling%2520from%2520Diverse%2520Public%2520High-Quality%2520Data%2520Sets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26issue%3D1%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kitagawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiwaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirii, Y.</span><span> </span><span class="NLM_article-title">Activity-Based Kinase Profiling of Approved Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1111%2Fgtc.12022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=23279183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlajurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=110-122&issue=2&author=D.+Kitagawaauthor=K.+Yokotaauthor=M.+Goudaauthor=Y.+Narumiauthor=H.+Ohmotoauthor=E.+Nishiwakiauthor=K.+Akitaauthor=Y.+Kirii&title=Activity-Based+Kinase+Profiling+of+Approved+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based kinase profiling of approved tyrosine kinase inhibitors</span></div><div class="casAuthors">Kitagawa, Daisuke; Yokota, Koichi; Gouda, Masaki; Narumi, Yugo; Ohmoto, Hiroshi; Nishiwaki, Eiji; Akita, Kensaku; Kirii, Yasuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">110-122</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The specificities of nine approved tyrosine kinase inhibitors (imatinib, dasatinib, nilotinib, gefitinib, erlotinib, lapatinib, sorafenib, sunitinib, and pazopanib) were detd. by activity-based kinase profiling using a large panel of human recombinant active kinases.  This panel consisted of 79 tyrosine kinases, 199 serine/threonine kinases, three lipid kinases, and 29 disease-relevant mutant kinases.  Many potential targets of each inhibitor were identified by kinase profiling at the Km for ATP.  In addn., profiling at a physiol. ATP concn. (1 mm) was carried out, and the IC50 values of the inhibitors against each kinase were compared with the estd. plasma-free concn. (calcd. from published pharmacokinetic parameters of plasma Ctrough and Cmax values).  This anal. revealed that the approved kinase inhibitors were well optimized for their target kinases.  This profiling also implicates activity at particular off-target kinases in drug side effects.  Thus, large-scale kinase profiling at both Km and physiol. ATP concns. could be useful in characterizing the targets and off-targets of kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUe0U00YKTHbVg90H21EOLACvtfcHk0lhyLVm-CihCkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlajurs%253D&md5=a30fd15aa57d46e7d6d461a80907e0e2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fgtc.12022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgtc.12022%26sid%3Dliteratum%253Aachs%26aulast%3DKitagawa%26aufirst%3DD.%26aulast%3DYokota%26aufirst%3DK.%26aulast%3DGouda%26aufirst%3DM.%26aulast%3DNarumi%26aufirst%3DY.%26aulast%3DOhmoto%26aufirst%3DH.%26aulast%3DNishiwaki%26aufirst%3DE.%26aulast%3DAkita%26aufirst%3DK.%26aulast%3DKirii%26aufirst%3DY.%26atitle%3DActivity-Based%2520Kinase%2520Profiling%2520of%2520Approved%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DGenes%2520Cells%26date%3D2013%26volume%3D18%26issue%3D2%26spage%3D110%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Anastassiadis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devarajan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. R.</span><span> </span><span class="NLM_article-title">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1045</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1038%2Fnbt.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=22037377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1039-1045&issue=11&author=T.+Anastassiadisauthor=S.+W.+Deaconauthor=K.+Devarajanauthor=H.+Maauthor=J.+R.+Peterson&title=Comprehensive+assay+of+kinase+catalytic+activity+reveals+features+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity</span></div><div class="casAuthors">Anastassiadis, Theonie; Deacon, Sean W.; Devarajan, Karthik; Ma, Haiching; Peterson, Jeffrey R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1039-1045</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Small-mol. protein kinase inhibitors are widely used to elucidate cellular signaling pathways and are promising therapeutic agents.  Owing to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases.  Interpretation of expts. that use these compds. is confounded by a lack of data on the comprehensive kinase selectivity of most inhibitors.  Here we used functional assays to profile the activity of 178 com. available kinase inhibitors against a panel of 300 recombinant protein kinases.  Quant. anal. revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity.  Many off-target interactions occur with seemingly unrelated kinases, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.  The results have implications for drug development and provide a resource for selecting compds. to elucidate kinase function and for interpreting the results of expts. involving kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUljWIhZGPkrVg90H21EOLACvtfcHk0lhyLVm-CihCkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisL7E&md5=b2f705509b0e09afa46b01d4669f0515</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2017%26sid%3Dliteratum%253Aachs%26aulast%3DAnastassiadis%26aufirst%3DT.%26aulast%3DDeacon%26aufirst%3DS.%2BW.%26aulast%3DDevarajan%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPeterson%26aufirst%3DJ.%2BR.%26atitle%3DComprehensive%2520assay%2520of%2520kinase%2520catalytic%2520activity%2520reveals%2520features%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26issue%3D11%26spage%3D1039%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the Reversible Inhibition of Enzyme-Catalysed Reactions by Tight-Binding Inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27a&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&issue=2&author=J.+F.+Morrison&title=Kinetics+of+the+Reversible+Inhibition+of+Enzyme-Catalysed+Reactions+by+Tight-Binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27aR"><div class="casContent"><span class="casTitleNuber">27a</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lhyLVm-CihCkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520Reversible%2520Inhibition%2520of%2520Enzyme-Catalysed%2520Reactions%2520by%2520Tight-Binding%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26issue%3D2%26spage%3D269%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of Enzyme Inhibitors in Drug Discovery. A guide for Medicinal Chemists and Pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=178-189&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibitors+in+Drug+Discovery.+A+guide+for+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520Enzyme%2520Inhibitors%2520in%2520Drug%2520Discovery.%2520A%2520guide%2520for%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D178%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500749d&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500749d&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500749d&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&issue=6&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.+D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+Situ+Kinase+Profiling+Reveals+Functionally+Relevant+Properties+of+Native+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0lgI1Byas4R9VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520Situ%2520Kinase%2520Profiling%2520Reveals%2520Functionally%2520Relevant%2520Properties%2520of%2520Native%2520Kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D6%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Walters, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffregen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span> </span><span class="NLM_article-title">RNAi-Induced down-Regulation of FLT3 Expression in AML Cell Lines Increases Sensitivity to MLN518</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2952</span><span class="NLM_x">–</span> <span class="NLM_lpage">2954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=2952-2954&issue=7&author=D.+K.+Waltersauthor=E.+P.+Stoffregenauthor=M.+C.+Heinrichauthor=M.+W.+Deiningerauthor=B.+J.+Druker&title=RNAi-Induced+down-Regulation+of+FLT3+Expression+in+AML+Cell+Lines+Increases+Sensitivity+to+MLN518"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DD.%2BK.%26aulast%3DStoffregen%26aufirst%3DE.%2BP.%26aulast%3DHeinrich%26aufirst%3DM.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26atitle%3DRNAi-Induced%2520down-Regulation%2520of%2520FLT3%2520Expression%2520in%2520AML%2520Cell%2520Lines%2520Increases%2520Sensitivity%2520to%2520MLN518%26jtitle%3DBlood%26date%3D2005%26volume%3D105%26issue%3D7%26spage%3D2952%26epage%3D2954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a href="/doi/suppl/10.1021/jm500749d">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27832"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and characterization of all compounds and biological methods. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500749d/suppl_file/jm500749d_si_001.pdf">jm500749d_si_001.pdf (636.11 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500749d&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-16%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm500749d%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500749d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ac808aa6f3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
